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ABSTRACT
Cell migration is a dynamic process essential for many fundamental physiological
functions, including wound repair and the immune response. Migration relies on precisely
orchestrated events that are regulated in a spatially and temporally controlled manner. Most
traditional approaches for studying migration, such as genetic methods or the use of chemical
inhibitors, do not offer insight into these important components of protein function. However,
chemical tools, which function on a more rapid timescale and in localized regions of the cell, are
capable of providing real-time information about protein activity. Herein, the development and
application of chemical approaches to investigate proteins central to cell migration are presented.
Myosin II, an ATPase motor protein required for cell motility, is activated by
phosphorylation of the associated myosin regulatory light chain (mRLC) protein at Serl9. To
generate a photoactivated mRLC variant that offers control over the timing and localization of
myosin activity, the mRLC has been prepared by expressed protein ligation for the site-specific
incorporation of 1-(2-nitrophenyl)ethyl (NPE)-caged phosphoserine at position 19. The NPE
caging group masks the phosphate functionality and inhibits protein function until irradiation at
365 nm releases the native phospho-mRLC to restore myosin activity. Introduction of the caged
mRLC into cells enables interrogation of the role of myosin in coordinating cell contractility.
To expand the scope of the caging approaches, the NPE caging group has been applied in
concert with the [7-(diethylamino)coumarin-4-yl]methyl (DEACM) group, which is released by
irradiation at 420 nm, to enable two different phosphopeptides to be sequentially released within
one system. Preparation of DEACM-caged phosphoamino acid building blocks for solid phase
peptide synthesis enables convenient incorporation of these residues into peptides and proteins.
This sequential uncaging approach has been exploited to initiate and subsequently inhibit a
biochemical reaction in an enzyme-independent fashion using two wavelengths of light.
Finally, a fluorogenic sensor to monitor the real-time activity of the GTPase Cdc42, an
essential regulator of migratory processes, has been developed. The solvatochromic fluorophore
4-N,N-dimethylamino-1,8-naphthalimide has been incorporated into a protein fragment that
binds only the activated conformation of Cdc42. This sensor reports Cdc42 activation through
significant increases in fluorescence and has been applied in a cellular context to monitor
endogenous Cdc42 activity. This fluorogenic sensor and the caging approaches together
demonstrate the power of chemical tools for interrogating diverse aspects of cell migration.
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Chapter 1 : Exploiting Chemical Biology for
Interrogating the Details of Cell Migration
Introduction
Cell migration is a complex process essential for many fundamental functions including
wound repair, the immune response, and embryogenesis. In addition to supporting normal
physiology, cell migration contributes to pathological processes including cancer metastasis,
vascular disease, and inflammatory conditions such as rheumatoid arthritis.1 Migration is a
highly dynamic process, governed by precisely coordinated protein interactions in specific
regions of the cell. In addition, the timing of gene transcription and protein activation and
2deactivation is tightly regulated at defined points of the migration cycle. Techniques to study
migration, including genetic approaches such as gene deletions, siRNA-knockdown of gene
expression, and site-directed mutagenesis, have revealed many details about the mechanisms
involved.3 However, migration and associated processes occur on the seconds to minutes
timescale, and genetic techniques, which act on the order of hours to days, preclude detailed
study of the temporal component of protein activity. The application of small molecule
inhibitors has also been used to provide information about protein function,4 but effects from
such inhibitors are global and cannot be localized to a specific region of the cell. In contrast to
these more conventional techniques, chemical approaches can be applied more rapidly and with
tunable effects.5 These technologies provide precise control over the location and timing of
protein activation, enabling elucidation of the spatial and temporal roles of the protein within a
complex network of interactions. Thus, methods drawing on chemical biology are poised to
make substantial contributions to the study of cell migration.
This chapter describes the steps involved in cell migration and highlights approaches that
have been developed to dissect the functions and interactions of proteins integral to the process.
Techniques that will be addressed include light-activated proteins, chemical genetics methods,
and fluorescent sensors of protein activity.
1.1 Cell Migration
Cell migration is an iterative process, characterized through five primary stages (Figure
1-1).1 First, upon exposure to a migration-inducing signal, the cell becomes polarized with a
distinct front (leading edge) and rear (trailing edge) (1). The cell then extends protrusions in the
direction of movement (2) and forms transient adhesions with the extracellular matrix (3)
through interactions between integrins and the actin network. The adhesions provide traction as
the cell body translocates forward (4). Finally, the adhesions at the rear of the cell are
disassembled, allowing the cell to advance forward (5).
1. PolarizationAdhesions
2. Extension
3. Adhesion Formation
4. Cell Body Translocation
5. Dissociation of the Rear
Figure 1-1. Steps of cell migration. Migration begins with polarization of the cell. The cell
then extends protrusions in the direction of migration. Adhesions to the extracellular matrix
provide the stabilizing forces for the cell to propel forward. The final step of the migration cycle
involves disassembly of adhesions at the rear of the cell.
Cell polarization is the first step in migration and results in an asymmetric distribution of
proteins to create distinct leading and trailing edges and to define the direction of migration.
Integrin receptors, the signaling molecule phosphatidylinositol (3,4,5)-triphosphate (PIP3), and
actin-regulating proteins, such as the GTPases Cdc42 and Rac, concentrate at the leading edge,
while myosin and the GTPase Rho accumulate toward the sides and rear of the cell.6
Additionally, the microtubule-organizing center is positioned in front of the nucleus, enabling
microtubules to grow toward the leading edge.7
Following the establishment of polarity, the cell extends protrusions at the leading edge
through formation of lamellopodia and filopodia (Figure 1-2). These protrusions are driven by
the actin network, which undergoes constant reorganization as migration progresses., 8 Thus,
this protrusive machinery is tightly regulated by actin-binding proteins, including the Arp2/3
complex, formins, and cofilin. Arp2/3, which is modulated by the small GTPases Rac and
Cdc42, binds along the actin filaments, thereby nucleating the growth of new branching
filaments and creating a broad network that comprises the lamellopodia.9 Alternatively, the cell
can extend finger-like filopodial extensions, mediated by parallel bundles of actin. Formins,
which are regulated by Cdc42, generate these structures by promoting polymerization at the
rapidly growing, or barbed, ends of actin filaments. In addition, cofilin contributes to actin
polymerization by severing the filaments to provide new sites of nucleation. This protein also
promotes dissociation of actin monomers at the slow-growing end to increase the pool of actin
available for polymerization at the barbed end.'
Direction of Migration
Figure 1-2. Actin dynamics at the leading edge of the cell. Filopodia formation is mediated by
Cdc42, while lamellopodia formation is controlled by Cdc42 and Rac1 through the Arp2/3
complex.
As the migrating cell extends protrusions, adhesions to the substrate are established.
Integrin receptors cluster into focal complexes by binding the extracellular matrix or other cells
and interacting with intracellular adaptor proteins, such as paxillin and talin, which bind actin
filaments within the cell. The integrin-mediated adhesions provide the mechanical support
necessary for the cell to propel forward.10 They function in concert with the ATPase motor
protein myosin 1I, which generates contractile forces by bundling actin filaments into stress
fibers.'1 Importantly, the adhesions also serve as signaling foci to facilitate communication
between the extracellular matrix and the cytoplasmic region of the cell. While the signaling
cascades at these hubs regulate migration, they also control cell proliferation, apoptosis, and
differentiation.10 The final step in migration, adhesion disassembly and rear retraction, is
controlled by multiple mechanisms, including mechanical contraction from myosin II motor
activity,' 2 phosphorylation by focal adhesion kinase (FAK) and Src, and proteolytic degradation
of proteins in the adhesion.' 3
1.2 Rho GTPases
In the development of tools to investigate migration, particular focus has been devoted to
examining the Rho-family GTPases, including RhoA, Rac1, and Cdc42, because of the
fundamental role that they play in orchestrating the process. Cycling between an inactive GDP-
bound state and an active GTP-bound state, these proteins function as molecular switches and
together regulate many aspects of the actin cytoskeleton.9 All three GTPases can be localized to
the membrane through prenylation of the cysteine residue within the C-terminal CAAX
sequence, where C is cysteine, A is an aliphatic residue, and X is any residue. Although these
GTPases can also be localized to the cytosol and to other organelles, in migration they are
activated at the membrane and exert effects there.' 4 In addition to this spatially controlled
regulation, the activities of these GTPases are highly coordinated through the action of many
accessory proteins (Figure 1-3). Guanine nucleotide exchange factors (GEFs) activate the
GTPases by promoting exchange of GDP for GTP, while GTPase activating proteins (GAPs)
accelerate the rate of intrinsic GTP hydrolysis to deactivate them. A third regulatory mechanism
occurs through guanine nucleotide dissociation inhibitors (GDIs), which inhibit GTPase
activation by preventing nucleotide exchange and by sequestering the proteins in the
cytoplasm.' 5
GDP
Figure 1-3. GTPase regulation by GEFs and GAPs. GEFs exchange GDP for GTP to activate
the GTPase, while GAPs accelerate the rate of intrinsic GTP hydrolysis. GDI sequesters the
GTPase in the cytoplasm to prevent activation.
The Rho GTPases in turn mediate cellular functions through interactions with over 60
known effector proteins, including kinases and scaffold proteins.'5 Both Cdc42 and Rac activate
the actin-regulating Arp2/3 complex to induce the assembly of branched actin filaments at the
leading edge of the cell. Additionally, Cdc42 induces formation of filopodia, whereas Rac
activation causes lamellopodial protrusions (Figure 1-2).9 RhoA activation is involved in
membrane protrusions,1 but it also leads to the formation of stress fibers and induces cell
contractility. In addition to these roles, the GTPases participate in signaling pathways and
control gene expression and cell cycle progression." 4
Although much is known about cell migration, recent advances in chemical biology have
enabled investigations of protein dynamics with greater resolution. A summary of the protein
targets and corresponding methods of study described in this chapter are provided in Table 1-1.
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Table 1-1. Summary of protein targets discussed in this chapter.
Protein Approach for Study
FAK Caged peptide
FKBP12-FRB system
Cofilin Caged protein
PKA Caged protein
mRLC Caged phosphoprotein
Paxillin Caged phosphoprotein
Raci Photoactivation
* LOV domain fusion
* FKF1 / GI system
* PhyB / PIF3 system
FKBP12-FRB system
Bimolecular FRET
Cdc42 Photoactivation: PhyB / PIF3
Biosensor designs
* Intramolecular FRET
* Merocyanine environment sensitive fluorophore
* 4-DMN environment sensitive fluorophore
Vinculin Intramolecular FRET
1.3 Light-Activated Proteins
Approaches in chemical biology have proven to be particularly valuable for gaining
insight into the transient protein-protein interactions that mediate migration. Many of these
techniques rely on the application of light-sensitive compounds to systematically control or
perturb cellular processes. The use of light activation provides unique advantages for
investigating complex signaling networks because it is noninvasive and affects only the
photoactivatable molecule in the cell. The light intensity and wavelength can be readily
controlled to enable dose-dependent activation and fine-tuning of the light-mediated event. The
localization of irradiation can be defined through the use of lasers or directed light sources to
produce activation at a particular region of a cell, allowing investigation of the spatial component
of protein function. 17 However, it must be noted that the effects of localized photoactivation
may not be apparent due to rapid diffusion and dilution of the activated molecule. 18 Thus, in
some cases, anchoring the light-sensitive protein at the plasma membrane or at an organelle can
better reveal the consequences of spatially defined uncaging. Light-activated proteins can be
chemically derived by appending an organic photolabile protecting group onto an essential
functionality of the protein,19 or the protein can be fused to a naturally occurring photoreceptor
domain.17 Both techniques have been successfully applied to interrogate processes in cell
migration.
1.3.1 Caged Peptides and Proteins
Caged peptides and proteins exploit the versatility of chemical synthesis for the study of
biological processes. With the caging technique, the functional portion of a signaling molecule
or the catalytic residue of a protein, for instance, is prepared with a covalently bound, photolabile
protecting group. This caging group renders the molecule inactive within the biological system.
However, upon irradiation, the mask is removed and the native active species is immediately
2
released, enabling the downstream effects of the molecule to be observed in real-time. 0 Figure
1-4 depicts an example of caging in which a phosphate is the key determinant for function, 2but
this technique can be applied to other functionalities, such as the side chain of cysteine,2 2
23 o 24 onserine, or lysine, or the protein backbone.2
The most commonly used caging groups are derived from the ortho-nitrobenzyl family.
Due to synthetic tractability, many analogs with variable photophysical properties have been
described,26 but the 1-(2-nitrophenyl)ethyl (NPE) group is particularly useful because it is
released at wavelengths that are compatible with cellular studies (365 nm). In addition, the
photobyproduct, nitrosoacetophenone, is less reactive than the nitrosobenzaldehyde released
upon photolysis of nitrobenzyl groups.27 More recently, caging groups from the coumarinly
family28, 29 and derivatives such as the nitrodibenzofuran chromophore30 for two-photon
uncaging have been developed for cellular applications. Caged peptides have been successfully
applied for the study of myosin light chain kinase (MLCK)31 and FAK,3 2 while caged proteins,
including cofilin, PKA,33 myosin regulatory light chain,34 and paxillin, 3 5 have been developed
to probe the cellular functions of these proteins.
0 2N
O=P-O O=P-0-
0 365 nm 0
Protein ~ NO O rti
Inactive Active
Figure 1-4. General caging strategy. Caging of an important functionality of a protein renders
the protein inactive within the biological system. Irradiation at 365 nm releases the caging group
to generate the active protein that can exert native effects within the system.
Caged Peptides
Caged peptides have been applied for cellular studies because they combine specificity
with synthetic accessibility. Peptide inhibitors of calmodulin and MLCK have been synthesized
with a-carboxyl 2'-nitrobenzyl tyrosine and have been used to investigate the role of myosin
phosphorylation during the migration of eosinophil (white blood) cells.? Irradiation of motile
eosinophils that had been microinjected with the caged peptides inhibited further migration,
implicating calmodulin-dependent MLCK and myosin II as essential components for
locomotion.
Another study used caged peptides for investigation of focal adhesion signaling. 32 Focal
adhesions connect the cell to the extracellular matrix and enable signaling between external
factors and cytoplasmic proteins.13 A central component of these structures is the non-receptor
tyrosine kinase FAK. Integrin clustering induces the autophosphorylation of FAK at Tyr397,
which recruits other proteins to create a signaling complex. FAK-mediated signal transduction
not only governs migratory processes but also influences cell growth and apoptosis.' 0
The role of FAK phosphorylation was investigated by the microinjection of caged
peptides based on the FAK autophosphorylation sequence.3 2 NPE-caged phosphotyrosine397
was incorporated into the peptides by Fmoc-based solid phase peptide synthesis using the
corresponding caged phosphorylated amino acid building block.36 Microinjection and uncaging
of these peptides within cells temporarily inhibited lamellar protrusions by competitively binding
FAK effectors such as Src and PI3K, which are necessary for proper migration (Figure 1-5a).
Subsequent dephosphorylation of the uncaged peptides by cellular phosphatases reversed the
effects of irradiation. This study illustrates an advantage of the caging technology because
although injection of the phosphorylated peptide induced an immediate response, the caged
peptides were inactive until irradiation and offered precise temporal control over phosphopeptide
release within the cell.
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Figure 1-5. Caged peptides and proteins for studying migration. a) NPE-caged pTyr397
peptide based on the FAK autophosphorylation sequence. Upon irradiation and uncaging, Src
and other effectors can bind the peptide and disrupt migration. b) Constitutively active cofilin
can be caged by reaction with a-bromo-(2-nitrophenyl)acetic acid. The caged protein mimics the
inactive phosphorylated protein. c) The multi-functional reagent for caging PKA. The PKA
binding peptide targets the reagent to PKA and positions the maleimide near Cys343 for
labeling. The QSY7 chromophore quenches fluorescence of the TAMRA fluorophore.
Uncaging releases the PKA inhibitor peptide and the quencher to restore PKA activity and to
generate a fluorescence signal. d) Incorporation of the caged mRLC into myosin eliminates
activity. Uncaging releases the native phosphoprotein to restore myosin function.
While the application of caged peptides has enabled the study of FAK phosphorylation
and MLCK activity during migration, this approach is limited by several drawbacks. With the
FAK study, for instance, the short peptides may not faithfully represent the specificity of the
corresponding protein in a cellular context and may interact with non-cognate binding partners.
Second, following irradiation, caged peptides generally function as inhibitors of the target
protein rather than as activators. Although this is useful in many situations, a more
O=P-0-
pY397
FAK (391 -40)
straightforward approach to examine the function of a protein of interest is to cage the full-length
protein itself. This allows irradiation to directly activate the protein and induce the native
downstream effects. Additionally, application of the full-length protein ensures that other
binding sites or signaling interactions are maintained. Caging of full-length proteins has been
achieved through site-specific cysteine labeling, though a more general approach exploits protein
semisynthesis.
Caged Proteins by Cysteine Labeling
Cysteine-targeted caging has been successfully employed to cage the actin-regulating
protein cofilin. 2  Cofilin is involved in the reorganization of actin networks, primarily by
severing actin filaments and creating new sites of nucleation for actin polymerization. As the
protein is deactivated by phosphorylation at Ser3, a photoactivated variant of this protein was
generated by selectively labeling a Ser3Cys mutant with a-bromo-(2-nitrophenyl)acetic acid
(Figure 1-5b). While the negatively charged caging group mimicked the phosphorylated residue
and rendered the protein inactive, irradiation released the constitutively active Ser3Cys protein.
Microinjection of the protein into cells and uncaging induced actin polymerization and cell
protrusions and, in contrast to previous studies, suggested that active cofilin is required for
migration.
The cysteine labeling methodology has recently been extended to cAMP-dependent
protein kinase (PKA), which contains multiple reactive residues.33 This kinase is involved in
signaling cascades governing many aspects of migration, including actin rearrangements, Rho
GTPases, and mRLC phosphorylation.37 The photoactivatable PKA was modified with a multi-
functional caging group, designed to liberate the active kinase upon irradiation and to
concomitantly generate a fluorescent signal to report successful photolysis (Figure 1-5c). With
this strategy, a short inhibitory peptide sequence targeted to PKA was elaborated with a caged
linker, a fluorophore-quencher pair, and an electrophilic maleimide. Binding of the peptide to
the enzyme positioned the maleimide near reactive Cys343 to promote alkylation with the caging
agent, thereby covalently tethering the peptide inhibitor to the protein. Microinjection of caged
PKA into cells and uncaging generated a fluorescent signal, released the inhibitor, and,
consistent with the role of PKA in cytoskeletal rearrangements, induced stress fiber degradation.
Caged Proteins by Semisynthesis
While cysteine labeling represents an efficient and direct approach for the attachment of
caging groups onto a protein, this strategy is not feasible when the essential residue cannot be
selectively targeted for reaction. In these cases, protein semisynthesis and native chemical
ligation can by exploited for the site-specific incorporation of unnatural residues into full-length
proteins (Figure 1-6).38 With this technique, a C-terminal peptide thioester reacts with a peptide
containing an N-terminal cysteine to generate a native amide bond between the two fragments.39
The portion of the protein containing the unnatural residue is prepared through solid phase
peptide synthesis, while the remainder of the protein is recombinantly expressed. Methods to
generate the N-terminal cysteine and C-terminal thioester by peptide synthesis or through protein
expression have been developed, enabling convenient incorporation of unnatural residues into
full-length proteins. However, as robust peptide synthesis is limited to chains of 40 to 50
residues, this approach is most convenient when the unnatural residue is incorporated near either
terminus of the protein.
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Figure 1-6. Mechanism of native chemical ligation. A C-terminal peptide thioester is reacted
with a peptide containing an N-terminal cysteine. Transthioesterification occurs until the
N-terminal cysteine reacts. A spontaneous S to N acyl shift generates the native amide bond
between the two fragments to yield the full-length protein. The unnatural residue can be
incorporated into either peptide fragment.
In this thesis, we have applied this semisynthetic technique to prepare a photoactivated
myosin (Figure 1-5d). Myosin II is an ATPase motor protein responsible for generating the
contractile forces necessary to initiate focal complex formation at the leading edge of a migrating
cell as well as to release adhesions at the rear. The protein complex is activated upon
phosphorylation of the associated myosin regulatory light chain (mRLC) protein at Serl9. To
directly probe the effects of myosin on cellular actin dynamics, a photoactivated variant of the
mRLC was generated through protein semisynthesis to install NPE-caged phosphoserine at
position 19.3 Following incorporation of this caged protein into the myosin complex, myosin
was inactive in the caged state, but activity was restored through irradiation and release of the
native phospho-mRLC (Figure 1-5d). When introduced into a cell, this protein tool can be used
to activate myosin to probe the localized effects of myosin contractility in real-time. These
studies are further detailed in Chapters 2 and 3 of this thesis.
Another attractive target for caging is paxillin, which is a multi-domain protein that
functions as a scaffold within focal adhesions to recruit proteins to control migration, cell
survival, and proliferation. Phosphorylation occurs throughout the molecule and creates docking
sites for other adaptor and regulatory proteins. For instance, phosphorylation at Tyr31 stimulates
the Rho GTPases Cdc42 and Rac1 through binding of GTPase regulatory proteins. These
GTPases in turn promote the formation of membrane protrusions and control focal adhesion
turnover.40 To interrogate the role of this protein in migration, and particularly the effect of
Tyr31 phosphorylation, paxillin was synthesized by native chemical ligation to incorporate NPE-
caged phosphotyrosine at position 31.35 The semisynthetic protein was tested to ensure that
binding to native protein partners was intact and that it remained a substrate for known kinases.
Irradiation released phospho-paxillin, validating the potential of the tool for unraveling signaling
pathways at focal adhesions. To further facilitate the semisynthesis, examinations into
heterologous expression of paxillin in E. coli are described in Appendix 1 of this thesis.
While protein semisynthesis has efficiently yielded caged proteins for probing various
aspects of migration, an alternative to this approach relies on in vivo amber suppression methods
41using evolved orthogonal tRNA/tRNA synthetase pairs specific for the unnatural amino acid.
Recent studies have shown that this system can be applied in mammalian cells to produce caged
proteins in situ.4 2, 43 While caged derivatives of lysine have been successfully incorporated in
HEK293 cells, the tRNA/tRNA synthetase pairs for caged serine and caged tyrosine44 have
been established for use in bacterial systems. This technology complements semisynthetic
approaches by providing an alternative route for the preparation and delivery of the caged
proteins. Specifically, a three-segment semisynthesis is required if the unnatural residue must be
incorporated in the middle of a protein because solid phase peptide synthesis is limited to
peptides of about 50 residues. 38 In contrast, with amber suppression, the unnatural residue may
be incorporated at any position within the protein. Additionally, semisynthetic proteins must be
introduced into cells through microinjection, which requires specialized equipment and restricts
the number of cells that can be analyzed, whereas the amber suppression technology eliminates
the need for external delivery methods. Despite these advantages, application of this technique
to any new unnatural amino acid requires evolution of a new tRNA/tRNA synthestase pair that is
compatible with mammalian expression. In addition, the amino acid must be non-toxic and
efficiently taken up into the cell.41 Finally, incomplete suppression and the formation of
truncated protein may introduce compounding effects. Nonetheless, this method, in combination
with semisynthetic approaches, offers flexibility for the preparation of protein tools for
investigating cell migration.
1.3.2 Photoreceptor Fusions
As a complementary approach to caging, plant photoreceptors have been adapted to
provide genetically encoded proteins that can be activated by light. 17  Proteins from the
phytochrome and phototropin classes respond to light through bound chromophores and undergo
reversible conformational changes upon irradiation. In plants, these proteins are involved in
mediating phototropism, the process of directional growth in response to light. While
phytochromes respond to red light through a bilin chromophore, phototropins bind flavins and
absorb blue light.45 Both families of protein domains have been engineered to enable
photoactivation of the Rho GTPases.
LOV Domain Fusions
Phototropins react to light through light-oxygen-voltage (LOV) domains, which bind
flavin mononucleotide and undergo a characteristic photocycle in which the protein forms a
noncovalent complex with FMN in the dark. Irradiation with light at 450 nm triggers the
formation of a covalent adduct through a cysteine residue of the LOV domain and the FMN
molecule. The bond formation induces a concomitant conformational change, in which an
associated a-helix, termed the Ja helix, is released and unwinds.46 Fusion of the LOV domain to
a protein at an appropriate position generates photo-dependent allosteric inhibition and can
render protein-protein interactions or activity sensitive to light. This approach has been
successfully applied for the generation of a photoactivated Rac 1.
The photoactivated Racl was created by fusing a LOV domain to a constitutively active
mutant of Rac1 (Figure 1-7a).47 In the dark state, the LOV domain sterically inhibits interactions
between Rac1 and effector proteins. However, upon irradiation at 458 or 473 nm, unwinding of
the Ja helix relieves inhibition and enables the active Racl to interact with native effectors.
When expressed in mammalian cells, brief laser pulses localized to specific regions at the edge
of the cell initiated protrusions and ruffling events, which were reversible and dependent on the
intensity of irradiation. In subsequent studies, this tool was applied to examine the role of Racl
during migration in more complex systems. In zebrafish neutrophils, localized Rac1 activation
48
enabled interactions with regulatory proteins to be examined, while application of the protein in
the Drosophila egg chamber allowed interrogation of the influence of the GTPase on coordinated
migration. 49 These studies together demonstrate that this tool can be exploited to extract detailed
information about Racl in live cells. Further investigation of the light-dependent dynamics of
the LOV domains has revealed mutations that can modulate the properties of the domains for
specific applications.50
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Figure 1-7. Light-activated Raci based on plant photoreceptors. a) Photoactivated Rac1 was
generated by fusing constitutively active Rac1 to the LOV domain. Irradiation causes the Ja
helix to unravel and allows effectors to bind Rac1. b) In the FKF1/GI system, irradiation at
450 nm recruits the FKF1-Racl construct to the membrane-bound GI protein. Because Rac1 is
active at the membrane, irradiation induces lamellopodia formation. c) The PhyB/PIF system
enables reversible activation of endogenous Rac1. Upon irradiation, the PJF-Tiam construct
binds to membrane-bound PhyB. This recruitment leads to Rac1 activation. Irradiation at
750 nm reverses the PhyB/PIF interaction.
In addition to the LOV domain fusion, two other photoreceptor systems, the flavin
binding, Kelch repeat, F-box1 (FKFl) / GIGANTEA (GI) system5' and the phytochrome B
(PhyB) / phytochrome interaction factor 3 (PIF3) system,5 2 have been engineered for
applications to control protein activity. For both protein pairs, irradiation induces binding
between the two partners: FKF1 and GI or PhyB and PIF3. Thus, fusion of these photoreceptor
domains to two proteins of interest enables irradiation to drive dimerization. Both systems have
been adapted for investigating the function of the GTPase Rac1 at the cell membrane. In these
studies, the photoreceptor domain is expressed with a C-terminal CAAX sequence to anchor the
module to the membrane, and the GTPase or a GTPase activating protein is fused to the
corresponding photoreceptor binding partner. This construct remains cytosolic until irradiation
promotes binding between the light-sensitive proteins and localizes the GTPase or activator to
the membrane. Because Rac1 is active primarily at the plasma membrane, light-mediated
recruitment stimulates lamellopodia formation.
FKF1/GI System
In the case of FKF1 and GI from Arabidopsis thaliana, exposure to blue light induces
dimerization (Figure 1-7b).5 FKF1 contains a LOV domain, and when irradiated, Cys91 forms
a covalent bond with FMN. The resulting conformational change enables the protein to bind the
nuclear protein GI. To create a tool for the study of Racl, the FKF1 and GI proteins were
engineered to remain cytosolic and to only dimerize when exposed to light, even if expressed at
high concentrations. Rac1, without the native C-terminal CAAX box, was expressed as a fusion
to FKFl, and a GI-mCherry-CAAX construct was co-expressed within the cell. Irradiation of
the entire cell or a localized region of the cell with 450 nm light resulted in recruitment of the
cytoplasmic FKFl-Racl to the membrane via the GI-mCherry-CAAX protein, thereby inducing
lamellipodia formation. Due to the long half-life of the FMN-FKF1 complex, sustained
interactions were achieved, though extended irradiation for 5 min was necessary. This strategy is
promising, but further improvements in the association and dissociation kinetics of the two
binding partners will create a system that can be more generally applied. Additionally, because
this approach relies on the interaction between two protein constructs, the expression levels must
be carefully controlled to ensure proper responses.
Phytochromes
In contrast to the LOV domains, phytochromes respond to red light when the associated
bilin chromophore undergoes a cis-to-trans isomerization. PhyB from A. thaliana covalently
binds the tetrapyrrole chromophore phycocyanobilin (PCB), which undergoes reversible
photoisomerization upon irradiation with red or near-infared light and mediates the transition of
PhyB between the red-absorbing (Pr) state and the far-red-absorbing (Pfr) state. The PIF3
protein binds PhyB only after it has absorbed 650 nm light and exists in the Pfr state, and in
plants, this heterodimer translocates from the cytoplasm to the nucleus to mediate gene
transcription. Spontaneous dissociation occurs over hours, but irradiation with infrared light
(750 nm) immediately reverses binding.45
The ability of the PhyB/PIF3 system to control protein-protein interactions was first
validated through an in vitro study using the Cdc42 GTPase and an effector binding domain. 54
In subsequent studies, the PhyB/PIF system was adapted for application in mammalian cells and
was optimized for reversible association on the seconds timescale.5 2 The protein binding pair
was then exploited for the light-driven recruitment of proteins to the plasma membrane. The
PhyB domain was expressed with a CAAX box, and the catalytic domain of the Rac GEF Tiam
was fused to the phytochrome-binding domain of PIF6 (Figure 1-7c). Cells were treated with
PCB and a patterned light source, which transmitted the deactivating infrared light to the entire
sample while focusing a red laser (-3 [tm) to a localized area of the cell. This patterning ensured
that the activated protein was present only in the desired region by deactivating molecules that
diffused away from that area. The 650-nm red laser initiated the PhyB(Prf)-PIF6 interaction to
recruit the Rac GEF to the membrane, thereby activating endogenous Racl to induce
lamellipodia formation. While this system offers the advantages of rapid interaction kinetics and
reversibility, the PCB cofactor, which is not produced in mammalian cells, must be isolated from
natural sources and added to the culture. Additionally, like the FKFl-GI system, the PhyB and
PIF6 fusions must be expressed at similar levels for robust responses.
Table 1-2. Comparison of methods for light-mediated protein function.
Approach Molecular Weight Reversible?
Caging Group 150 - 300 Da No
LOV Domain 16,000 Da Yes
FKF1/GI FKF1: 68,000 Da; GI: 129,000 Da Slowly
PhyB/PIF PhyB: 100,000 Da; PIF: 11,000 Da Immediately with infared light
Table 1-2 summarizes the approaches that have been described in the preceding sections.
Compared to small molecule caging techniques, the light-sensitive protein domains are
advantageous because they are genetically encoded and do not require complex delivery
methods. Second, unlike small molecule caged compounds that are irreversibly activated upon
irradiation, the activities of these proteins are generally reversible, and in the case of the
phytochromes, reversibility can even be controlled through application of far-red light (750 nm).
Finally, the wavelengths of photoreceptor activation are longer than those used for photolysis of
organic caging groups and generate less photodamage after repeated irradiation. However,
despite these advantages, the light-activated domains suffer from some drawbacks. In particular,
these proteins are large and in some cases, even larger than the protein being studied. This
additional steric bulk can disrupt native interactions or produce artificial effects. In this regard,
small molecule caging groups are superior, as they introduce far fewer structural perturbations.
Uncaging releases the native protein, which then maintains proper interactions and functions.
Nonetheless, both families of probes demonstrate great promise for exploring complex pathways.
As the technology expands, other migration-related targets beyond the small GTPases must be
addressed.
1.4 Chemical Inducers of Dimerization
The aforementioned methods exploit light to control protein-protein interactions and
activity. A complementary, small molecule-based approach that offers precise temporal control
over specific protein interactions is based on chemical inducers of dimerization (CID). This
technique exploits the natural product rapamycin, or chemically derived analogs, for
dimerization of two protein modules.5 5 Rapamycin is a macrolide natural product isolated from
the bacterium Streptomyces hygroscopicus and, with two binding domains, mediates interactions
between the mammalian protein FKBP12 and the FKBP-rapamycin-binding domain of mTor
(FRB).56 Rapamycin binds the 12 kDa FKBP with a KD of 0.2 nM,57 and this complex in turn
binds the 11 kDa FRB fragment with a KD of 4.2 nM.58 When these two protein fragments are
fused to two proteins of interest, addition of rapamycin leads to dimerization. This approach can
be used to recruit a protein to a particular region of the cell, or the technique can be exploited to
control protein activity. 59 Second-generation modifications of the CID technology improve
spatial control over protein dimerization through caging of rapamycin.60,61
Dimerization
The FKBP12-FRB system has been exploited to control the localization and activity of
small GTPases, including Raci, Cdc42, and RhoA, by recruiting them to cell membrane where
they induce lamellipodia, filopodia, or cell contraction, respectively. 62-64 In initial studies with
this system, a membrane receptor was fused to FKBP12, and Cdc42 was appended to FRB.
However, addition of rapamycin caused membrane protrusions only after the membrane-bound
receptors were artificially clustered using beads modified with antibodies to the receptors.62, 63
Since these reports, the efficiency of dimerization has been optimized.64 In particular, the Lyn
N-terminal sequence, a membrane targeting sequence, was fused to the FRB domain, and a
constitutively active form of Racl was expressed as a C-terminal fusion to a YFP-FKBP12
construct (Figure 1-8). Addition of a rapamycin analog, iRap, containing an indole modification,
recruited the YFP-FKBP12-Racl chimera to the FRB protein at the plasma membrane and
induced lamellipodia formation within minutes of iRap addition. In addition to recruitment of
the exogenous GTPase to the plasma membrane, activators of the GTPases could be fused to the
FKBP construct and translocated to the membrane to stimulate endogenous GTPases.
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Figure 1-8. Chemical inducers of dimerization. a) Rapamycin mediates recruitment of Rac1-
FKBP12 to membrane-bound FRB. b) Introduction of a caging group onto position C-40 of
rapamycin enables light-mediated dimerization. c) -An alternative caging strategy complexes
rapamycin with avidin to prevent it from diffusing into the cell. Irradiation and uncaging then
allows localized release of the dimerizer.
Control of Kinase Activity
Another application of the FKBP12-FRB system exploits rapamycin to directly initiate
kinase activity. A genetically encoded, chemically regulated FAK was developed and applied
for studies of this kinase in regulating membrane dynamics. 59 A truncated form of the FKBP12
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domain, iFKBP, was inserted into the conserved catalytic domain of FAK, and with the
increased conformational dynamics of the domain, kinase activity was significantly reduced.
Addition of rapamycin induced FRB binding to impart greater structural rigidity and restore
activity to near wildtype levels. This allosterically regulated protein was utilized for
investigating mechanisms by which FAK promotes increased motility in tumor cells. The
general approach was also shown to be suitable for the study of other protein kinases.
Caged Rapamycin
While the CID technology has proven useful in studies of FAK and other protein
interactions, spatial control over rapamycin release is not possible. In more recent studies,
precise temporal and spatial control of the FKBP12-FRB system has been conferred through the
development of caged rapamycin analogs.60 , 61 In an extension of the FAK study, the a-methyl-
6-nitropiperonyloxycarbonyl caging group was appended to the rapamycin molecule at position
C-40 (Figure 1-8b). 60 When the caged rapamycin was added to iFKBP-FAK and FRB, no
dimerization or kinase activation occurred. However, upon irradiation, the caging group was
released from the rapamycin molecule, allowing it to induce iFKBP-FRB dimerization to rescue
kinase activity. This system was then used to generate light-induced membrane protrusions in
mammalian cells.
Another study used a similar caging approach to control rapamycin-mediated membrane
recruitment, but because incorporation of a nitrobenzyl derivative at position C-40 did not
sufficiently inhibit FKBP12-FRB heterodimerization, the strategy was modified to prevent the
caged rapamycin from entering the cells before irradiation (Figure 1-8c). 61 The 4,5-dimethoxy
a-methyl nitrobenzyl group was derivatized with a biotin group, allowing formation of an
extracellular avidin complex and thereby preventing translocation of the caged molecule into
cells. Irradiation removed the caging group-biotin-avidin conjugate and released the free
rapamycin molecule, which could then diffuse into the cell and mediate dimerization. With this
system, irradiation of the caged rapamycin complex at an isolated area of the cell recruited an
FKBP-Rac GEF to membrane-targeted FRB and induced localized Racl activation and
membrane ruffling.
With the recent developments of caged rapamycin, the CID technology represents a
robust alternative to the light-activated protein systems. While the protein targets of the CID
methods extend beyond those of the photoreceptors, further development will be required for the
examination of more diverse events in migration. For example, these methodologies are well-
suited for the systematic study of signal transduction at focal adhesions because protein
recruitment to scaffolds such as paxillin is responsible for initiating signaling cascades. The CID
methods provide a convenient avenue for dictating these protein interactions.
1.5 Fluorescent Sensors of Protein Activity
In addition to enabling methods to precisely manipulate processes involved in cell
migration, chemical biology has also produced technologies that allow researchers to detect the
activity of a protein or process in real-time through fluorescence outputs. Monitoring the activity
of proteins within the cell is particularly important for deciphering localized and transient
activity that may not be apparent through traditional biochemical methods, such as Western
blotting, which average responses over a population of cells from a single time point.65 In fact,
more subtle aspects of protein signaling often vary between cells and even at the subcellular
level.66 The most common platform for visualizing protein activity within live cells is through
the use of genetically encoded fluorescence resonance energy transfer (FRET)-based sensors.
More recently, environment sensitive fluorophores have been demonstrated to be particularly
valuable in these applications. Like the light-activated proteins, the most common targets of
these sensors are the Rho GTPases.
1.5.1 FRET-Based Sensors
Sensors utilizing FRET have been developed for over 30 proteins involved in
migration.65 These sensors are based primarily on two general strategies (Figure 1-9a and Figure
1-9b). Intermolecular, or bimolecular, FRET relies on a protein of interest and an effector
domain partner that are each fused to a fluorescent protein. Upon activation of the protein of
interest, interactions with the binding partner occur, thereby bringing the two fluorescent proteins
closer together and increasing the FRET signal. In contrast, with intramolecular or unimolecular
FRET, the protein of interest and an effector binding domain are sandwiched between a pair of
fluorescent proteins. Activation of the sensor protein by endogenous signals within the cell
promotes binding with the tethered effector and alters the relative proximity of the two
fluorescent proteins to modulate the FRET signal. Selected examples of each FRET strategy will
be described, but more detailed reviews appear elsewhere.6s,67-69
a) Bimolecular FRET Strategy for Rac1
Low FRET
480 nm 508 nm 480 nm
rjj#* 568 nmRac1 Activation
GTP GDP
0 = Alexa Fluor 546
b) Intramolecular FRET Strategy for Cdc42
Low FRET
Cdc42 Activation
GTP GDP
High FRET
433 nm
CFP
Figure 1-9. Fluorescent sensors for GTPase activation. a) Bimolecular FRET strategy. Raci is
expressed as a fusion to GFP, and PAK is labeled with Alexa Fluor 546. Rac1 activation induces
PAK binding and increases the FRET signal. b) Unimolecular FRET strategy. A single protein
chain, in which Cdc42 and the CRIB binding domain are inserted between the CFP/YFP FRET
pair, is localized to the membrane. Cdc42 activation causes the CRIB domain to bind the
GTPases and increases the FRET signal.
Intermolecular FRET
A sensor for activated Rac 1 has been generated through the bimolecular FRET strategy.70
The Cdc42/Rac interactive binding (CRIB) domain of the PAK effector, which binds only the
High FRET
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GTP-bound, activated form of Rac1, was labeled with Alexa Fluor 546 and was microinjected
into cells that had been transfected with a GFP-Rac1 fusion construct (Figure 1-9a). An increase
in FRET was observed upon Rac1 activation due to binding of the two fluorescently labeled
proteins. This sensor system was used to decipher the spatial regulation of Rac1 activation by
Rho-GDI, which down-regulates the GTPase by sequestering it in the cytoplasm and preventing
effector binding.71 Although this probe has been used to uncover details about Rac1 regulation
and activity, the technique suffers drawbacks due to the bimolecular nature of the probe. First,
data analysis is complicated by the disparate subcellular localization of the two proteins.
Second, tight control over the levels of GFP-Racl and fluorescent PAK is necessary to ensure
that normal cellular processes are not disrupted by the presence of excessive probe. Finally, this
sensor does not measure endogenous Racl activation and instead relies on regulation of the
fluorescent Racl conjugate. To overcome issues with sensor localization and expression levels,
unimolecular FRET approaches have been developed.
Intramolecular FRET
The most common sensor design with the intramolecular FRET platform involves fusing
the protein of interest and an effector binding domain between a fluorescent protein FRET pair.
This design was used for sensors of activated Rac1 and Cdc42. In the case of Cdc42, a CRIB
72domain, which binds only activated Cdc42, was fused to the GTPase. YFP and CFP were
included at the N- and C-termini, respectively, and a CAAX box was appended at the C-terminus
of the sensor. Activation of Cdc42 by endogenous signals promoted binding of the tethered
CRIB domain to bring the two fluorescent proteins into closer proximity and increase the FRET
output. This probe could be applied to monitor Cdc42 activation at the leading edge of the cell
during migration.
A variation on intramolecular FRET has been applied to create a sensor to monitor the
tension across vinculin at focal adhesions. 73 Vinculin is a multi-domain protein that binds
integrins at the head domain and actin filaments through the tail domain. It is recruited to focal
adhesions and is subject to varying forces as a focal adhesion forms, matures, and
74disassembles. The sensor was constructed by introducing a flexible elastic domain between a
FRET pair, which was fused between the head and tail domains of the protein. When the protein
is under low tension, FRET is high, but as forces across the sensor increase, the elastic domain is
pulled apart, and FRET decreases. The sensor was calibrated to quantify cellular forces on the
pico-newton scale and was used to map local changes in tension during migration. The forces on
vinculin were high during focal adhesion assembly at the leading edge of the cell, but low
tension on vinculin correlated with focal adhesion disassembly at the trailing edge. 73
1.5.2 Environment Sensitive Fluorophores
Although FRET-based sensors have been successfully applied to probe processes in
migration, the use of environment sensitive fluorophores represents a complementary strategy for
monitoring protein-protein interactions. Environment sensitive fluorophores have emissive
properties that are sensitive to the polarity of the solvent environment. In an aqueous-solvated
state, fluorescence is low, but in a nonpolar environment, such as that at a protein-protein
binding interface, fluorescence intensities can increase significantly. Thus, when appropriately
positioned within a protein, these fluorophores can signal a binding interaction or conformational
rearrangement through a change in fluorescence.
The solvatochromic fluorophore strategy has been successfully applied to generate a
sensor for Cdc42. A merocyanine fluorophore, which undergoes a 12-fold increase in
fluorescence in DMF compared to methanol, 7 6 was attached to the CRIB domain of the Wiskott-
Aldrich Syndrome Protein (WASP) effector (Figure 1-10). Binding of the sensor to activated
Cdc42 positioned the fluorophore in a hydrophobic pocket and increased the emission intensity
of the fluorophore. Studies in vitro revealed a 3-fold increase in fluorescence in the presence of
the activated GTP-bound form of Cdc42 compared to the inactive GDP-bound form. The sensor
was then used to examine Cdc42 activation during cell adhesion and spreading and at the
77Golgi.
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Figure 1-10. Fluorogenic sensor for Cdc42. A sensor for Cdc42 activation can be constructed
by labeling the CRIB binding domain with an environment sensitive fluorophore. Fluorescence
is low when Cdc42 is bound to GDP, but increases when Cdc42 is activated. The structures of
the merocyanine and 4-DMN fluorophores are shown.
FRET-based sensors for RhoA and Racl have been combined with the merocyanine-
modified fluorogenic Cdc42 sensor to analyze the coordinated activities of these three GTPases
during cell protrusions.16 These studies revealed the timing and localization of GTPase
activation relative to membrane protrusions and showed that RhoA activity was directly
correlated with protrusions, whereas Cdc42 and Raci were active 40 s later and 2 [tm behind the
leading edge. This multiplexed approach demonstrates the power of fluorescent biosensors to
provide exquisitely detailed information about cellular processes.
In this thesis, we have expanded the utility of the fluorogenic Cdc42 sensor by
incorporating the 4-NN-dimethylamino-1,8-naphthalimide (4-DMN) fluorophore into the WASP
fragment (Figure 1-10). Compared to commercially available solvatochromic fluorophores,
4-DMN demonstrates much more dramatic increases in fluorescence intensity when positioned
in a hydrophobic binding pocket.78' 79 A panel of five Cdc42 sensor variants was generated
through cysteine labeling using 4-DMN a-bromoacetamide and maleimide reagents and through
protein semisynthesis to incorporate the 4-DMN amino acid.80 These studies revealed a
derivative that exhibits a 32-fold increase in fluorescence in the presence of active GTP-bound
Cdc42 compared to incubation with the inactive GDP-bound protein. An advantage of this
fluorophore over other dyes is that the sensor effectively acts as a "turn-on" switch for the
activated GTPase because background fluorescence is virtually non-existent. This property is
particularly promising for in vitro studies of Cdc42 or associated regulatory proteins as well as
for high-throughput screens of Cdc42 inhibitors. This work is described in greater detail in
Chapter 5 of this thesis.
While the synthesis and delivery of probes based on solvatochromic dyes are often more
challenging than methods for FRET-based sensors, the use of organic fluorophores offers many
advantages. FRET-based probes often suffer from the presence of high background fluorescence
and only modest signal increases upon a binding event or protein activation. In contrast, sensors
based on solvatochromic fluorophores exhibit high sensitivity to the solvent environment and
have the potential to yield fluorescence responses with a greater dynamic range. Additionally,
whereas the fluorescent proteins that are fused to the FRET-based sensors are large and can
disrupt native functions or introduce aberrant interactions, environment sensitive fluorophores
introduce minimal structural perturbations and require only one chromophore. Thus, further
studies must be performed to expand the applications of these solvatochromic dyes to exploit the
unique properties they offer.
Conclusions
The field of chemical biology offers biologists a multitude of technologies for
interrogating processes and proteins involved in cell migration. Many of these tools overcome
the drawbacks of traditional genetic approaches and the use of small molecule inhibitors by
increasing the resolution with which migration can be observed. Both the light-activated
proteins and the systems based on CID enable protein activation to be rapidly and directly
initiated, and these methods can also specify the subcellular region of investigation. The
fluorescent sensors of protein activation complement light- and chemical-mediated protein
regulation by allowing the real-time activity of these proteins to be directly visualized. The
fluorescent tools can be exploited together with the protein activation approaches, or they can be
used independently in native systems. Through these techniques, specific proteins are uniquely
targeted to offer information about their individual roles within the complex signaling networks
regulating migration. The studies described herein demonstrate the value of the approaches for
gaining time-resolved information about these dynamic interactions. Future improvements and
investigations must extend these technologies to new targets and will undoubtedly reveal greater
insights into cell migration.
Thesis Outlook
This thesis presents the development of chemical tools for studying proteins essential to
cell migration, including the myosin motor protein and the GTPase Cdc42. Chapter 2 details the
semisynthesis of the mRLC by expressed protein ligation for the site-specific incorporation of
phosphorylated and caged phosphorylated amino acid residues into the N-terminus of the protein.
The semisynthetic protein can be incorporated into the myosin complex, or the proteolytic
derivative heavy meromyosin, to investigate the effects of defined phosphorylation. In vitro
ATPase and sliding filament assays demonstrate that the caged mRLC enables irradiation to
drive myosin activation. Investigations of the semisynthetic protein are expanded in Chapter 3,
which describes cellular studies with the protein tool. Strategies to incorporate the caged protein
into cellular myosin and results of mRLC photoactivation are detailed.
In Chapter 4, the caging approach is extended beyond the investigation of only a single
caged species in an experiment. Application of the NPE caging group together with the
[7-(diethylamino)coumarin-4-yl]methyl (DEACM) group enables two phosphopeptides to be
sequentially released to initiate two separate processes in one system. The preparation of
DEACM-caged phosphoamino acid building blocks for Fmoc-based solid phase peptide
synthesis is presented, and then this system is exploited to control the initiation and inhibition of
a phosphatase reaction in a wavelength-dependent and enzyme-independent manner.
Finally, in contrast to studies in which light is used to manipulate biological systems,
Chapter 5 focuses on the development of a probe to monitor the activity of Cdc42 in real-time.
The environment sensitive fluorophore 4-DMN is incorporated into the WASP Cdc42 binding
domain, and dramatic increases in fluorescence are observed upon Cdc42 activation.
Additionally, preliminary studies in which this sensor is applied in a cellular context are
described. Collectively, this fluorogenic sensor and the caging approaches expand the repertoire
of tools available to examine processes in cell migration with exact spatial and temporal
resolution.
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Chapter 2: Light-Triggered Myosin
Activation for Probing Dynamic Cellular
Processes
A portion of the work described in this chapter has been published in
Goguen, B. N.; Hoffman, B. D.; Sellers, J. R.; Schwartz, M. A.; Imperiali, B. Light-Triggered
Myosin Activation for Probing Dynamic Cellular Processes. Angew. Chem. Int. Ed. 2011, In
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Introduction
Myosin I is an ATPase motor protein essential for many cellular functions including cell
migration' and division.2 During migration of nonmuscle cells, myosin modulates protrusions at
the leading edge and promotes retraction at the trailing edge,3 while during cytokinesis, myosin
is required for contraction of the cleavage furrow.4 For nonmuscle myosin, these varied
functions are regulated by phosphorylation of the associated myosin regulatory light chain
(mRLC) protein at Serl9, which activates the myosin complex to promote myosin assembly, cell
contractility, and stress fiber formation.' 6 Upon phosphorylation of the mRLC at both Thr18
and Serl9, these functions are further enhanced.7 The dramatic effects of phosphorylation can
also be recapitulated in vitro. Specifically, myosin and the proteolytic derivative heavy
meromyosin (HMM),8 which contains only one-third of the C-terminal myosin tail, exhibit low
in vitro activities when associated with the nonphosphorylated mRLC. Phosphorylation of Ser19
amplifies actin-activated ATPase activities 10 - 1000-fold, 9'1 0 and leads to myosin-mediated
actin translocation.11
While myosin has been studied extensively for almost five decades, questions
surrounding the dynamic interactions of the protein within live cells remain. Methods currently
used to study myosin and modulate activity include gene deletions or siRNA-mediated
knockdown of gene expression, 3 overexpression of kinases that phosphorylate the mRLC, 12,13
and small molecule inhibitors of myosin,14 mRLC kinases, 5,16 and myosin phosphatase.1 7 While
these methods have provided a wealth of valuable information about myosin, they do not enable
studies of the spatial dynamics of myosin regulation because localized activation cannot be
achieved. Additionally, genetic approaches provide imprecise temporal control over protein
function, preventing real-time studies of the protein. Thus, we sought to develop chemical tools
to overcome these drawbacks and enable direct and controlled myosin activation through a
photoactivated mRLC. With this approach, the mRLC is derived through protein semisynthesis,
and the light-mediated activation is achieved by the incorporation of a photolabile protecting
group, or "caging group," onto the essential phosphate of pSerl9 within the full-length mRLC.
The caging group masks the phosphate functionality and renders the protein biologically inactive
until irradiation removes the masking group and releases the active native phosphoprotein. By
using light as the trigger for phosphorylation, this strategy offers a kinase-independent method to
activate myosin with precise spatial and temporal resolution and enables researchers to obtain
real-time information about the downstream effects of myosin phosphorylation within a complex
network of interactions.'8
For these studies, we chose the 1-(2-nitrophenyl)ethyl (NPE) caging group, which has
been employed for cellular applications because it is efficiently released, under biologically-
compatible conditions, at 365 nm (Figure 2-1). Peptides and proteins containing NPE-caged
phosphorylated amino acids have been successfully exploited for the study of many diverse
19,20 .21 22 2
systems, 1 including paxillin, 14-3-3 binding proteins, and focal adhesion kinase.
Additionally, a general method for incorporating NPE-caged thiophosphoamino acids, which,
upon irradiation, function similarly to the corresponding phosphorylated species but with greater
resistance to phosphatases, has been reported and can be used for advancing studies of myosin.
O+O -N O ,OHN H H )
-O0 h0 0O=6-O- hv0-O O= -O-
O O O H*
Caged Phosphoprotein Aci-nitro Intermediate
-O,.+,0- 
_'0
O=P-O~ O0P- O=P-O~ 0-O! O O +I I N 0
Native Phosphoprotein Nitrosoacetophenone
Figure 2-1. Mechanism of NPE uncaging. Irradiation excites the NPE group and leads to
tautomerization to generate the aci-nitro intermediate. Cyclization and subsequent ring opening
release the free phosphoprotein and generate nitrosoacetophenone as a byproduct.
In this chapter, we report the development of a chemical approach to investigate myosin
function through the preparation of unnatural amino acid mutants of the mRLC. We present an
efficient semisynthesis of full-length mRLC through expressed protein ligation for the site-
specific incorporation of phosphorylation at Ser19 (pSerl9) and Thrl8 (pThrl8) and the genesis
of caged phosphoserine (cpSer) at position 19. In vitro assays of myosin and HMM activity with
these derivatives are then discussed. Specifically, the development of new caged derivatives,
guided by myosin ATPase assays, and then further validation in HMM ATPase and myosin
motility assays are detailed. We show that caging of pSerl9 eliminates myosin and HMM
activities, and irradiation releases the native phospho-mRLC to restore activity to nearly native
phosphorylated levels (Figure 2-2).
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Figure 2-2. Photoactivated mRLC. Installation of NPE-caged pSerl9 into the mRLC is
achieved by expressed protein ligation. The caging group masks the phosphate necessary for
myosin activation until irradiation releases it to generate the native phosphoprotein and restore
activity. The image was modified from Protein Data Bank file lWDC.
Results and Discussion
2.1 Protein Semisynthesis
In order to incorporate the phosphorylated or caged phosphorylated residues into the full-
length mRLC protein, a strategy for expressed protein ligation and native chemical ligation
(NCL) was developed (Figure 2-3). NCL is a chemoselective process in which a protein
segment carrying a C-terminal thioester undergoes trans-thioesterification with a protein
fragment containing an N-terminal cysteine. Once the N-terminal cysteine residue reacts, a
spontaneous S-to-N-acyl shift occurs to generate a native peptide bond between the two
fragments. 25  The mRLC is well-suited for semisynthesis by this method because
phosphothreonine and phosphoserine occur at positions 18 and 19, respectively. Variants of
these residues can be incorporated by Fmoc-based solid phase peptide synthesis (SPPS) into a
peptide thioester containing the N-terminal residues of the mRLC (residues 1 - 23). The
remainder of the protein, mRLC(25 - 171), with Met24Cys can be recombinantly expressed.
The ligation junction between Ala23 and Met24Cys was selected for two reasons. First, ligation
with an alanine at the C-terminus of the thioester is known to proceed efficiently,26 and second,
the Met24Cys mutation, which introduces the cysteine required for NCL, was not expected to
significantly disrupt protein function since Met24 is not known to be involved in
27 28phosphorylation-mediated regulation or kinase recognition. Additionally, to facilitate
isolation and purification of the semisynthetic protein, a FLAG epitope tag (sequence =
DYKDDDDK) was included by SPPS at the N-terminus of the peptide and a C-terminal
hexahistidine tag was fused to the expressed protein fragment.
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Figure 2-3. Synthesis of the mRLC by native chemical ligation to incorporate phosphorylated or
caged phosphorylated residues at Thr18 or Serl9. The N-terminus is synthesized by solid phase
peptide synthesis, and the C-terminal residues are recombinantly expressed. The key native
chemical ligation reaction between these two fragments generates the full-length protein.
To probe the effects of phosphorylation at discrete sites of the mRLC, the protein was
synthesized with no phosphorylation (2-1) and with pSer19 (2-2), pThrl8 (2-3), and pThrl8
pSerl9 (2-4). Caged derivatives that were examined include NPE-cpSerl9 (2-5), NPE-caged
thiophosphoserine19 (NPE-c(S)pSerl9, 2-6), [7-(diethylamino)coumarin-4-yl]methyl
(DEACM)-cpSerl9 (2-7), double NPE-cpSerl9 (2-8), and guanidinium-modified carboxy-
nitrobenzyl (CNB)-cpSerl9 (2-9) (Table 2-1).
The development of these new caged derivatives was motivated by efforts to optimize the
outcome with myosin ATPase assays. However, these caged compounds are valuable in their
own right because of the unique structural or photophysical properties they offer. In particular,
the NPE-caged thiophosphate, as in 2-6, proved to be very useful for cellular studies because the
released thiophosphoprotein is more resistant to phosphatases than the corresponding protein
phosphate, thus extending the time over which the effects of uncaging can be studied. Similarly,
the DEACM group, as applied in mRLC 2-7, is released at longer wavelengths compared to the
NPE group (410 nm vs. 365 nm), making it valuable for studies in cellular systems that are
sensitive to UV irradiation. Finally, we expect the double caged phosphate from 2-8 to be
generally applicable in situations in which the presence of only one caging group does not fully
suppress activity.
Table 2-1. Semisynthetic mRLC Derivatives.
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The N-terminal fragment of the protein (residues 1 - 23) containing the phosphorylated
or caged phosphorylated Thr18 or Serl9 was synthesized by Fmoc-based SPPS on highly acid-
labile carboxytrityl-linked (NovaSyn-TGT) resin2 9 preloaded with an alanine residue. Once
peptide elongation was complete, the peptide was cleaved from the resin under mildly acidic
conditions (0.5% TFA in CH 2Cl2), which maintained the amino acid side chain protecting
groups. The C-terminal acid of the peptide was converted to the corresponding thioester by
treatment with benzyl mercaptan, HATU, HOAt, and collidine (Scheme 2-1). Although initial
thioesterification conditions induced 40% epimerization of the C-terminal alanine residue as
observed through HPLC analysis, modification of the conditions and activating agents reduced
epimerization to about 6% in model studies. The reaction conditions and resulting
diastereomeric ratios are given in Table 2-2. Global deprotection of the peptide was performed
following the thioesterification, and purification of the desired thioester peptide was achieved by
reversed phase HPLC.
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Scheme 2-1. Synthesis of the C-terminal mRLC thioester.
Table 2-2. Reaction Conditions for Peptide Thioesterification.
Test Peptide: Ac-Ser-Asn-Val-Phe-Ala-COOH
Trial Activating Agent Benzyl mercaptan Base Solvent DAla:LAIa
1 PyBOPa (4 eq.) 4 eq. DIPEAa (8 eq.) DMF 40:60
2 HATUa (4 eq.) 4 eq. DIPEA (8 eq.) DMF 42:58
3 PyBOP (4 eq.) 4 eq. DIPEA (8 eq.) DCM 38:62
4 PyBOP (3 eq.) 3 eq. DIPEA (3 eq.) DCM 37:63
5 PyBOP (3 eq.) 25 eq. DIPEA (1.5 eq.) DCM 37:63
6 PyBOP (4 eq.) 25 eq. DIPEA (3 eq.) DMF 7:93
7 HATU/HOAta (4 eq.) 8 eq. Collidine (8 eq.) DCM 6:94
[a]: PyBOP, benzotriazole-1-yl-oxy-tris-pyrrolidino-phosphonium hexafluorophosphate;
DIPEA, NN-diisopropylethylamine; HATU, 0-(7-azabenzotriazol-1 -yl)-N,N,N',N'-tetramethyluronium
hexafluorophosphate; HOAt, 1-hydroxy-7-azabenzotriazole.
The syntheses of the thioester peptides for mRLC analogs 2-5 and 2-6 employed the
corresponding amino acid building blocks N-a-Fmoc-phospho(1-nitrophenylethyl-2-cyanoethyl)-
L-serine30 (Figure 2-4, 2-14) and N-a-Fmoc-phosphorothioyl(1-nitrophenylethyl-2-cyanoethyl)-
L-serine (Figure 2-4, 2-15),24 respectively. The synthesis of the DEACM-cpSer building block
(Figure 2-4, 2-16) for derivative 2-7 is described in Chapter 4.
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Figure 2-4. Structures of caged phosphoamino acid building blocks for Fmoc-based solid phase
peptide synthesis.
For mRLC 2-8, the incorporation of the double-caged phosphate into the peptide as a
building block was not feasible because the basicity of the Fmoc deprotection steps would lead
to p-elimination of the phosphotriester of serine and yield the dehydroalaninyl peptide. In
contrast, an attractive approach for the incorporation of the double-caged phosphate involved
reaction of the free oxyanion of the single NPE-caged phosphate with
1-(2-nitrophenyl)diazoethane (Scheme 2-2), which has been widely used in the syntheses of
NPE-caged ATPh and cAMP.32 The reaction was performed on the full-length protected peptide
before cleavage from the resin. Two sequential treatments with 20 equivalents of
1-(2-nitrophenyl)diazoethane (2-19) in a 1:1 mixture of DMSO:DMF resulted in about 60%
conversion to the double caged peptide (2-21). Following thioesterification and side chain
deprotection, RP-HPLC purification facilitated efficient separation of the single and double
caged peptide thioesters. The phosphotriester was found to be stable for synthesis and analysis.
a) Synthesis of 1-(2-nitrophenyl)diazoethane
SN 'NH 2  tN
NO2 H2N-NH2  NO2 MnO2 , NO2
DMSO
2-17 2-18 2-19
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Scheme 2-2. Synthetic route to the double NPE-caged pSer19 peptide thioester (2-23).
In the case of mRLC analog 2-9, an interassembly approach, which involved elaboration
of a resin-bound peptide with the caged phosphate, was used to introduce the guanidinium-
modified CNB caging group into the mRLC peptide (Scheme 2-3). First, o-nitrobenzaldehyde
(2-24) was converted to o-nitromandelic acid (2-26) through a cyanohydrin intermediate (2-25)
according to Rossi and Kao (Scheme 2-3a).33 Protection of the free acid with allyl bromide was
selectively achieved in the presence of the hydroxyl group using a phase-transfer catalyst in a
mixture of water and dichloromethane. Compound 2-27 was then reacted with 2-cyanoethyl
diisopropylchlorophosphoramidite to generate phosphoramidite 2-28.34
The peptide was assembled via SPPS on TGT resin, and Serl9 was coupled without side
chain protection (Scheme 2-3b). The free serine side chain was phosphitylated by treatment with
phosphoramidite 2-28 in the presence of 1H-tetrazole. The peptide phosphite was then oxidized
to the corresponding phosphotriester using tBuOOH. Treatment with 4-methylpiperidine
removed the Fmoc group for subsequent coupling and concomitantly eliminated the
p-cyanoethyl group to yield a phosphodiester, which is stable to f-elimination, enabling Fmoc
SPPS to proceed under the standard conditions. Following completion of the peptide (2-31), the
allyl protecting group of the CNB moeity was removed by repeated treatment with Pd(PPh3)4 and
phenylsilane to yield 2-32. Next, the guanidinium reagent was coupled to the free carboxylic
acid of the CNB group to furnish 2-33. Thioesterification and side chain deprotection were
performed as previously described to yield 2-34.
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Scheme 2-3. Synthesis of a guanidinium-modified CNB-caged peptide thioester.
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All peptide thioesters described above were ligated to the recombinant segment of the
mRLC. A construct (2-35) comprising the C-terminal portion of the mRLC protein (residues
25-171) was expressed in Escherichia coli as a fusion to glutathione-S-transferase (GST), which
improved expression and facilitated purification. A tobacco etch virus (TEV) protease
recognition site (sequence = ENLYFQ) was inserted immediately before the Met24Cys mutation,
enabling TEV proteolysis to release GST and reveal the free N-terminal cysteine that was
required for NCL. Following isolation of the GST-mRLC protein (yield: 70 mg/L) and
quantitative TEV cleavage, the protein (2-36) was directly used for NCL (Figure 2-5a). The
reaction was performed under non-denaturing conditions with sodium
2-mercaptoethanesulfonate (MESNa) as a catalyst for transthioesterification and yielded the
mRLC protein in milligram quantities at about 50 - 75% conversion relative to the unligated
protein (Figure 2-5b). Ni-NTA affinity chromatography was performed on the crude NCL
reaction to eliminate excess peptide, and agarose beads modified with an anti-FLAG antibody
were used to isolate the semisynthetic product from unligated protein and the TEV protease. The
mass of the protein was confirmed by MALDI-MS analysis (Figure 2-5c).
Met4Cys SH
TEV protease
0
2-35
via heterologous expression
0
2-13
via solid phase peptide synthesis
Native chemical ligation
MESNa, pH 8
SH
H2N
0
2-36
0 H0
2-1
Full length semisynthetic mRLC
1 2 3 4 5
W mow -woo.
1245 t 4- GST-mRLC(25-171)-His 6 (2-35)
4- Cleaved GST and TEV
4- FLAG-mRLC(1-171)-His (2-1)
4- H2N-Cys-mRLC(25-171)-His 6 (2-36)
10738.91
[M+2H]2+
Expected [M+H]+:
21480.83
Mass (m/z)
Figure 2-5. Semisynthesis of the full-length mRLC. a) The C-terminal portion of the protein is
expressed heterologously in E. coli. TEV proteolysis releases GST and reveals the N-terminal
cysteine residue, which reacts in the NCL with the synthetic peptide thioester to generate the
full-length mRLC. b) Coomassie-stained 12% SDS PAGE gel of the mRLC semisynthesis
showing the GST-TEV-mRLC-His 6 after purification on glutathione resin (lane 1), the products
of the TEV cleavage of GST-TEV-mRLC-His 6 (lane 2), the crude native chemical ligation
reaction (lane 3), the protein purified by Ni-NTA affinity chromatography (lane 4), and the final
semisynthetic mRLC after FLAG-affinity purification (lane 5). c) MALDI-MS spectrum of
purified semisynthetic mRLC 2-1.
2.2 Semisynthetic mRLC Regulation of Myosin Activity
We performed biochemical assays to compare the semisynthetic mRLC to the native
protein. Because the mRLC protein itself exhibits no measurable activity, it must first be
b) k.
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incorporated into the myosin complex in place of the native mRLC. The ability of the
semisynthetic mRLC to regulate myosin activity can then be assessed. For biochemical
evaluations, the semisynthetic proteins were exchanged into myosin and the proteolytic
derivative heavy meromyosin (HMM, 334,000 kDa), which contains only one-third of the C-
terminal coiled-coil tail. Smooth muscle myosin was obtained in good yield and high purity via
extraction from chicken gizzards following an established protocol, and HMM was obtained
through limited proteolysis of full-length myosin with the Staphylococcus aureus V8 protease.
With the exchange procedure, myosin or HMM was incubated with a 5-fold molar excess of
semisynthetic mRLC in the presence of EDTA and EGTA, which chelate Mg 2+ and Ca 2+ ions to
dissociate the native mRLC from the myosin complex. Under these conditions, association of
the excess semisynthetic mRLC with the myosin heavy chain is favored. Upon the addition of
MgCl 2, the binding interaction is stabilized. Two consecutive exchange procedures resulted in
over 95% incorporation of the semisynthetic protein into the myosin or HMM complex (Figure
2-6).
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Figure 2-6. 12% SDS PAGE gel of representative myosin and HMM exchanges. Both gels
show native myosin or HMM (lane 1), the caged semisynthetic mRLC (lane 2), myosin or HMM
after the first exchange (lane 3), and myosin or HMM after the second exchange (lane 4). a)
SDS PAGE gel of the myosin exchange. b) SDS PAGE gel of the HMM exchange.
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To assess the ability of the semisynthetic mRLC to regulate myosin, we first focused on
analyzing myosin ATPase activity, though later examinations utilized HMM. These
measurements of actin-activated, myosin-catalyzed ATP hydrolysis were performed by
monitoring the release of inorganic phosphate through a colorimetric assay. Activities of gizzard
myosin exchanged with the semisynthetic nonphosphorylated (2-1) and phosphorylated proteins
(2-2) were compared to those of native nonphosphorylated myosin and myosin phosphorylated
by gizzard myosin light chain kinase (MLCK) (Figure 2-7). These assays revealed a 4- to 6-fold
increase in activity upon phosphorylation, with the semisynthetic proteins mimicking the trends
in activity observed for the native myosin. Activity of myosin with semisynthetic mRLC 2-2
was moderately higher than that of myosin phosphorylated by MLCK because the semisynthetic
protein introduced defined phosphorylation, whereas enzyme-catalyzed phosphorylation may not
have proceeded to completion. The extent of phosphorylation was assessed by glycerol-urea gel
electrophoresis, which could separate the mRLC based on phosphorylation state (Figure 2-8).36
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Figure 2-7. Results of the myosin ATPase assays. Activities of native myosin and myosin
exchanged with semisynthetic derivatives are presented. The values are the means of at least
three experiments. The error bars denote the standard deviations (SD). NonP,
nonphosphorylated; P, phosphorylated by MLCK.
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Figure 2-8. 10% Glycerol-urea gel of of nonphosphorylated and phosphorylated mRLC. This is
a representative gel following treatment of myosin with MLCK. In the absence of SDS, the
phosphorylation state of the mRLC can be resolved by electrophoresis because the negatively
charged phosphate increases the mobility of the protein compared to the nonphosphorylated
protein. In this method, the myosin heavy chain does not enter the gel. The mobility of the
ladder in this type of PAGE is not representative of the actual molecular weight of the protein.
Encouraged by the result that the semisynthetic protein faithfully regulated myosin
activity, we next explored photoactivation of the NPE-caged pSerl9 mRLC (2-5). First, model
uncaging studies with a caged peptide were performed. RP-HPLC analysis was used to examine
the kinetics of NPE removal after irradiation of the caged peptide on a DNA transilluminator at
365 nm (Figure 2-9). Nearly maximal release of the free phosphopeptide (70%) was achieved
after irradiation for 90 s, a dosage previously shown to be compatible for cellular studies.
Moreover, Western blot analysis of the full-length caged protein (2-5) probed with an anti-
pSerl9 mRLC antibody confirmed that the phosphoprotein was generated upon irradiation
(Figure 2-10).
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Figure 2-9. Uncaging time course of the NPE-caged pSerl9 mRLC peptide. A solution of the
caged pSerl9-mRLC peptide acid (86 pM) in 10 mM HEPES (pH 7.1), 5 mM DTT, and 0.8 pM
inosine (as an internal standard) was irradiated at 365 nm for the indicated times in a glass vessel
on a transilluminator (1 mm pathlength). The peptide species were quantified by analytical RP-
HPLC monitored at 228 nm by determining the areas of the caged and uncaged peptide peaks
relative to the area of the inosine peak. The percent of each species relative to the initial amount
of the caged peptide is plotted against the duration of irradiation.
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Figure 2-10. Uncaging of NPE-caged pSerl9 mRLC (2-5) verified by Western blotting. The
Western blot was probed with an antibody specific for the pSerl9 mRLC (GeneTex) and shows
the NPE-cpSerl9 mRLC with no irradiation (lane 1) and after 90 s irradiation on a
transilluminator (lane 2). The antibody displays no recognition of the caged protein, and the
band at approximately 20 kDa in lane 2 is the uncaged, pSerl9 mRLC protein.
Following exchange of protein 2-5 into myosin, the actin-activated ATPase assays
unexpectedly showed high activity with both the caged and uncaged forms of the protein (Figure
2-11). However, Western blots probed with an antibody specific for the pSerl9 mRLC indicated
that the protein maintained the NPE caging group before irradiation and that the free
phosphoprotein was generated following exposure to 365 nm light. This suggested that the
presence of the NPE-caging group was not sufficient to inhibit myosin activation. Although the
mechanism by which phosphorylation activates myosin has not been elucidated, potential
electrostatic interactions between pSerl9 and basic arginine residues in the C-terminal domain of
the mRLC have been reported.37 Therefore, we hypothesized that the remaining free phosphate
oxyanion of the caged phosphate could still support the electrostatic interactions necessary for
activity.
To improve these initial uncaging results, we tried various caging groups that could better
reduce the activity of the caged state and enable irradiation to activate the protein. Specifically,
we synthesized the mRLC with NPE-c(S)pSerl9 (2-6), DEACM-cpSerl9 (2-7), double NPE-
caged pSerl9 (2-8), and guanidinium-modified CNB-cpSerl9 (2-9) (Table 2-1) and explored
myosin ATPase activity with these derivatives (Figure 2-11).
UV:- + - + - + - + - +
0.6
0.5-
- 0.4-
J>- 0.3 -
<0.2-
0.1.
0.0
2-1 2-2 2-5 2-5 2-6 2-6 2-7 2-7 2-8 2-8 2-9 2-9
Myosin Derivative
Figure 2-11. Myosin ATPase activity with caged semisynthetic mRLC derivatives before
(- UV) and after (+ UV) irradiation. Derivatives 2-5, 2-6, 2-7, and 2-9 were irradiated at 365 nm
(90 s for 2-5 and 2-6, 4 min for 2-8, and 9 min for 2-9). DEACM derivative 2-7 was irradiated at
410 nm for 2 min.
We proposed that the NPE-c(S)pSerl9 mRLC (2-6) could yield the desired properties
because the caged thiophosphate provides less hydrogen bonding potential compared to the
caged phosphate. However, activity assays did not demonstrate the desired improvement (Figure
2-11). Next, the DEACM group (2-7) was introduced to impart greater steric hindrance on the
phosphate. With this derivative, activities of both the caged and uncaged states of the protein
appeared comparably high. In both cases, Western blotting analysis verified that the caging
group was maintained before uncaging and that the phosphoprotein was released following
irradiation.
To better eliminate activity of the caged state, the double NPE-caged pSerl 9 protein (2-8)
was generated. We anticipated that protection of both oxygen atoms would preclude any
interactions that occur with the negatively charged oxyanion of the single caged protein. An
uncaging time course of the double NPE-cpSerl9 peptide (2-23), monitored and quantified by
RP-HPLC analysis, revealed that removal of both NPE groups was nearly complete following a
2 min irradiation at 365 nm (Figure 2-12). Myosin activity assays with this derivative were
greatly improved compared to assays with 2-5, 2-6, or 2-7 and showed a 3.7-fold increase in
activity upon irradiation (Figure 2-11).
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Figure 2-12. Uncaging time course of the double NPE-caged pSerl9 peptide (2-23) at 365 nm.
Analysis of the caged species was performed similarly to that from Figure 2-9.
In construct 2-9, a guanidinium-modified CNB caging group was designed to
electrostatically repel the positively charged C-terminal residues that putatively interact with
pSerl9. Alternatively, we predicted that this group could coordinate the oxyanion of the caged
phosphate to prevent further interactions. The a-CNB caging group, which has been used to
3 39protect phosphate3 8 and glutamate, was selected because the carboxylic acid provided a
convenient handle for linking the guanidinium group.
The uncaging efficiency of the guanidinium-modified CNB caging group was evaluated
by RP-HPLC analysis. Compared to the double NPE-caged peptide (2-23), release of the
guanidinium-modified CNB group from 2-34 was slow, yielding only about 54% of the uncaged
peptide after irradiation for 9 min at 365 nm. This derivative was tested in myosin ATPase
activity assays and, like derivative 2-8, demonstrated the desired activity trends with low activity
before uncaging and increased activity following irradition. However, due to inefficient
photolysis that would preclude applicability in cellular studies, this mRLC variant was not
further pursued in subsequent investigations.
While differences in activity between the native nonphosphorylated and phosphorylated
myosin and between the caged and uncaged proteins were observed with smooth muscle myosin,
the increases in ATPase activity were less dramatic than previously reported values, which
demonstrated 10- to 15-fold increases in activity.9 Additionally, extended studies with HMM
and myosin sliding filament assays have indicated that the differences in the capabilities of 2-8
and 2-9 to regulate myosin activity, compared to 2-5, 2-6, and 2-7, resulted from the poor
reproducibility of the gizzard myosin preparation. In particular, the batches of myosin used for
assessing 2-8 and 2-9 provided more robust data than those used for 2-5, 2-6, and 2-7, which
may have been damaged during isolation and could not be regulated by caging. A compounding
factor contributing to the difficulty in measuring myosin ATPase activity was the tendency of
myosin to assemble into filaments in the low-salt buffers required for the assay. In the presence
of filamentous actin, the assay mixture becomes more complex, thereby preventing reproducible
measurements. However, a more tractable surrogate for myosin that has been widely used for
biochemical characterization is heavy meromyosin (HMM). This truncated myosin maintains
phosphorylation-mediated regulation but remains soluble under a broad range of ionic
conditions. Thus, in biochemical assays, HMM is more robust and produces greater differences
in activity upon phosphorylation.
2.3 HMM ATPase Activity with Semisynthetic mRLC
To characterize the HMM system, activity with native HMM was compared to that of
HMM exchanged with the semisynthetic derivatives 2-1, 2-2, 2-3, and 2-4. Similar to HMM
with the native nonphosphorylated mRLC, the actin-activated ATPase activity of HMM
exchanged with 2-1 was negligible (Figure 2-13). HMM exchanged with 2-2 displayed activity
similar to that of HMM phosphorylated by MLCK (0.80 ± 0.07 and 0.98 ± 0.13 s-1, respectively).
These experiments validate that the semisynthetic mRLC fully and faithfully regulates HMM
enzymatic activity. Additionally, introduction of the FLAG epitope and hexahistidine tags do
not influence function. These observed differences in ATPase activity are considerably more
significant and reproducible compared to those observed with full-length myosin, confirming
that HMM represents a superior system for measuring phosphorylation-dependent ATPase
activity.
In addition to phosphorylation of Serl9, the mRLC can also be phosphorylated at
Thr18. 40 Studies of Thr18 phosphorylation alone have relied on a Serl9Ala mutation because
Ser19 is normally phosphorylated first. 41 4 2 Moreover, mRLC diphosphorylation has been
observed in vitro and in cells, but complete in vitro phosphorylation requires high concentrations
of MLCK.40  Our semisynthetic approach provides convenient access to homogenously
phosphorylated proteins, allowing the effects of defined phosphorylation to be examined without
the need for additional mutations at positions 18 or 19 of the mRLC. ATPase activity assays of
HMM exchanged with mRLC 2-3 showed that phosphorylation of Thr18 moderately increased
activity to 0.18 ± 0.03 s-, whereas phosphorylation at both Thr18 and Ser19 (2-4) generated
even greater activity (1.16 ± 0.11 s1) than pSer19 alone (Figure 2-13). These trends are
consistent with previous studies on the effects of kinase-mediated Thr18 phosphorylation and
diphosphorylation on myosin activity.41,42 Specifically, in a study by Bresnick, et al.,
phosphorylation at Thr18, Serl9, and Thr18 Ser19 of the mRLC generated myosin ATPase
activities of 0.05, 0.74, and 1.63 s-1, respectively, 4 2 and in a study by Kamisoyama, et al., the
myosin activities were 0.08, 0.18, and 0.41 s', respectively.41
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Figure 2-13. Results of HMM ATPase assays with native HMM and HMM exchanged with
semisynthetic derivatives. The values are the means of at least three experiments. The error bars
denote the SD. NonP, nonphosphorylated; P, phosphorylated by MLCK.
Following exchange of caged mRLC 2-5 into HMM, actin-activated ATPase assays
demonstrated that the activity of the caged protein was low and mimicked that of
nonphosphorylated mRLC 2-1 (Figure 2-14). Irradiation at 365 nm for 90 s increased activity
about 20-fold to a level near that of HMM exchanged with the semisynthetic pSerl9 mRLC
(2-2). Importantly, the caged protein completely suppresses HMM ATPase activity, indicating
that the caging group is sufficient to inhibit the interactions necessary for activity. The activity
following uncaging (0.48 ± 0.04 s-1) is consistent with restoration of about 60% activity
compared to that of HMM with semisynthetic pSerl9 mRLC 2-2 and lies within the range
expected based on the HPLC peptide uncaging analysis. Thus, irradiation enables direct control
over HMM activation. HMM assays with caged derivatives 2-6, 2-7, and 2-8 yielded similar
results in which HMM exchanged with the caged proteins exhibited low activity (Figure 2-14),
while exposure to irradiation significantly increased activity (0.43 ± 0.05, 0.70 ± 0.03, and
0.38 ± 0.02 s-1 for HMM exchanged with 2-6, 2-7, and 2-8, respectively). Thus, all derivatives
from this panel of caged mRLCs provide the desired trends in activity and can be exploited for
the unique photophysical and structural properties they possess.
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Figure 2-14. Results of HMM ATPase assays with caged semisynthetic mRLCs. The values are
the means ± SD of at least three experiments. The activities of HMM exchanged with the caged
semisynthetic derivatives before (-UV) and after (+UV) irradiation are plotted. The data from
derivatives 2-1 and 2-2 are included for comparison. Derivatives 2-5, 2-6, and 2-8 were
irradiated at 365 nm (90 s for 2-5 and 2-6, 4 min for 2-8), while derivative 2-7 was irradiated at
410 nm (2 min).
2.4 Sliding Filament Assays
To further characterize the semisynthetic proteins and the caging system, we performed
sliding filament assays, which assess the force-generating ability of myosin. 3 In this assay,
myosin is bound to a nitrocellulose-coated glass coverslip. The movement of fluorescently
labeled actin filaments propelled by the bound myosin is recorded using fluorescence
microscopy, and the velocities of the filaments are measured (Figure 2-15a). Full-length gizzard
myosin was used in these assays because it produced more consistent filament movement than
HMM and, unlike the myosin ATPase studies, in this case myosin filament formation did not
hinder measurements because the protein was bound to the coverslip while it was solubilized in a
high-salt buffer.
Nonphosphorylated native myosin and myosin exchanged with 2-1 did not move the actin
filaments, but both MLCK-phosphorylated myosin and myosin exchanged with 2-2 led to
significant movement with velocities around 0.9 pm s-1 (Figure 2-15b). Each phosphorylated
semisynthetic derivative generated filament movement at velocities between 0.7 tm s-1 and
1.0 [tm s1. A one-way ANOVA followed by Tukey's post-hoc test indicated that the differences
among myosin exchanged with 2-2, 2-3, and 2-4 are statistically significant, with all comparisons
yielding p < 0.0001 (Figure 2-15b). The velocities follow the relative trends observed in the
ATPase assays with pThrl8 (2-3) producing the smallest and pThrl8 pSerl9 (2-4) generating the
greatest velocities. These results are consistent with a previous study in which myosin with an
mRLC phosphorylated at Thr18 and containing a Serl9Ala mutation generated slightly lower
42filament velocities than the pSerl9 and pThrl8 pSerl9 derivatives. However, our results also
indicate differences between phosphorylation at Ser19 (2-2) and double phosphorylation
(pThrl8 pSerl9, 2-4), which have not been previously reported.
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Figure 2-15. Myosin sliding filament assays. a) Graphical representation of the myosin sliding
filament assay. Myosin is bound to a nitrocellulose-coated glass coverslip. The movements of
fluorescently labeled actin filaments are observed under a microscope and recorded. The paths
of the filaments can be digitally tracked, and the velocities are measured. b) Results of the in
vitro myosin sliding filament assays. The mean velocities ±SD of at least 45 actin filaments
during incubation with native nonphosphorylated (NonP) and phosphorylated (P) myosin and
myosin exchanged with noncaged semisynthetic dervatives. NMO, no motility observed.
With the caged proteins 2-5, 2-6, 2-7, and 2-8, negligible filament movement was
observed before irradiation (Figure 2-16). In contrast, irradiation of myosin prior to the assay
generated significant filament movement with velocities comparable to those observed with
MLCK-phosphorylated myosin or myosin exchanged with the semisynthetic pSer19 mRLC
(2-2). This assay independently validates that the caging strategies enable efficient light-driven
activation of myosin function. Although about 60% of the HMM ATPase activity was observed
after uncaging, the sliding filament velocities were fully restored following irradiation. Previous
studies have shown that while steady-state ATPase acivitives increase proportionally with the
degree of myosin phosphorylation, sliding filament velocities follow a nonlinear trend and
reach a maximal value even in the presence of up to 50% nonphosphorylated myosini 5
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Figure 2-16. Results of in vitro sliding filament assays with caged mRLC variants. a) The
mean velocities ± SD of at least 50 actin filaments during incubation with native
nonphosphorylated (NonP) and phosphorylated (P) myosin and myosin exchanged with the
caged semisynthetic mRLCs before (-UV) and after (+ UV) irradiation. NMO, no motility
observed. b) Actin filament paths from a representative field before (- UV) and after (+ UV)
90 s irradiation of myosin exchanged with NPE-cpSerl9 mRLC 2-5.
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Conclusions
The semisynthetic approach applied herein provides convenient access to milligram
quantities of various phosphorylated and caged phosphorylated derivatives of the mRLC to
facilitate studies of individual phosphorylation sites. This general semisynthetic strategy can be
readily adapted for the incorporation of other unnatural elements into the N-terminal domain of
the mRLC. Although initial studies of ATPase activity with myosin were complicated by
difficulties in obtaining robust activity data, independent studies through HMM ATPase and
myosin sliding filament assays demonstrated that the semisynthetic mRLC faithfully regulates
myosin activity. Furthermore, these results show that the caged derivatives enable precise
photocontrol over HMM and myosin activity. Examination of multiple caging groups allows the
caged proteins to be appropriately tailored for distinct applications and provides the basis for
these new caging strategies to be exploited in other systems. The in vitro studies presented in
this chapter represent the foundation for the investigations described in Chapter 3, which focus
on introduction of the semisynthetic mRLC into a cellular environment.
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Methods
Peptide Synthesis
All peptides were synthesized by 9-fluoenylmethoxycarbonyl (Fmoc)-based solid phase peptide
synthesis either manually or on an automated peptide synthesizer using standard Fmoc-protected
amino acids (Novabiochem). Each peptide synthesis was performed on a 0.04 mmol scale using
Fmoc-Ala-NovaSyn TGT resin (Novabiochem, 0.2 mmol/g), which installed alanine as the
C-terminal residue for all peptides. Phosphopeptides were synthesized by employing
commercially available Fmoc-Thr(PO(OBn)-OH) or Fmoc-Ser(PO(OBn)-OH) (Novabiochem).
The caged residues N-a-Fmoc-phospho(1-nitrophenylethyl-2-cyanoethyl)-L-serine and N-a-
Fmoc-phosphorothioyl(1-nitrophenylethyl-2-cyanoethyl)-L-serine were synthesized according to
Rothman, et al. 0 and Aemissegger, et al., respectively. These residues (0.08 mmol) were
always manually coupled with 0-(7-azabenzotriazol-1-yl)-N,N,NN'-tetramethyluronium
hexafluorophosphate (HATU, 0.08 mmol), 1-hydroxy-7-azabenzotriazole (HOAt, 0.08 mmol),
and 2,4,6-collidine (0.10 mmol) to prevent B-elimination of the phosphotriester.
Manual Synthesis. The resin (0.2 g, 0.04 mmol) was swelled in DCM (5 mL) for 5 min and then
in DMF (5 mL) for 5 min. Fmoc deprotection was performed by incubating the resin with
20% (v/v) 4-methylpiperidine in DMF (5 mL, 5 x 5 min) and then washing the resin with DMF
(5 mL, 5 x 1 min). The next Fmoc-amino acid (0.24 mmol) dissolved in DMF (5 mL) with
benzotriazole-1-yl-oxy-tris-pyrrolidino-phosphonium hexafluorophosphate (PyBOP, 0.12 g,
0.24 mmol) was added. NN-Diisopropylethylamine (DIPEA, 113 [1, 0.48 mmol) was added,
and the reaction was allowed to proceed for at least 45 min. The success of coupling was
evaluated by a trinitrobenzene sulfonic acid (TNBS) test, and if no beads turned red, the
procedure was repeated using the next amino acid. The N-terminus of each peptide was
acetylated by reaction with acetic anhydride and pyridine (0.15 M each in DMF).
Automated SPPS. Peptides were prepared by automated solid phase peptide synthesis (Applied
Biosystems 431 A synthesizer) employing standard Fmoc-protected amino acids (4 equivalents
relative to resin loading per coupling), 1-hydroxy-lH-benzotriazole (HOBt) and 0-benzotriazol-
lyl-N,N,N',N'-tetramethyluronium hexafluorophosphate (HBTU) coupling reagents
(Novabiochem), and 4-methylpiperidine deprotections. Double couplings and acyl capping were
performed. Serl and Ser2 were coupled as the corresponding pseudoproline dipeptide Fmoc-
Ser(tBu)-Ser(Tm*'"*pro)-OH, and Lys8 and Thr9 were incorporated using Fmoc-Lys(Boc)-
Thr(TPMeMepro)-OH (Novabiochem).
Double NPE-cpSer19 mRLC (2-7)
NO2
OH kN- 0
O-p=O O O- I
NO2 O O02 NO2 O O
2 R DMSO, DMF mR2
2-20 2-21
The NPE-caged phosphoserine peptide was synthesized following SPPS protocols (see above).
1-(2-Nitrophenyl)diazoethane was synthesized by reacting 1-(2-nitrophenyl)hydrazone (38 mg,
209 [tmol, prepared by M. Sainlos) with manganese (IV) oxide (182 mg, 2.09 mmol) in DMSO
31(375 [tL) for 30 min in the dark, as previously described. The solution was filtered directly into
the resin (45 mg, 9 [mol), DMF was added (375 tL), and the mixture was agitated in the dark
for 1 day. The extent of the reaction was analyzed by test cleavage and HPLC. The reaction was
repeated until a sufficient conversion (about 50-60%) was achieved.
Guanidinium-Modified CNB-cpSer19 mRLC (2-8)
a. Allyl-2-hydroxy-2-(2-nitrophenyl)acetate (2-27)
NaHCO 3 / H20NO2 OH Aliquat 336 NO2 OH
OH Allyl bromide / DCM O
- o 79% I.0
2-26 2-27
Nitromandelic acid (2-26) was synthesized according to Rossi and Kao.33 The allyl ester of
nitromandelic acid was synthesized by dissolving 2-26 (0.30 g, 1.51 mmol) in an aqueous
solution (4.5 mL) of sodium bicarbonate (0.13 g, 1.51 mmol). This solution was added to a
stirring solution of Aliquat 336 (0.61 g, 1.51 mmol) and allyl bromide (677 [tL, 7.82 mmol) in
9 mL DCM. The reaction was stirred vigorously for 24 h, and the aqueous portion was extracted
with DCM (3x, 15 mL). The combined organic extracts were dried over Na2SO 4 and
concentrated in vacuo. The material was purified by flash chromatography (SiO 2,
EtOAc/hexanes 1:1) to yield 0.28 g (79%) of 2-27. 1H-NMR (400 mHz, CDCl3) 6 ppm: 8.01 (d,
1H, J=7.9 Hz), 7.67 (m, 2H), 7.52 (m, 1 H), 5.87 (d, 1H, J=4.9 Hz), 5.81 (m, 1H), 5.22 (m, 1H),
5.18 (m, 1H), 4.65 (m, 2H), 3.62 (d, lH, J=4.8 Hz).
b. O-Allyl-2-hydroxy-2-(2-nitrophenyl)acetate-O'-p-cyanoethyl-N,N-
diisopropylphosphoramidite (2-28)
CN
NP 
-- CN ?
NO2 OH Triethylamine N -
0 DCM 0
O 88% O O NO2
2-27
2-28
The phosphitylating agent 2-28 was synthesized by modified procedures from Rothman, et al.34
Under anhydrous conditions, a solution of 2-cyanoethyl diisopropylchlorophosphoramidite
(318 ptL, 1.43 mmol) in DCM (1.1 mL) was added to a stirring solution of 2-27 (0.28 g,
1.19 mmol) and triethylamine (398 ptL, 2.86 mmol) in DCM (6 mL). After 6 h, the reaction
mixture was washed with 10% (w/v) NaHCO3 (20 mL), and the organic portion was dried over
Na2SO 4 and concentrated in vacuo to give 2-28 in 88% yield. The product was used without
further purification. 1H-NMR (400 mHz, CDCl3) 5 ppm: 8.0 (m, 1 H), 7.83 (m, 1H), 7.65 (m,
1H), 7.46 (m, 1H), 6.04 (d, 1H, J=11 Hz), 5.80 (m, 1H), 5.20 (m, 2H), 4.59 (m, 2H), 4.13 - 3.93
(m, 1H), 3.80 - 3.44 (m, 2H), 2.79 - 2.60 (m, 1H), 1.19 (m, 12H), 0.90 (d, 2H, J=6.8 Hz).
c. Peptide Phosphitylation and Oxidation
The phosphitylation and oxidation were performed according to modifications of procedures by
Vazquez, et al.19 The peptide Fmoc-SNVFA was synthesized on TGT resin (100 mg, 20 [tmol)
by standard SPPS protocols. The serine to be phosphorylated was incorporated without a side
chain protecting group. The resin was dried overnight in a dessicator under reduced pressure.
Molecular sieves were added to the resin, and the resin was swelled for 10 min in anhydrous
THF/DCM (1:1). To a solution of the phosphitylating agent 2-28 (70 mg, 160 ptmol) in
anhydrous THF/DCM was added a 0.45 M solution of 1H-tetrazole in acetonitrile (356 [tL,
160 [tmol). This solution was added to the resin, and the mixture was agitated overnight in the
dark. After filtration, the resin was treated with a solution of 10% (w/v) NaHCO3, and the
mixture was agitated for 10 min. The resin was washed with DMF and DCM, and phosphite
oxidation was immediately performed by swelling the resin in anhydrous DCM and adding a
5.5 M solution of tBuOOH in decane (546 [tL, 3 mmol). The reaction was agitated in the dark
for 1 h, and the resin was washed with DMF and DCM. Standard Fmoc-SPPS was then
performed to complete the peptide. Allyl deprotection was achieved by incubating the peptide
with Pd(PPh 3)4 (20 mg, 17 kmol) and phenylsilane (70 [tL, 568 ptmol) in DCM (3 x 20 min).
After the resin was washed with DCM, 2-(2-aminoethyl)-1,3-di-Boc-guanidine (18 mg, 60 [tmol)
was coupled to the free acid of the CNB group using PyAOP (31 mg, 60 ptmol), HOAt (8 mg,
60 [tmol), and collidine (16 ptL, 120 kmol) in anhydrous DMF for 3 h. Thioesterification then
proceeded as described below.
Peptide Thioester Synthesis
The N-terminal acyl-capped peptides (200 mg resin, 0.04 mmol) were cleaved from the TGT
resin without side chain deprotection using 0.5% TFA (v/v) in DCM (15 mL) for 2 h. The
solution was reduced to about 1 mL under a stream of N2, and the peptide was precipitated with
hexanes (30 mL). The reaction mixture was concentrated under reduced pressure, and the
peptide was dried in vacuo. The peptide was dissolved under argon in freshly distilled DCM (12
mL). HATU (61 mg, 0.16 mmol), HOAt (22 mg, 0.16 mmol), benzyl mercaptan (94 piL, 0.8
mmol), and 2,4,6-collidine (42.3 p1, 0.32 mmol) were added, and the reaction was stirred at room
temperature under argon for 4 h. The solution was concentrated under reduced pressure, and the
side chain protecting groups were removed in TFA/triisopropyl silane/H 20 (95/2.5/2.5, v/v/v,
12 mL) for 2 h. The volatile components were evaporated, and the peptide was triturated with
cold diethyl ether (40 mL, 3x). Thioester peptides were purified on a semi-preparative scale by
reversed phase HPLC with a Waters 600 automated control module on a YMC C18 semi-
preparative column (YMC-Pack, ODS-A, 20 x 250 mm, 5 [tm, 12 nm) eluting with
acetonitrile/water containing 0.1% (v/v) TFA. For detection, a Waters 2487 dual wavelength
absorbance detector was used to record at 228 nm and 280 nm. HPLC conditions were 5%
acetonitrile in water with 0.1% TFA for 5 min followed by a linear gradient from 20% to 50%
acetonitrile in water with 0.1% TFA over 45 min. Following lyophilization, correct mass was
validated by ESI-MS (PerSeptives Biosystems).
Peptide Characterization
Sequence
Ac-DYKDDDDKSSKKAKTKT
TKKRPQRATSNVFA-COSBn
Ac-DYKDDDDKSSKKAKTKT
TKKRPQRAT pS NVFA-COSBn
Ac-DYKDDDDKSSKKAKTKT
TKKRPQRA pT SNVFA-COSBn
Ac-DYKDDDDKSSKKAKTKT
TKKRPQRA pTpS NVFA-
COSBn
Ac-DYKDDDDKSSKKAKTKT
TKKRPQRAT cpS NVFA-
COSBn
Ac-DYKDDDDKSSKKAKTKT
TKKRPQRAT cp(S)S NVFA-
COSBn
Ac-DYKDDDDKSSKKAKTKT
TKKRPQRAT cpS NVFA-
COSBn
Ac-DYKDDDDKSSKKAKTKT
TKKRPQRAT cpS NVFA-
COSBn
Ac-DYKDDDDKSSKKAKTKT
TKKRPQRAT cpS NVFA-
COSBn
Molecular Formula
C16oH261 N47052S
C16oH262N47055PS
C16oH 262N470 55PS
C16oH263N47058P2S
C168H269N48057PS
NonP
pS19
pT18
pT1 8
pS19
NPE-
cpS19
NPE-
c(S)pS19
Double
NPE-
cpS19
DEACM-
cpS19
Guan-
CNB-
cpS19
Molecular
Weight
Calcd.
3704.89
3784.86
3784.86
3864.83
3933.91
3949.89
4082.96
4019.01
4047.96
[MH5]5*
Calcd.
742.0
758.0
758.0
774.0
787.8
791.0
817.6
804.8
810.6
[MH5]5
Found [al
742.0
758.0
758.0
774.0
787.9
791.1
817.6
804.3
810.6
HPLC
(tR)[bl
(min)
21.3
21.0
20.9
20.6
22.1
22.6
27.5
22.5
18.2
[a] The data were collected by positive ion electrospray ionization mass spectrometry. [b] Retention
times were obtained from reversed phase HPLC analytical runs (YMC Pack, ODS-A, 4.6 x 250 mm, 5 pm,
12 nm) using the following method: 5% acetonitrile in water with 0.1% TFA for 5 min, followed by a linear
gradient of 5-95% acetonitrile in water with 0.1% TFA over 30 min at 1 mL min'.
Cloning
To generate the GST-mRLC protein fusion, the C-terminal portion of the mRLC was subcloned
into the pGEX-4T-2 vector. The gene fragment encoding the murine nonmuscle mRLC(25 -
171) was amplified by polymerase chain reaction from a vector containing the full mRLC gene
(GenBank Accession AK002885), which was provided by Professor Martin Schwartz
(University of Virginia). The translated protein has the same sequence as the human mRLC 12B
Peptide
Thioester
C176H276N49059PS
C174H282N48057PS
C171 H275N520 58PS
(NM_001144944.1). The forward primer for PCR encoded a 5' EcoRI restriction site, followed
by the TEV protease cleavage sequence (ENLYFQ) and the Met24Cys mutation, and the reverse
primer was used to encode a C-terminal hexahistidine tag and a 3' NotI restriction site. The
sequences of the primers used for PCR are given below:
Forward primer:
5'-GCCGGAATTCGTGAGAACCTGTATTTCCAGTGCTTTGACCAGTCCCAGATC-3'
Reverse Primer:
5'-GCGAAAGACAAAGATGACCATCACCATCACCATCACTAGGCGGCCGCAAAAGG
GGGC-3'
The standard PCR protocol is given below:
94'C 4C 94C 94C 94C 94'C 94'C 94'C 9 C
3min 30s 30s 30s 30s 30s 30s 30s 30s
72-C 72C 72'C 72* C 72'C 72C 72'C
I min I rmin Imin I n-on lmin 1min 1min
63' C
46s 4s (c 
_f
45s s-C
4 45s'
45s W ssC
45s
4'C
2x 2x 2x 2x 2x 2x 2x 25x
The PCR amplicons were digested with EcoRI and NotI according to the manufacturer's
protocol, and the gene was ligated into the pGEX-4T-2 vector (GE Healthcare), which had been
digested with EcoRI and NotI (Promega) and treated with calf intenstine alkaline phosphatase
(CIP, New England Biolabs). The ligated plasmid was transformed into DH5a cells (Invitrogen)
and grown on Luria-Bertani (LB) plates containing carbenicillin (50 pg/mL).
mRLC Expression
The pGEX-mRLC plasmid was transformed into BL-21 Codon Plus RP cells (Agilent
Technologies), and the bacteria were grown on LB plates containing carbenicillin (50 gg/mL)
and chloramphenicol (30 pg/mL). A single colony was selected and grown in LB media (5 mL)
supplemented with carbenicillin (50 ig/mL) and chloramphenicol (30 [tg/mL). This starter
culture was used to inoculate a 1 L culture, which was incubated in a shaker at 225 rpm and
370 C until an OD of -0.6 at 600 nm was reached. The culture was cooled to 160 C, and
isopropyl-1-thio-p-D-galactopyranoside (IPTG) was added to 0.2 mM to induce protein
expression. The culture was incubated overnight at 160 C with shaking. The cells were
harvested by centrifugation, and the cell pellets were stored at -80' C until use.
GST Purification of GST-mRLC
The cell pellet was thawed on ice and brought up in 40 mL of PBS (5 mM NaH2PO4, 5 mM
Na2HPO4 , 150 mM NaCl, pH 7.7) containing 1 mg/mL lysozyme, 1 mM DTIT, and 1 L/~mL
protease inhibitor cocktail III (Calbiochem: 100 [M AEBSF, 80 nM Aprotinin, 5 1 M Bestatin,
1.5 pM E-64, 2 [tM Leupeptin, 1 pM Pepstatin A) for each liter of cells harvested. The cells
were incubated on ice for 20 min and then sonicated on ice at 40% amplitude, 1 s on/1 s off for
45 s with a Sonics Vibra Cell sonicator. Cell debris were pelleted at 90,000 x g for 1 h at 4' C,
and the lysate was filtered through a 0.2 [tm filter. Glutathione Sepharose 4 Fast Flow
(Amersham Biosciences, 3 mL) was incubated with the cell lysate for 1.5 h. The resin was
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isolated with a brief centrifugation and washed with 120 mL PBS at 4 'C. The protein was
eluted in four 3-mL fractions with elution buffer (50 mlM Tris, 10 mM reduced glutathione, 2
UmL protease inhibitor cocktail III, pH 8.0). The protein was dialyzed in a 3,500 MWCO
Slide-A-Lyzer dialysis cassette (Pierce) against PBS (3 x 2 L). Protein concentration was
determined through a BioRad assay with BSA as a standard.
TEV Cleavage
TEV cleavage was performed by incubating the GST-mRLC protein (1.6 mg/mE) with TEV
protease (prepared in-house, 25 L/~mL) in cleavage buffer (50 mM Tris, 0.5 mM EDTA, 5 mM
BME, pH 8.0) for 3.5 h at 30 'C and then overnight at 4 'C. SDS polyacrylamide gel
electrophoresis confirmed complete proteolytic cleavage.
Native Chemical Ligation
The TEV-cleaved protein (H2N-Cys-mRLC(25-171)-His 6 , MW = 17,900) was concentrated to
14 mg/mL with a Millipore Amicon Ultra Centrifugal filter device (MWCO 3,000). Native
chemical ligation reactions were performed by combining the thioester peptide (1.2 mM) with
the protein (0.8 mM) in PBS containing 150 mM MESNa and 50 mM Tris, pH 8.0. The
reactions were incubated overnight at room temperature. Following ligation, the mixture was
diluted to 2 mg/mL (0.1 mM) and dialyzed against PBS (3 x 2 L) in a Slide-A-Lyzer dialysis
cassette (3,500 MWCO) to remove the thiol additives. Ligations were routinely performed on
2 - 5 mg scales.
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The sequence of the full length mRLC is given below. The FLAG tag is shown in green, the
peptide by SPPS is shown in blue, Thr18 and Serl9 are shown in red, the expressed C-terminal
region is shown in black, and the His6 tag is shown in purple.
Ac -DYKDDDDKSSKKAKTKTTKKRPQRATSNVFACFDQSQIQEFKEAFNMIDQNRDGFIDKEDL
HDMLASLGKNPTDAYLDAMMNEAPGP INFTMFLTMFGEKLNGTDPEDVIRNAFACFDEEATGTI
QEDYLRELLTTMGDRFTDEEVDELYREAPIDKKGNFNY IEFTRI LKHGAKDKDDHHHHHH
Purification of Semisynthetic mRLC
The ligation mixture was purified from excess peptide using Ni-NTA affinity chromatography.
The protein mixture was incubated with Ni-NTA resin (Qiagen, 1 mL/mg mRLC) in PBS
(25 mM NaH2PO4, 25 mM Na2HPO4, 300 mM NaCl, pH 7.9) containing 5 mM imidazole for 1 h
at 4 'C, and then the resin was collected and washed with 120 mL PBS containing 5 mM
imidazole. The protein was eluted with 12 mL PBS containing 300 mM imidazole and dialyzed
against TBS (50 mM Tris, 200 mM NaCl, pH 7.5, 3 x 2 L). The unligated protein was
subsequently removed from the FLAG epitope-tagged ligation product using anti-FLAG M2
agarose from mouse (Sigma, 1 mL/mg mRLC). After incubating the protein with the resin in
TBS for 1 h at 4 'C with gentle agitation, the resin was washed with 120 mL TBS. The protein
was eluted in 1 mL fractions with 0.1 M glycine, pH 3.5 into 50 iL of a solution of 1 M Tris and
0.8 M NaCl, pH 7.8. The purification was repeated using the flow through to recover unbound
protein. The pooled elutions from each purification were dialyzed into PBS.
MALDI-MS Analysis
Mass analysis of the purified protein was obtained on a Voyager DESTR MALDI by the MIT
Biopolymers Lab.
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Myosin Extraction and Purification
Myosin was isolated from chicken gizzards (PelFreeze) according to Ikebe and Hartshorne. 35
The chicken gizzards were thawed in PBS, trimmed of fat, and cut into small pieces. A standard
preparation with 10 gizzards yielded 150 g tissue. The tissue was homogenized in a Black &
Decker blender (4 x 15 s) in 3 volumes of buffer 1 (10 mM Tris-HCl, 50 mM KCl, 25 mM
MgCl 2, 2 mM EGTA, 3% (v/v) Triton-X 100, 0.2 mM DTT, 1/1000 (v/v) Protease Inhibitor
Cocktail Set III, pH 7.5). The mixture was centrifuged for 5 min at 1,500 x g at 4' C. The pellet
was resuspended in 3 volumes of buffer 1, homogenized (1 x 20 s), and centrifuged twice more.
The pellet was then resuspended in 3 volumes of buffer 2 (10 mM Tris-HCl, 100 mM KCl, 2
mM EGTA, 0.2 mM DTT, 1/1000 (v/v) Protease Inhibitor Cocktail Set III, pH 7.5) and
homogenized (1 x 20 s). The mixture was centrifuged for 10 min at 8,000 x g at 40 C. This was
repeated twice more. The pellet was resuspended in 1.5 volumes of extraction buffer (40 mM
imidazole, 5 mM ATP, 4 mM EDTA, 2 mM EGTA, 0.5 mM DTT, 1/1000 (v/v) Protease
Inhibitor Cocktail Set III, pH 6.8) and homogenized (2 x 20 s). The pH was adjusted to 6.9, and
the solution was stirred on ice for 15 min. The mixture was centrifuged at 14,000 x g for 20 min
at 40 C, and the supernatant was filtered through glass wool. The pH of the solution was
adjusted to 7.6 with 0.1 N KOH, and 1 M MgCl 2 was added to a final concentration of 150 mM
while maintaining the pH at 7.6. Neutralized ATP was added to a final concentration of 2.5 mM,
and the mixture was stirred on ice for 10 min. The mixture was centrifuged at 14,000 x g for 10
min at 40 C, and the supernatant was then centrifuged at 75,000 x g overnight at 40 C. The
supernatant was filtered through glass wool and slowly diluted with 10 volumes of cold distilled
water. The solution was centrifuged at 10,000 x g for 10 min, the pellets were resuspended in 10
pellet volumes of buffer 3 (5 mM NaH 2PO4, 5 mM Na2HPO4, 1.5 mM EGTA, 5 mM ATP, 0.5
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mM DTT, pH 7.6) and homogenized with a Dounce homogenizer. The solution was adjusted to
pH 7.6, and 1 M MgCl2 was added dropwise to a final concentration of 150 mM. The mixture
was centrifuged for 3 h at 98,000 x g, and the supernatant was diluted with 10 volumes of cold
distilled water and stirred for 10 min on ice. The mixture was centrifuged at 10,000 x g for 10
min, and the pellet was resuspended in 10 pellet volumes of buffer 4 (10 mM Tris-HCl, 0.5 M
KCl, 1 mM DTT, pH 7.5). Cold distilled water was added such that the final KCl concentration
would be 0.1 M, and the mixture was stirred on ice for 15 min. The mixture was centrifuged at
14,000 x g for 15 min, and the supernatant was collected and diluted with an equal volume of
cold distilled water. MgCl2 was added to a final concentration of 10 mM, and the mixture was
incubated at 0' C for 1 h to precipitate the myosin. The mixture was centrifuged at 10,000 x g
for 15 min, the pellets were resuspended in buffer 4, and the solution was dialyzed overnight
against buffer 4. The dialyzed solution was clarified by centrifugation at 130,000 x g for 1 h in
the presence of 5 mM ATP. The protein was then dialyzed into storage buffer (12.5 mM
NaH2PO4 , 12.5 mM Na2HPO4, 0.6 M KCl, 1 mM DTT, 1 mM EGTA, 1 mM NaN 3, pH 7.5).
Protein concentration was measured using &(1 mg/mL) = 0.506 at 280 nm. An equal volume of
glycerol was added, and the myosin was stored at -20' C with a final concentration of about
3 mg/mL. Protein was 95% pure as assessed by SDS PAGE. Routine yields were between 100
and 200 mg myosin.
HMM Preparation
46HMM was generated by myosin proteolysis according to Ikebe and Hartshorne. Myosin
(8 mg/mL) in cleavage buffer (30 mM Tris, 200 mM KCl, 1 mM MgC12 , 0.2 mM EGTA, 1 mM
DTT, 5 mM ATP, pH 7.5) was incubated with S. aureus V8 protease (Sigma, 0.013 mg/mg
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myosin) for 45 min. Diisopropylfluorophosphate and phenylmethylsulfonyl fluoride were each
added to 1 mM, and the MgCl 2 concentration was adjusted to 15 mM. The digest was dialyzed
for 1 h into a low-salt buffer (30 mM Tris, 15 mM MgCl 2, 0.2 mM DTT, pH 7.5). The
precipitated myosin was collected by centrifugation at 180,000 x g for 50 min, and NaCl was
added to the supernatant to a final concentration of 300 mM. The solution was applied to a GE
Healthcare Superdex 200 HiLoad (16/60) size exclusion chromatography column equilibrated
with HMM buffer (30 mM Tris, 300 mM NaCl, 0.2 mM DTT, pH 7.5) using the AKTAprime
plus system to separate HMM from S 1, another product of proteolysis. HMM concentration was
determined with c = 2.28 x 105 M- cm-1 at 280 nm using a molecular weight of 334,000. From
73 mg myosin, 9 mg pure HMM was obtained. HMM (20-iiL droplets, 4 mg/mL) was flash-
frozen in liquid N2 and stored in the liquid N2 dewar.
Purification of Myosin Light Chain Kinase
Myosin light chain kinase was purified from chicken gizzards (PelFreeze) according to Ikebe, et
al.7 The chicken gizzards were thawed in PBS, trimmed of fat, and cut into small pieces. For 9
gizzards, 140 g tissue was obtained. The tissue was homogenized in a Black & Decker blender
(3 x 5 s) in 4 volumes of buffer 1 (20 mM Tris, 40 mM KCl, 1 mM MgCl 2 , 1 mM EGTA, 1 mM
DTT, 0.05% (v/v) Triton X-100, pH 7.5). The mixture was centrifuged for 15 min at 15,000 x g
at 4' C. The pellet was resuspended in buffer 1 without Triton X-100, homogenized (3 x 5 s),
and centrifuged twice more. The kinase was extracted by homogenizing the pellet in 4 volumes
of buffer 2 (40 mM Tris, 80 mM KCl, 30 mM MgCl 2, 1 mM EGTA, 1 mM DTT, pH 7.6). The
mixture was centrifuged for 30 min at 15,000 x g. Ammonium sulfate was added to the
supernatant to 60% saturation. Buffer 2 was then added to dilute the ammonium sulfate to 40%
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saturation. The mixture was centrifuged for 30 min at 15,000 x g, and ammonium sulfate was
added to the supernatant to 60% saturation. The mixture was centrifuged, and the pellet was
dissolved into buffer 3 (20 mM Tris, 1 mM EGTA, 1 mM EDTA, 1 mM DTT, pH 7.5). The
solution was dialyzed overnight against buffer 3 and clarified for 30 min at 70,000 x g at 40 C.
The kinase was purified with a DEAE-Sepharose Fast Flow column (Amersham Biosciences, 1 x
25 cm, 20 mL resin) on the AKTAprime plus protein purification system. The column was
equilibrated with buffer 3, and following sample injection (20 mL), the column was rinsed with
five column volumes of buffer 3 at a flow rate of 0.9 mUmin. The protein was eluted with a
linear gradient of 0.3 M NaCl in buffer 3. The fractions (6 mL) containing the kinase were
pooled and dialyzed into buffer 4 (40 mM Tris, 20 mM NaCl, 1 mM EGTA, 1 mM DTT,
pH 7.5). This solution (30 mL) was applied at a flow rate of 0.5 mL/min to a column of
cellulose phosphate (Sigma, fine mesh, 1 x 25 cm) equilibrated with buffer 4. After washing
with five column volumes of buffer 4, the protein was eluted with a linear gradient of 0.3 M
NaCl in buffer 4. Fractions (6 mL) containing the purified kinase, which eluted around 0.15 M
NaCl, were pooled, and the kinase (0.6 mg/mL) was stored at -20' C with 5% (w/v) sucrose.
Protein concentration was determined using s = 3.24 x 104 M 1 cm~1 at 280 nm.
Actin Purification
Actin was purified from rabbit skeletal muscle acetone powder (PelFreeze) following protocols
by Pardee and Spudich.48 Actin was extracted from the acetone powder by stirring on ice for
30 min in buffer 1 (2 mM Tris, 0.2 mM ATP, 0.5 mM p-mercaptoethanol, 0.2 mM CaCl2,
0.005% (w/v) NaN 3, pH 8.0, 20 mUg acetone powder). The extract was centrifuged at
10,000 x g for 15 min, and the supernatant was retained. The residue was re-extracted for
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10 min in buffer 1. The combined extracts were filtered through glass wool and centrifuged at
20,000 x g for 1 h at 40 C. The supernatant was brought to 50 mM KCl, 2 mM MgCl 2, and
1 mM ATP. The actin was allowed to polymerize for 2 h at 40 C. Solid KCl was then added to a
final concentration of 0.8 M, and the solution was stirred for 30 min. The mixture was
centrifuged at 130,000 x g for 2 h at 40 C, and the pellets were homogenized into F-actin buffer
(2 mM Tris, 0.6 M KCl, 1 mM ATP, 2 mM MgCl 2, 0.5 mM f-mercaptoethanol, 0.2 mM CaCl2,
0.005% (w/v) NaN3, pH 8.0). The protein was resedimented at 130,000 x g for 2 h at 40 C. The
supernatant was discarded, and the pellets were rinsed with buffer 1 and then resuspended in
buffer 1 by homogenization. The mixture was dialyzed into buffer 1 over 3 days to allow
depolymerization to occur. The G-actin was clarified by centrifugation at 130,000 x g for 2 h.
The concentration of actin was determined with c(l mg/mL, 280 nm) = 0.62. The purity of the
protein was determined by SDS PAGE. From 10 g muscle acetone powder, about 30 mg actin
could be isolated. For storage, G-actin was lyophilized with 2 mg sucrose/mg actin and stored in
aliquots at -20 'C.
Myosin and HMM Exchange
Myosin Exchange. The semisynthetic mRLC was exchanged into smooth muscle myosin
according to modified procedures by Sherwood, et al.49 and Ikebe, et al.5 0 Myosin (0.5 mg/mL)
in exchange buffer (10 mM NaH 2PO4 , 10 mM Na2HPO 4, 0.6 M NaCl, 10 mM DTT, 5 mM
EGTA, 1 mM EDTA, 5 mM ATP, pH 7.5) was incubated for 30 min at 420 C with about 5 molar
equivalents of the semisynthetic RLC. After cooling on ice, MgCl 2 was added to 20 mM. To
remove excess light chains, the myosin was precipitated by overnight dialysis into a salt-free
buffer (15 mM Tris, 10 mM MgCl 2 , 1 mM DTT, pH 7.5). The pellet was collected by
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centrifugation and washed with dialysis buffer. The pelleted protein was dissolved in the
exchange buffer, and the protein was subjected to a second exchange to increase incorporation of
the semisynthetic protein to at least 90%.
HMM Exchange. The conditions for exchange into HMM were modified from Ellison, et al.44
HMM was diluted into exchange buffer (10 mM NaH 2PO4 , 10 mM Na2HPO 4, 0.5 M NaCl,
10 mM DTT, 5 mM EGTA, 1 mM EDTA, 1 mM ATP, pH 7.5) and incubated with a 5-fold
excess of the semisynthetic mRLC at 42 'C for 30 min. After cooling on ice, MgCl2 was added
to 20 mM, and the excess light chains were purified from HMM through size exclusion
chromatography on a GE Healthcare Superdex 200 (10/300 GL) column equilibrated in TBS
(30 mM Tris, 300 mM NaCl, 1 mM MgCl 2 , 0.5 mM DTT, pH 7.5) using the AKTAprime plus
system. The flow rate was 1 mL min-, and 1 mL fractions were collected. Fractions containing
HMM were pooled and concentrated in a 50,000 MWCO centrifugal filter unit, and the exchange
was repeated.
HMM Phosphorylation by Myosin Light Chain Kinase
HMM was phosphorylated though a modified protocol from Ellison, et al.44 HMM (0.5 mg/mL)
in phosphorylation buffer (15 mM Tris, 50 mM NaCl, 2.5 mM MgCl 2 , 3.5 mM CaC12, pH 7.4)
was incubated with 1.4 mM ATP, myosin light chain kinase (30 pg/fmL), and calmodulin
(4 tg/mL) for 1 h at room temperature and then overnight at 4 'C. The phosphorylated protein
was used directly in activity assays. The exent of phosphorylation was assessed through
glycerol/urea gel electrophoresis. The gel and running buffer were prepared according to
protocols from Trybus,36 and the gel was run at 345 V until the bands of the prestained ladder
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had adequately separated (-3 h). The gel was stained using standard Coomassie-based staining
solutions.
Uncaging
Myosin or HMM exchanged with the caged semisynthetic mRLC was dissolved in the
appropriate assay buffer supplemented with 5 mM DTT. The solution was irradiated in a quartz
vessel with a 1 mm pathlength on a DNA transilluminator with light centered at 365 nm
(7330 gW/cm 2) for 90 s.
Western Blots
Standard SDS PAGE on a 12% polyacrylamide gel was performed, and the proteins were
transferred to a nitrocellulose membrane at 100 V for 1 h. The blot was blocked with 5% BSA in
TBS-T overnight at 4 'C and then incubated with a rabbit anti-pSer19 mRLC antibody
(1/1000 dilution, GeneTex, P.N.: GTX24720) in 3% BSA in TBS-T for 2 h at room temperature.
The blot was washed with TBS-T (5 x 5 min) and incubated with a goat anti-rabbit IgG + IgM
(H+L) alkaline phosphatase 2' antibody (1/5000 dilution, Pierce) in TBS-T for 1 h at room
temperature. The blot was then washed with TBS-T (3 x 5 min) and TBS (1 x 5 min) and
developed with 1-Step NBT/BCIP substrate for alkaline phosphatase (Pierce).
ATPase Assays
The actin-activated ATPase activity of HMM was determined by measuring the inorganic
phosphate released over 30 min. All protein used in the assay was dialyzed into the assay buffer
prior to the assay. HMM (0.1-0.2 mg/mL) in assay buffer (30 mM Tris, 2.5 mM MgCl 2 , 20 mM
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KCl, 0.1 mM EGTA, 1 mM DTT, pH 7.5) was incubated at 25 'C with actin (1 mg/mL) in a
final volume of 150 L. The assay was started by the addition of ATP to a concentration of
1 mM. For each time point, 30 [tL of the reaction mixture was added to 30 L of the stop
solution (60 mM EDTA, 6.6% (w/v) SDS, pH 6.5). To quantify the amount of inorganic
phosphate present in each sample, 120 [tL of color developing solution (0.5% ammonium
molybdate in 1 N H2 SO 4,18 mM ferrous sulfate) was added. After incubating the samples at
room temperature for 20 min, the absorbance of the sample at 700 nm was measured.36 The
phosphate concentration was calculated based on a phosphate standard curve with phosphate
amounts between 5 and 50 nmol.
Sliding Filament Assays
Sliding filament assays were performed according to Sellers.43 To improve the quality of the
actin filament movement, prior to each assay, myosin at 1 mg/mL in high-salt buffer (10 mM
MOPS, 0.5 M KCl, 0.1 mM EGTA, 5 mM MgCl 2, 2 mM ATP, pH 7.4) with 6 jIM actin was
centrifuged at 480,000 x g for 7 min to remove myosin containing heads that bind actin but that
do not hydrolyze ATP. The supernatant was added at a concentration of about 0.2 mg/mL to a
flow chamber constructed from a nitrocellulose-coated coverslip and microscope slide. The flow
chamber was then blocked with three volumes BSA (1 mg/mL) in a high-salt buffer (10 mM
MOPS, 0.5 M KCl, 0.1 mM EGTA, pH 7.4) and then washed with three volumes of motility
buffer (20 mM MOPS, 50 mM KCl, 4 mM MgCl 2 , 0.1 mM EGTA, pH 7.4). Sheared actin
(5 jiM), prepared by repeated passage of actin through a fine syringe, with 1 mM ATP in motility
buffer was added to block myosin heads that do not hydrolyze ATP, and the flow cell was
washed with three volumes of motility buffer. TRITC-phalloidin labeled F-actin (20 nM) in
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motility buffer was added, and then the assay was started by the addition of assay buffer
(motility buffer supplemented with 1 mM ATP, 10 mM DTT, 0.7% methylcellulose, 2.5 mg/mL
glucose, 0.5 mg/mL glucose oxidase, and 2 pg/mL catalase). For native myosin phosphorylated
by myosin light chain kinase, the wash containing sheared actin also contained 2 pg/mL myosin
light chain kinase, 0.2 mM calmodulin, and 0.2 mM CaCl2. Analysis of the uncaged myosin was
performed by uncaging the protein in the presence of 5 mM DTT prior to its addition to the flow
chamber. While movement was observed if the flow chamber itself was irradiated, the quality of
the images was compromised due to photobleaching of the TRITC-labeled actin during
irradiation. Filament movement was observed with a 1OOX objective on an Olympus IX50
microscope equipped with a Videoscope ICCD intensified CCD camera and recorded on a
Panasonic VHS recorder. Data was quantified using the Cell Tracker software from Motion
Analysis and was analyzed according to Homsher, et al.5 '
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Introduction
Photolabile protecting groups, or "caging groups," have been widely used in cellular
investigations because they offer researchers the ability to control the region and timing of
biomolecule release or protein activation with great specificity. Exposure of a caged compound
to irradiation releases an "immediate" burst of the active molecule and provides a defined
starting point for investigations of that compound.' This feature is particularly important for
studying biological processes, which require precise spatial and temporal coordination of protein
signaling events. Caged small molecules, including caged ATP, cAMP, glutamate, and calcium,
are commercially available and have been exploited for the study of various cellular processes,
including kinetic and mechanistic properties of receptors and ion channels.3 Caged glutamate
and cAMP have proven to be particularly useful for the study of neuronal signaling, while caged
calcium has been applied in investigations probing the effect of calcium signaling during early
development.4 Although the application of caged proteins has been less common, a number of
studies have successfully demonstrated the value of this approach. For instance, caged MEK1
kinase has been used to dissect the kinetics of the MEK signaling cascade within mammalian
cells,5 while caged cofilin has been employed to demonstrate the role of this protein in actin
polymerization and in cell migration. 6
Motivated by the potential of caged molecules to reveal detailed information about
cellular processes, we exploited the caged myosin regulatory light chain (mRLC) protein
described in Chapter 2 for the study of cell migration. Cell migration is involved not only in
normal physiological functions such as wound repair, but also in diseases, including
inflammatory conditions and cancer metastasis. An essential event during migration is the
formation of cellular adhesions to the extracellular matrix. These structures provide mechanical
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support to enable protrusive forces to advance the cell forward. Adhesions, including stress
fibers and focal complexes, are assembled upon phosphorylation of the mRLC (Figure 3-1 ).7
Activated myosin exerts forces on actin filaments to bundle them into stress fibers, which
produce cellular tension, maintain adhesion to the substrate, and provide contractility forces
during migration.8  Additionally, integrins, which span the cell membrane to connect the
extracellular matrix to proteins within the cytoplasm, become aggregated into focal complexes
and adhesions through the contractile forces generated from acto-myosin interactions. Focal
complexes are located at the base of a protruding lamellipodium and rapidly turnover as the
leading edge of the cell advances forward.9 These complexes can also mature into more stable
focal adhesions, which recruit proteins, such as vinculin, talin, and a-actinin, and become sites
for signal transduction to regulate migration and other functions, including cell growth and
apoptosis.10 Given the central role of myosin in orchestrating these spatially and temporally
defined events, elucidating the functions of this protein complex is critical for understanding
motility and associated pathological conditions.
Chapter 2 focused on the development and in vitro validation of semisynthetic caged
phosphorylated mRLCs. Heavy meromyosin (HMM) ATPase and myosin sliding filament
assays together demonstrated that incorporation of a caging group onto pSer19 of the mRLC
eliminates HMM and myosin activities and that irradiation releases the native phosphoprotein to
restore activity. With this chemical approach, light triggers phosphorylation without disrupting
the complex signaling network of kinases and myosin phosphatase that regulate the modification
(Figure 3-1). Additionally, irradiation enables precise control over the timing and localization of
the phosphorylated mRLC. We sought to exploit these unique properties to interrogate the
dynamics of stress fiber and focal adhesion formation in live cells. This chapter presents cellular
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studies with the semisynthetic mRLC, including approaches for incorporating this protein into
native cellular myosin and initial uncaging experiments with this construct. These results
demonstrate that the protein can be efficiently uncaged within the cell and show promise for
future experiments aimed at investigating the effects of myosin activity on cell contractility. The
work described herein was performed in collaboration with Professor Martin A. Schwartz and
Dr. Brenton Hoffman at the University of Virginia.
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Phosphorylated myosin
Figure 3-1. mRLC phosphorylation within the cell. mRLC phosphorylation is regulated by a
complex network of kinases and myosin phosphatase. The kinases shown all phosphorylate the
mRLC at Serl9, though MLCK has also been shown to phosphorylate Thr18. Phosphorylation
of the mRLC activates myosin and induces stress fiber and focal adhesion formation, which are
processes essential in cell migration. a) Stress fibers can be visualized in fixed cells by treating
the cells with fluorescently labeled phalloidin, which binds filamentous actin. Stress fibers
appear as parallel bundles, and representative structures are denoted by the white arrows. b) The
focal adhesions in this image were stained with an antibody to vinculin, a protein that localizes to
adhesions. The white arrows point to representative focal adhesions.
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Results and Discussion
3.1 Incorporation of the mRLC into Cellular Myosin
We first sought to use the caged mRLC to probe how localized myosin activation affects
global stress fiber formation in live cells. Because the caged protein is chemically synthesized,
microinjection was necessary to introduce it into cells. The first trials involved injecting a caged,
fluorescently labeled mRLC into NIH 3T3 mouse embryonic fibroblast cells. Studies have
shown that myosin containing mRLC mutants that cannot be phosphorylated can still associate in
stress fibers, albeit with decreased propensity.11 Thus, we anticipated that the injected mRLC
would incorporate into endogenous cellular myosin. We hypothesized that in the caged state,
myosin incorporation into stress fibers would be minimal, but upon uncaging, the exchanged
myosin could promote further stress fiber formation. To evaluate the efficiency of mRLC
incorporation, we aimed to observe the irradiation-dependent formation or increase of stress
fibers containing fluorescently labeled myosin. These studies were performed before the HMM
ATPase assays that indicated that all the caged derivatives studied in Chapter 2 provided the
desired activities. Thus, at the time, the double NPE-caged pSerl9 mRLC (2-8) was believed to
be the best derivative for cellular applications.
To generate the fluorescently labeled, caged protein, the peptide thioester was
synthesized with the Oregon Green 488 fluorophore to allow the cellular localization of the
injected protein to be directly observed. For incorporation of the fluorophore, Fmoc-Lys(alloc)-
OH was coupled to the N-terminus of the peptide (Scheme 3-1, 3-1). Following addition of the
second NPE group onto the caged phosphopeptide (3-2), the alloc group was removed, and the
commercially available Oregon Green 488-succinimidyl ester was coupled to the lysine side
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chain (3-4). To prevent thioesterification of the free acid of the fluorophore, it was protected as a
Boc ester before cleavage from the resin. Thioesterification and global deprotection then
proceeded as described in Chapter 2 (3-5). The full-length mRLC was synthesized, and
microinjection of this protein led primarily to nuclear localization and diffuse cytoplasmic
fluorescence. Irradiation of the cells under the microscope induced aggregation in the nucleus
but did not lead to the anticipated stress fiber formation (Figure 3-2), which would have been
detected by the presence of parallel bands of fluorescence similar to the structures shown in
Figure 3-1a.
For microinjection studies of the semisynthetic mRLC, a 10- to 20-fold dilution of the
stock protein solution was approximated following introduction into the cell.' 2 Myosin is present
in nonmuscle cells at a concentration of about 1 mg/mL (2 ptM), and the concentration of the
endogenous mRLC is therefore 4 [tM.13 The stock semisynthetic mRLC solution used for
microinjection was 1 - 2 mg/mL (50 - 100 [tM). With the estimated 10- to 20-fold dilution, the
concentration of the microinjected semisynthetic mRLC within the cell was calculated to be 2.5
- 10 [tM.
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Scheme 3-1. Synthesis of the Oregon Green 488-labeled peptide thioester.
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Oregon Green 488
succinimidyl ester
Figure 3-2. Cells injected with Oregon Green 488-labeled double NPE-cpSerl9 mRLC.
a) Injected cell before irradiation. b) Injected cell following irradiation at 365 nm. No
uncaging-induced stress fibers, which would have been observed as parallel bands of
fluorescence, were generated upon irradiation.
Further studies to investigate mRLC incorporation utilized recombinant mRLC that had
been labeled with Oregon Green 488 and then phosphorylated by gizzard myosin light chain
kinase (MLCK) in vitro. NIH 3T3 cells were microinjected with this labeled mRLC and imaged
live and after fixation. Parallel bundles of fluorescence were not observed in any of the live cells
following microinjection, indicating that neither the recombinant nonphosphorylated nor
phosphorylated mRLC incorporated into the native stress fibers of these cells. After 8 hours, the
protein was observed in vesicles, suggesting that protein degradation was a competing process
(Figure 3-3a and b). The cells were then fixed and permeabilized to eliminate soluble proteins
but retain those associated with the cytoskeleton, including any myosin-associated mRLC. The
fixed cells were also stained with fluorescently labeled phalloidin, which binds filamentous actin
(F-actin) and labels stress fibers. After this treatment, the native stress fibers of the cells could
be observed (Figure 3-3e and f). However, the Oregon Green 488 fluorescence of these cells
was very dim and did not correlate with the F-actin staining, confirming that the injected protein
had not incorporated into stress fibers (Figure 3-3c and d). Similar results were observed with
mouse embryonic fibroblast (MEF) cells. Only minor incorporation occurred with vascular
smooth muscle cells, which have large stress fibers, though much of the injected protein
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appeared in vesicles. The difficulty in achieving mRLC incorporation was consistent with in
vitro myosin exchange methods, which required forcing conditions and the use of metal chelators
to disrupt native mRLC binding.
Figure 3-3. NIH 3T3 cells injected with nonphosphorylated or phosphorylated Oregon Green
488-labeled mRLC. a) Image of Oregon Green 488 fluorescence in a live cell injected with the
nonphosphorylated, labeled mRLC. b) Image of Oregon Green 488 fluorescence in a live cell
injected with labeled mRLC that had been phosphorylated by MLCK prior to injection. c)
Image of Oregon Green 488 fluorescence after cells injected with the nonphosphorylated, labeled
mRLC were fixed and permeabilized. d) Image of Oregon Green 488 fluorescence after cells
injected with the phosphorylated, labeled mRLC were fixed and permeabilized. e) Phalloidin
staining of F-actin in the fixed cell shown in c. This treatment stains the native stress fibers of
the cell. f) Phalloidin staining of F-actin in the fixed cell shown in d. Note: No parallel bundles
of fluorescence indicative of stress fibers are observed in a - d.
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The aforementioned results failed to show incorporation of semisynthetic mRLC into the
stress fibers of live cells. Thus, efforts to enhance mRLC incorporation were undertaken. In the
first approach, siRNA-mediated knockdown of mRLC expression was performed to reduce the
endogenous mRLC and promote association of the injected protein. Alternatively, the
semisynthetic mRLC could be incorporated into gizzard smooth muscle myosin in vitro, and then
this exchanged myosin could be microinjected into cells.
Small interfering RNA (siRNA) methods were used to reduce expression of the native
mRLC to generate cellular myosin complexes that were poised to accept the microinjected
semisynthetic protein. siRNA complexes are short, double-stranded RNA molecules that interact
with an RNA-induced silencing complex and pair with a target mRNA to promote mRNA
cleavage and prevent translation of the target protein.' 4 NIH 3T3 cells treated with siRNA to the
mRLC lacked stress fibers, as assessed through F-actin staining, and exhibited a disrupted, "star-
shaped" morphology with many protrusions (Figure 3-4). Nonetheless, following injection of
Oregon Green-labeled NPE-cpSerl9 mRLC, fluorescently labeled stress fibers could be
immediately observed (Figure 3-5a). This result indicates that the knockdown approach enables
efficient mRLC incorporation into endogenous myosin. However, a caveat of this approach is
that cellular myosin lacking the mRLC may be prone to aggregation and additional control
studies would be necessary to verify that myosin remains functional after microinjection.
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Figure 3-4. Effect of siRNA knockdown of mRLC expression in NIH 3T3 cells. Following
treatment, the cells were fixed and stained with fluorescently labeled phalloidin to detect F-actin.
a) Cells with no siRNA treatment. b) Cells treated with siRNA for knockdown of the mRLC.
A second strategy to enable studies of the caged mRLC was microinjection of gizzard
smooth muscle myosin that had been pre-exchanged with the semisynthetic mRLC in vitro.
Although challenges in injection were encountered because myosin precipitation blocked the
injection needle, diluting the myosin and maintaining the cells in a high-salt buffer during
injection alleviated this difficulty. When recombinant mRLC labeled with Oregon Green 488
was pre-incorporated into gizzard smooth muscle myosin and microinjected, fluorescent stress
fibers could be observed within minutes (Figure 3-5b). This approach was used for subsequent
studies because application of siRNA dramatically disrupted normal cellular morphology.
However, a drawback of the pre-incorporation method was that the in vitro exchange required
much greater amounts of the semisynthetic protein compared to direct injection of the mRLC.
Because the fluorescently labeled caged proteins were synthesized on a small scale, only the
non-fluorescent analogs were incorporated into smooth muscle myosin and used for the cellular
studies described below.
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Figure 3-5. Methods to incorporate the semisynthetic mRLC into cells. a) NIH 3T3 cells were
treated with siRNA to the mRLC and microinjected with fluorescently labeled mRLC. The
image shows the fluorescence of the injected protein. The presence of fluorescent stress fibers
(white arrows) indicates that the injected mRLC had incorporated into the endogenous myosin
and stress fibers of the cell. b) Smooth muscle myosin exchanged with fluorescently labeled
mRLC was injected into NIH 3T3 cells. The image shows the fluorescence patterning of the
injected protein, and fluorescently labeled stress fibers can be seen following injection (white
arrows).
3.2 Uncaging Studies
Now that we could successfully incorporate the semisynthetic mRLC into cells, we next
sought to examine the effects of uncaging the mRLC. For these experiments, we chose rat
vascular smooth muscle cells (VSMC) because they are capable of generating larger, more
robust stress fibers and focal adhesions compared to the NIH 3T3 fibroblasts. In initial studies,
myosin exchanged with NPE-cpSerl9 mRLC (2-5) was microinjected. However, no differences
in stress fiber formation could be observed upon irradiation. This was due, in part, to the
extensive network of stress fibers that was present before injection. Thus, to increase our ability
to observe potential uncaging-mediated differences in stress fiber formation or size, we reduced
the basal stress fibers in the cells before injection. Because phosphorylated myosin is necessary
for stress fiber formation, treating the cells with MLCK15 and Rho-associated kinase (ROCK)
inhibitors (ML-7 and Y-27632, respectively)16 depleted these structures and created a
background that enabled more sensitive observation of the effects of protein uncaging.
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For the next experiments, myosin exchanged with mRLC 2-5 was microinjected into rat
VSMC, which had been treated with mRLC kinase inhibitors. Texas Red-labeled dextran was
co-injected with the myosin to provide a reference dye for quantifying the amount of protein that
had been introduced into the cell. Following irradiation on a transilluminator, the cells were
fixed, stained for F-actin with fluorescently labeled phalloidin and for phosphorylated mRLC
with an anti-pSerl9 mRLC antibody, and then imaged by immunofluorescence microscopy. For
these studies, about 20 cells were examined before and after irradiation. The results are shown in
Figure 3-6. Note that only the cells that are visible in the Texas Red Dextran column (images b,
e, h, and k) were microinjected. The differences in stress fiber abundance in the microinjected
cells before (Figure 3-6a and d) and after (Figure 3-6g and j) irradiation were not significant. In
particular, some injected cells contained few structures (Figure 3-6d and j), while other cells
(Figure 3-6a and g) showed prominent bands. Thus, these results do not demonstrate the
anticipated irradiation-dependent increase in stress fiber formation. In addition, antibody
staining for pSerl9 mRLC was variable, and no significant increases in mRLC phosphorylation
were observed after uncaging (Figure 3-6c and f vs. Figure 3-6i and 1). Finally, analysis of the
phalloidin staining in non-injected cells indicated that inhibitor treatment did not consistently
reduce the native stress fibers.
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Figure 3-6. Uncaging of mRLC 2-5 in VSMC. VSMC were treated with ROCK and MLCK
inhibitors. The cells were injected with myosin exchanged with pSerl9 mRLC 2-5, exposed to
365 nm irradiation, if indicated, and then fixed and permeabilized. Actin structures are shown by
phalloidin staining, Texas Red dextran was used a marker for injection, and phosphorylated
mRLC was evaluated by immunofluorescence with an anti-pSer19 mRLC antibody.
The small, irreproducible differences in pSerl9 mRLC antibody staining and stress fiber
formation were addressed through two approaches. First, COS-7 cells, which lack myosin IIA
and inherently have very few stress fibers (Figure 3-7a and c) and lower background levels of
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F-Actin Texas Red Dextran pSer19 mRLC Antibody
mRLC phosphorylation (Figure 3-7b and d) compared to the previously used VSMC, were
advantageous because they eliminated the need for kinase inhibitors, Second, NPE-caged
thiophosphoserinel9 (NPE-c(S)pSerl9) mRLC 2-6 was expected to provide more sustained
phosphorylation compared to the NPE-caged phosphoserine19 mRLC (2-5). Uncaging of
derivative 2-6 generates a thiophosphoprotein, which functions like the corresponding
phosphoprotein but with greater resistance to cellular phosphatases17 (Figure 3-8). Thus, analog
2-6 simplifies the experiments because it eliminates potential complications due to phosphatases,
which would reverse the effects of uncaging. Although not all classes of phosphatases may
demonstrate reduced dephosphorylation of thiophosphoproteins, the myosin phosphatases do not
efficently hydrolyze these substrates. 18
F-actin
COS-7
Rat VSMC
pSer19 mRLC
CO-
Figure 3-7. Comparison of stress fibers and Serl9 mRLC phosphorylation in COS-7 and rat
VSMC. COS-7 cells have fewer stress fibers and lower background levels of pSerl9 mRLC than
rat VSMC. a) Phalloidin staining in COS-7 cells. b) pSer19 mRLC antibody staining in COS-7
cells. c) Phalloidin staining in rat VSMC. d) pSer19 mRLC antibody staining in rat VSMC.
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Figure 3-8. Thiophosphate resistance to cellular phosphatases. This derivative prolongs the
signal from uncaging.
Following microinjection of COS-7 cells with myosin exchanged with 2-6, the cells were
exposed to irradiation, fixed, and then stained with an antibody specific for pSer19 mRLC.
Unfortunately, results from these studies were again inconsistent, with each trial showing
varying increases in pSer19 mRLC antibody staining following uncaging.
The antibody used in these studies was obtained from Cell Signaling and had previously
been validated through dot blot experiments, in which the caged and uncaged proteins were
spotted on a nitrocellulose membrane and then probed with the antibody. This technique was
initially chosen because it does not denature proteins and could better represent the antigen-
antibody interaction. However, the variable results from the cellular uncaging studies prompted
us to further examine the specificity of the antibody. More thorough Western blot analysis with
the caged and uncaged forms of the NPE-cpSerl9 and NPE-c(S)pSerl9 mRLCs revealed that the
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antibody from Cell Signaling recognized both forms of the protein, with only a moderate
increase in signal intensity upon uncaging (Figure 3-9a). Therefore, the inconsistent cellular
uncaging results described above were attributed to the poor specificity of the antibody. We
examined other commercially available pSerl9 mRLC antibodies and identified one from
Genscript that was compatible with immunofluorescence and could reliably discriminate
between the caged and uncaged forms of the protein. Although the Genscript antibody showed
minor recognition of the caged species, the difference between the two states was greater than
that with the Cell Signaling antibody (Figure 3-9c). Dot blot studies (Figure 3-9b and d) showed
trends that were similar to the Western blots and verified that the Genscript antibody would
provide the desired specificity for these experiments.
134
a) mRLC 2-5 mRLC 2-6
rL-- I
UV: - + - +
mRLC 2-5 mRLC 2-6
UV: - + - +
b) mRLC 2-5
UV: - +
d)
1x
mRLC 2-6
-
+
mRLC 2-5 mRLC 2-6
JV:- + - +
* 9
Figure 3-9. Comparison of antibodies specific for pSerl9 mRLC. Antibodies from Cell
Signaling and Genscript were tested with the NPE-cpSerl9 mRLC (2-5) and the NPE-
c(S)pSerl9 mRLC (2-6) before (- UV) and after (+ UV) irradiation. a) Western Blot probed
with an anti-pSer19 mRLC antibody from Cell Signaling. b) Dot blot with the antibody from
Cell Signaling. The samples were spotted with increasing concentrations (lx, 2x, and 3x). c)
Western blot probed with an anti-pSer19 mRLC antibody from Genscript. d) Dot blot with the
antibody from Genscript. The samples were spotted with increasing concentrations (1x, 2x, and
3x).
After identification of an antibody that better distinguishes between the caged and
uncaged forms of the mRLC, cellular results were much more robust. Myosin exchanged with
2-6 was injected into COS-7 cells, and irradiation was performed on a transilluminator. The
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results are depicted in Figure 3-10. The dextran fluorescence intensities of all four cells shown
in Figure 3-10 are similar, indicating that comparable amounts of protein had been microinjected
and that the anti-pSerl9 mRLC antibody staining intensities can be directly compared. The
signal from the Genscript anti-pSerl9 mRLC antibody was significantly higher following
uncaging (Figure 3-10i and 1) compared to injected cells that had not been irradiated (Figure
3-10c and f). This result demonstrates that the mRLC can be readily uncaged within a cellular
environment. Additionally, while the staining from the anti-pSer19 mRLC antibody increased
proportionally with the amount of injected protein in cells that were uncaged, this ratio remained
constant in cells that were not exposed to UV irradiation (Figure 3- 11). However, in contrast to
the dramatic light-triggered increase in phosphorylation, the change in stress fiber formation was
less pronounced (Figure 3-10a and d vs. Figure 3-10g and j). Further investigation will be
necessary to determine whether the stress fibers increase in size upon irradiation.
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Figure 3-10. Uncaging of mRLC 2-6 in COS-7 cells. COS-7 cells injected with myosin
exchanged with 2-6 and Texas Red-labeled dextran marker before (- UV) or after (+ UV)
irradiation. The cells were fixed and stained with fluorescently labeled phalloidin and an
antibody specific for pSer19 mRLC.
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Figure 3-11. Anti-pSerl9 mRLC antibody signals after uncaging. COS-7 cells were injected
with a solution of myosin exchanged with 2-6 and Texas Red dextran, exposed to UV irradiation
(2 min.on a transilluminator) if indicated, fixed, permeabilized, and stained for pSerl9 mRLC.
The intensity of anti-pSer19 mRLC antibody staining in individual cells is plotted against the
dextran fluorescence intensity, which corresponds to the amount of protein that was injected.
After demonstrating that the phosphoprotein could be generated by global irradiation, we
sought to examine uncaging with greater spatial resolution. This was achieved by irradiation
through a DAPI filter set (375/50 nm) on the microscope. To limit irradiation to only a portion
of a single cell, a pinhole filter was placed in the beam path. After the cells were injected with
myosin containing the NPE-c(S)pSerl9 mRLC (2-6), they were fixed to eliminate complicating
effects from diffusion of the uncaged myosin. A portion of an injected cell was exposed to
irradiation, and then the cells were permeabilized and stained for actin and pSerl9 mRLC. As
shown in Figure 3-12, phosphorylated mRLC was generated only within the irradiated region,
demonstrating that this tool can be effectively used to dissect the spatial and temporal dynamics
of myosin interactions.
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Figure 3-12. Localized uncaging within the cell. COS-7 cells were injected with a solution of
myosin exchanged with 2-6 and Texas Red dextran and then fixed. A portion of the cell was
exposed to UV irradiation under the microscope, and the cells were stained for pSerl9 mRLC.
The outlined region indicates the portion of the cell that was irradiated.
3.3 Future Directions: Studies of Uncaging on Focal Adhesion Formation
The aforementioned results demonstrate that the mRLC can be efficiently uncaged within
cells with spatial and temporal control. Although we anticipated that the caged protein would be
useful for examining the dynamics of stress fiber formation, the efficient incorporation of
injected myosin into stress fibers before irradiation complicates this application. While it is
possible that the stress fibers will increase in size upon irradiation, this effect has not yet been
observed. Another possible application is the investigation of myosin phosphorylation on focal
adhesion formation. Because phosphorylation drives the formation of these structures, it is
expected that uncaging the mRLC would cause new focal adhesions to form or increase the size
of existing adhesions. A preliminary assay was conducted, in which vinculin, a protein
associated with focal adhesions, was stained before and after uncaging. This initial assay
indicated that focal adhesions may be more prominent following uncaging (Figure 3-13b vs.
Figure 3-13e). These results are currently being validated, and efforts are now focused on
visualizing the effect of mRLC uncaging on fluorescently tagged vinculin within live cells.
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Figure 3-13. Preliminary studies on the effect of uncaging NPE-c(S)pSerl9 mRLC 2-6 on focal
adhesion formation. Myosin exchanged with 2-6 and Texas Red-labeled dextran were injected
into COS-7 cells. Cells were irradiated, if indicated, and then fixed and stained with antibodies
against vinculin and pSerl9 mRLC. Representative focal adhesions in image e are indicated by
the white arrows. These structures are less prominent before irradiation (image b).
Conclusions
The results described in this chapter demonstrate that the caged mRLC can be
incorporated into myosin and uncaged within the cell, and preliminary results on the effect of
myosin phosphorylation on focal adhesion formation are promising. Additionally, the ability to
release phosphorylated mRLC in only a portion of the cell enables studies of the spatial effects of
myosin activation. The caged mRLC is now poised to facilitate more detailed studies of many
aspects of myosin function. For instance, the effects of myosin phosphorylation on cellular force
generation could be assessed using traction force microscopy.' 9 Alternatively, the role of myosin
during cell division or tumor invasion could be studied. Finally, comparison of the cellular
effects of uncaging mRLCs 2-5 and 2-6 would enable the role of myosin phosphatase to be
directly addressed.
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Methods
Oregon Green 488-Labeled, Double NPE-cpSer19 mRLC
The Oregon Green 488-peptide thioester was synthesized by coupling Fmoc-Lys(alloc)-OH to
the N-terminus of the FLAG-mRLC(1-23) peptide. Following incorporation of the second NPE-
caging group onto the peptide (100 mg, 20 [tmol) as described in Chapter 2, the alloc protecting
group was removed on-resin by repeated treatment with Pd(PPh3)4 (20 mg, 17 [tmol) and
phenylsilane (70 [tL, 568 kmol) in DCM. After the resin was washed with DCM, the Oregon
Green 488 succinimidyl ester, 5-isomer (Invitrogen, 10 mg, 20 [imol) was coupled to the free
lysine side chain of the peptide in DMF with collidine (15 pL, 114 [tmol) overnight. The free
acid of the fluorophore was protected as the Boc ester by treatment with di-tert-butyl dicarbonate
(26 mg, 120 [tmol) and 4-dimethylaminopyridine (2.2 mg, 18 itmol) in 1:1 (v/v) tert-
butanol/THF (3 mL). Following an overnight reaction, the resin was washed with DCM and
DMF, and thioesterification proceeded as described in Chapter 2.
Cloning and Expression of Recombinant mRLC
The native mRLC (residues 1 - 171) was expressed and purified for initial microinjection
studies. The gene fragment encoding the protein was amplified by PCR, as described in
Chapter 2. The forward primer encoded an NdeI restriction site, and the reverse primer encoded
a XhoI restriction site. The sequences of the primers are given below:
Forward: 5'-CGAGGGAACTCCATATGTCGAGCAAAAAAGCG-3'
Reverse: 5'-GTTGATCTCGAGGTCATCTTTGTCTTTCGC-3'
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The mRLC DNA fragment was digested with NdeI and XhoI according to manufacturer's
protocols and ligated into the pET24a(+) vector (Novagen), which installed the C-terminal
hexahistidine tag. The ligation product was transformed into DH5a cells (Invitrogen) and grown
on LB plates supplemented with kanamycin (30 [tg/mL).
The mRLC-pET24a(+) vector was transformed into BL-21 Codon Plus RP competent cells
(Agilent Technologies). The protein was expressed in a l-L culture of LB containing kanamycin
and chloramphenicol (30 stg/mL each) by incubation at 37 'C with shaking at 200 rpm. Once an
OD of -0.6 at 600 nm was reached, the culture was cooled to 16 'C, and IPTG was added to
0.2 mM to induce protein expression. The culture was incubated overnight at 16 'C with
shaking. The next day, the cells were harvested by centrifugation, and the cell pellets were
stored at -80 'C until use.
Purification of Recombinant mRLC
The pellet from a 1-L culture was thawed in Gibco PBS with 300 mM NaCl, 10 mM p-
mercaptoethanol, 10 mM imidazole, 1 mg/mL lysozyme, and 1 tL/mL Protease Inhibitor
Cocktail Set III. The cells were lysed on ice by sonication at 40% amplitude, 1 s on/1 s off for
45 s with a Sonics Vibra Cell sonicator. Cell debris were pelleted at 100,000 x g for 45 min at 4
'C, and the lysate was incubated for 2 h with 3 mL Ni-NTA resin (Qiagen). The resin was first
washed with PBS containing 10 mM imidazole (100 mL) and then with PBS supplemented with
30 mM imidazole (100 mL). The protein was eluted with PBS containing 250 mM imidazole.
The protein was then dialyzed into labeling buffer (Gibco PBS, pH 7.4). Protein concentration
was measured by UV (s = 5,960 M 1cm-1 at 280 nm). Average Yield: 24 mg/L.
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Labeling Recombinant mRLC with Oregon Green 488
The native mRLC (1.6 mg/mL) was incubated with 1 mM TCEP for 1 h on ice. Oregon Green
488 iodoacetamide (Invitrogen, 20 molar equivalents from a 50 mM stock in DMSO) was added,
and the reaction was rotated overnight at 4 'C. The reaction was quenched by the addition of p-
mercaptoethanol to 1 mM. The labeled protein was purified from excess fluorophore using a
HiTrap desalting column (GE Healthcare, 5 mL), eluting with Gibco PBS. A portion of this
protein was phosphorylated by MLCK as described in Chapter 2. Protein concentration was
determined through a BioRad assay using BSA as a standard, and the Oregon Green 488
concentration was measured by absorbance (s = 76,000 M- cm 1 at 502 nm in MeOH). Labeling
efficiencies of 65% were routinely achieved.
Cell Culture and Microinjection
Cells were cultured in Dulbecco's Modified Eagle Media supplemented with 10% (v/v) fetal
bovine serum at 37 'C in a humidified environment with 5% CO 2. For injection and imaging
experiments, cells were transferred to custom-made, glass-bottom pertri dishes made from a
No. 1.5 coverslip coated with 2 gg/mL fibronectin overnight at 4 *C. Inhibitors (ML-7 and
Y-27632) were each added to the culture at 20 [tM, if indicated. Microinjection needles were
pulled from borosilicate glass micropipettes (Sutter Instrument Company, inner diameter = 0.78
mm, outer diameter = 1.0 mm, with filament) using a Model PC 84 Sachs-Flaming Micropipette
puller. Micropipette tip size was estimated to be -0.5 gm.20 To prevent the needle from
clogging when gizzard smooth muscle myosin was injected, myosin at ~2.5 mg/mL in sterile
PBS supplemented with 295 mM KCl, 0.5 mM DTT, and 1 mg/mL Texas Red-conjugated
10,000 MW lysine-fixable dextran was centrifuged at 75,000 x g for 30 min at 4 *C. The
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supernatant was then back-loaded into the micropipettes and injected into cells at a pressure of
0.8-1.8 psi using a Narishige IM 300 Microinjector mounted on a Nikon Diaphot microscope.
To prevent inadvertent uncaging during injection, a glass UV filter (blocking < 400 nm light) and
a red additive dichroic color filter (passing > 600 nm light) were placed in the transillumination
beam path, and cells were never exposed to arc lamp illumination. For myosin injections, cells
were maintained in culture media supplemented with 150 mM KCl to enhance myosin solubility
and to prevent the needle from clogging. Post-injection, cells were returned to culture media and
allowed to recover for 1-4 h.
siRNA Knockdown of mRLC Expression
NIH 3T3 cells were treated with siRNA targeted to the murine mRLC (GenBank accession
number: NM_023402.2) using standard protocols with Lipofectamine RNAiMax Transfection
Reagent (Invitrogen). The sequence providing the most efficient knockdown is given below:
Target DNA: CCTCCAATGTGTTCGCCAT
Sense: 5'-CCUCCAAUGUGUUCGCCAUdTdT-3'
Anti-sense: 5'-AUGGCGAACACAUUGGAGGdTdT-3'
Cellular Uncaging
Whole-cell uncaging was accomplished by exposing cells to the emission of a Stratagene 2020E
transilluminator for 2 min. Following irradiation, cells were allowed to recover for 20 min. The
cells were then fixed with 2% (v/v) formaldehyde in PBS and permeabilized with 0.05% (v/v)
saponin in PBS. Cells were blocked with a solution of 2% (w/v) BSA and 0.05% (v/v) saponin
in PBS and incubated with a rabbit phospho-specific mRLC antibody (Genscript, P.N.: A01 180)
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diluted 1:400 in blocking buffer. Cells were then blocked and stained with Alexa Fluor 647 goat
anti-rabbit antibody diluted 1:400 in blocking buffer. PBS was used as the media during imaging
experiments. Cells were imaged on a Nikon TE 300 Microscope equipped with a 100X TIRF
lens and a HQ2 Cool Snap Camera. Texas Red-conjugated dextran and Alexa Fluor 647 were
imaged through standard filter sets with 500 ms exposures.
Localized Uncaging
For experiments with localized uncaging, the cells were fixed following injection. On-scope
uncaging was accomplished using the same optical system, but with a pinhole placed in the beam
path to allow selective excitation of half of a cell. A 5 s exposure though a high-throughput
DAPI filter set (Semrock DAPI-5060B-NQF) was found to be sufficient for uncaging. Antibody
staining and imaging were performed as described above.
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Chapter 4 : Sequential Modulation of Protein
Function Using Spectrally Differentiated
Caged Phosphoamino Acids
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Introduction
Protein phosphorylation is a ubiquitous mechanism mediating protein function and
dynamic signaling interactions. Regulated by a complex balance of kinases and phosphatases,
phosphorylation governs fundamental physiological processes and can contribute to human
disease.' Traditional methods to interrogate the role of phosphorylation within a cellular
environment include genetic techniques, such as siRNA-mediated knockdown of gene
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expression and mutagenesis of phosphorylation sites.3 While these approaches have provided
valuable information, they do not offer insight into the spatial and temporal dynamics of the
modification, which are critical for proper cellular function. A complementary approach that
overcomes this limitation is the use of photolabile protecting groups, or "caging groups." These
groups are covalently attached to an essential phosphorylated amino acid residue of a peptide or
protein, masking the active component and rendering the molecule inactive within the biological
system. Upon irradiation, the caging group is released, liberating the active phosphorylated
species, which exerts normal functions within the system. The timing and region of uncaging
within the cell can be defined by the investigator, allowing precise control over
phosphorylation.4 The Imperiali group has previously reported the synthesis of 1-(2-
nitrophenyl)ethyl (NPE)-caged phosphorylated amino acid building blocks for Fmoc-based solid
phase peptide synthesis (SPPS). 5'6 Although peptides and proteins containing these residues
have been successfully exploited for the investigation of many systems, 7~11 the current caging
approach is limited to the study of only one caged phospho- peptide or protein in an experiment.
The development of orthogonal caging groups that can be independently released would
significantly expand the scope of the tools by enabling interrogation of two phosphorylation
pathways within one system using different wavelengths of light.
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Selective photolysis requires caging groups with distinct photophysical properties, and
the few studies that have addressed this challenge utilize caging groups from the o-nitrobenzyl
(NB) and coumarinyl families."- Kotzur, et al. caged the sulfhydryl side chain of cysteine with
derivatives from these two families to enable sequential deprotection in model peptide studies.12
Another report used the NB-caged PKG kinase and coumarinyl-caged cAMP, which stimulates
the PKA kinase upon uncaging, to sequentially activate these protein kinase pathways.' 3 Finally,
selective two-photon uncaging of dinitroindolinyl-caged glutamate and coumarinyl-caged y-
aminobutyric acid was employed to modulate action potentials.14 All of these studies
demonstrate the value of a sequential uncaging approach; however, they describe the synthesis of
specialized molecules and do not provide methods that can be readily applied to other systems.
To further advance the tools available to probe the role of phosphorylation in vitro and within
cellular systems, we sought to develop a general sequential uncaging strategy that can be
conveniently applied to diverse systems. In this chapter, we detail the synthesis of coumarinyl-
caged phosphorylated amino acid building blocks for Fmoc-based SPPS, which can be used
together with our previously reported NPE-caged phosphorylated residues to create peptides that
can be sequentially uncaged (Figure 4-1). We initially applied this system to sequentially release
mono- and diphosphorylated myosin regulatory light chain (mRLC), but later studies focused on
using this system to photochemically control the activity of wild-type p53 induced phosphatase
(Wip1).
Previous work in the Imperiali group focused on the NPE cage over other commonly
used NB derivatives for application in a biological environment because photolysis at 365 nm is
efficient and the nitrosoacetophenone photobyproduct is less reactive than the
nitrosobenzaldehyde byproduct of NB groups.' 5 To establish a method to sequentially uncage
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two different phosphopeptides in the same solution, we examined the photophysical properties of
other caging, groups that could be used in conjunction with the NPE group. NB caging groups
with variable properties have been reported, but they are activated within a similar range of
wavelengths or undergo inefficient photolysis.16 While alternatives, including the phenacyl and
benzoin groups, are activated at wavelengths below or similar to the NPE group, photoactivation
of the coumarinyl family occurs above 400 nm.17 Thus, we investigated photolysis of the
[7-(diethylamino)coumarin-4-yl]methyl (DEACM) caging group together with the NPE group.
The DEACM group has been reported to be an effective cage for cyclic nucleotides'8 and ATP,'9
and uncaging of this derivative is very efficient.18 Importantly, the peak of maximal absorbance
of the DEACM chromophore occurs at 390 nm, 20 allowing it to be selectively released in the
presence of the NPE group, which has minimal absorption at wavelengths above 380 nm (Figure
4-2). Additionally, this coumarinyl group is advantageous in its own right because, relative to
the NB family, the 7-diethylamino-4-(hydroxymethyl)coumarin (DEACM-OH) photobyproduct
is inert in solution and cellular systems that are sensitive to UV irradiation may benefit from long
wavelength activation.
o=0 -o- 0=02 .yN 2  365 nm
0 N Active NO Active Active
Inactive Inactive N Atv Inactive
HO
Figure 4-1. Sequential release of caged phosphopeptides. The initial irradiation at 420 nm
releases the coumarinyl group without affecting the NPE group. A subsequent irradiation at
365 nm liberates the NPE group to introduce a second phosphopeptide.
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Figure 4-2. UV-Vis spectra of DEACM- and NPE-caged peptides.
The mechanism of DEACM uncaging is proposed to occur through solvent-assisted
photoheterolysis.2 In the excited state, the amino group can donate electron density into the
coumarinyl system, which then enables rearomatization of the hydroxypyran moiety (Figure
4-3). This electronic rearrangement promotes an SNI reaction, in which the phosphopeptide is
the leaving group and a carbocation, which is stabilized by the aromatic system, is generated.
The complex is intially formed as an ion pair, and then the coumarinyl carbocation is quenched
by water.
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Figure 4-3. Proposed mechanism of DEACM uncaging.
Results and Discussion
4.1 Synthesis of DEACM-Caged Phosphorylated Amino Acid Building Blocks for Fmoc-
Based Solid Phase Peptide Synthesis
We synthesized DEACM-caged phosphoserine (4-1), threonine (4-2), and tyrosine (4-3)
amino acid building blocks for Fmoc-based SPPS (Figure 4-4, Scheme 4-1) to facilitate efficient
incorporation of these caged residues into peptides and proteins. First, a DEACM-modified
trivalent phosphitylating agent (4-5) was generated by reaction of DEACM-OH" (4-4) with
2-cyanoethyl NN-diisopropylchlorophosphoramidite. Each commercially available Fmoc-amino
acid was protected as the corresponding allyl ester (4-7 in the case of Fmoc-Ser), and the side
chain hydroxyl group of each derivative was treated with 4-5 to afford a DEACM phosphite
intermediate. Subsequent in situ oxidation with tert-butyl hydroperoxide yielded the
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corresponding caged phosphoamino acid (4-8), and final allyl deprotection with Wilkinson's
catalyst furnished the free acid building blocks (4-1, 4-2, and 4-3) for peptide synthesis.
~~N
N NN / CN
0/ \ C 0/ \ CN0
-- 0 0=0
0 0 0 0
O-P=O O-P=0
0 60
FmocN OH Fmoc.' OH Fmoc'N OH
H 0 H H 0
4-1 4-2 4-3
Figure 4-4. DEACM-caged phosphoserine, threonine, and tyrosine building blocks for SPPS.
a) Phosphitylating Agent Synthesis
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Scheme 4-1. Synthesis of DEACM-caged phosphoserine.
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Peptides were generated by standard SPPS employing PyBOP or HBTU/HOBt as
coupling agents. The caged amino acid was coupled onto the amino terminus of the growing
peptide using slightly modified conditions (HATU/HOAt and collidine) to prevent B-elimination
of the phosphotriester, which can be a deleterious side reaction with serine and, to some extent,
with threonine. After incorporation of the residue into a peptide, Fmoc removal with 20%
4-methylpiperidine in DMF concomitantly cleaved the $-cyanoethyl group to generate a
monoprotected phosphopeptide that is resistant to p-elimination, thereby allowing peptide
elongation to proceed under the standard conditions.
4.2 Sequential Uncaging of the Myosin Regulatory Light Chain
Our initial studies focused on ensuring that the DEACM group could be released from the
peptide under conditions that would not affect the NPE group. For preliminary studies, myosin
regulatory light chain (mRLC) peptides containing the DEACM-caged pSerl9 or NPE-caged
pSerl9 residues described in Chapter 2 were irradiated together at 410 nm and characterized by
RP HPLC analysis. To enable HPLC separation of the pSer19 mRLC peptides that would result
from uncaging of either peptide, the DEACM-caged peptide was synthesized as a C-terminal
thioester, and the NPE-caged peptide contained a C-terminal acid. Exposure of these peptides to
irradiation at 410 nm from a handheld light source led to efficient uncaging of the DEACM
group with only minor release of the NPE group after 2 min (Figure 4-5). This result indicated
that the NPE and DEACM caging groups have the potential to be used in one system for
selective photolysis and prompted us to explore sequential uncaging of the mRLC protein. Due
to absorbance at 365 nm, the DEACM group must be irradiated before the NPE group to achieve
wavelength-selective photolysis.
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Figure 4-5. HPLC uncaging time course of DEACM- and NPE-caged peptides at 410 nm. The
two peptides (55 [M each) were irradiated at 410 nm in 10 mM HEPES (pH 7.1) with 500 [M
inosine. The peptide species were quantified by analytical RP HPLC monitored at 228 nm by
determining the areas of the caged and uncaged peptide peaks relative to the area of the inosine
peak. The percent of uncaged Peptide 2 relative to the initial amount of DEACM-caged
Peptide 2 is plotted against the duration of irradiation.
As described in Chapter 2, the mRLC can be phosphorylated at Serl9 alone or at both
Thr18 and Serl9. Phosphorylation at Thr18 alone has not been observed in native systems, but
the effect of modification at this site was explored in Chapter 2 through protein semisynthesis.
While heavy meromyosin (HMM) associated with the nonphosphorylated mRLC showed
negligible ATPase activity, phosphorylation at either Thr18 or Ser19 increased activity about 10-
fold or 35-fold, respectively, over that of HMM with the nonphosphorylated mRLC. In addition,
phosphorylation at both Thr18 and Ser19 generated even greater activity (50-fold increase in
activity over nonphosphorylated mRLC). To test the sequential uncaging approach, we
synthesized the mRLC with NPE-caged pThrl8 and DEACM-caged pSerl9 (Figure 4-6). This
construct would allow the monophosphorylated pSerl9 and diphosphorylated Thr18 Ser19
mRLC to be sequentially generated. We anticipated that activity would be low in the caged state
and that the first irradiation at 410 nm would generate the NPE-cpThrl8 pSerl9 mRLC and
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significantly increase activity. The second irradiation at 365 nm would then lead to a further
increase in activity due to release of the pThrl8 pSerl9 mRLC (Figure 4-7a).
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Figure 4-6. Sequential uncaging of the mRLC. mRLC with DEACM-cpSerl9 and NPE-
cpThrl8 was tested for the ability to sequentially release each phosphorylated residue and
modulate HMM activity.
HMM exchanged with this DEACM- and NPE-caged protein showed relatively low
activity before irradiation (0.30 ± 0.002 s-1), and following exposure to 410 nm light for 2 min,
activity increased 5-fold to 1.5 ± 0.03 s-1. However, no further increase in activity was observed
after the 365 nm irradiation (Figure 4-7b). We reasoned that because the expected difference in
activity between the two irradiation states is modest (about 1.4-fold), this increase may be
difficult to observe. Additionally, if a small fraction of the NPE group had been removed during
the first irradiation, activity differences between the two irradiation events would be even
smaller. Finally, the fold-increase in activity following the first irradiation was only 5-fold.
However, as shown in Chapter 2, a 20-fold increase in activity was observed upon irradiation of
the NPE-cpSerl9 mRLC. This indicates that inclusion of the two adjacent caged phosphorylated
residues may not fully suppress activity and could increase the activity of the caged state, thereby
contributing to smaller differences in activity after irradiation.
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Figure 4-7. HMM ATPase activity with NPE-cpThrl8 DEACM-cpSerl9 mRLC. a) HMM
ATPase assays with semisynthetic mRLCs from Chapter 2. This graph shows the differences in
activity that would be expected after first uncaging DEACM-cpSerl9 and then releasing NPE-
cpThrl8. b) ATPase activity of HMM exchanged with NPE-cpThrl8 DEACM-cpSerl9 mRLC.
Irradiation 1 was at 410 nm for 2 min, and Irradiation 2 occurred at 365 nm for 2 min.
Because no increase in activity was observed after the 365 nm irradiation, a second
strategy was employed (Figure 4-8). In this design, the DEACM caging group was appended to
pThrl8 and the NPE group was attached to pSerl9. We predicted that removal of the DEACM
group to generate pThrl8 would lead to a marginal increase in HMM ATPase activity, while
subsequent photolysis of the NPE group would generate a more significant increase due to
release of the pThr18 pSer19 protein (Figure 4-9a).
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Figure 4-8. Sequential uncaging of the mRLC - Approach 2. mRLC with DEACM-cpThrl8
and NPE-cpSerl9 was tested for the ability to sequentially release each phosphorylated residue
and modulate HMM activity.
The caged peptide and corresponding protein were synthesized, and the semisynthetic
protein was exchanged into HMM. As expected, activity was low in the caged state
(0.14 ± 0.02 s-), and irradiation for 80 s at 410 nm led to a 2.9-fold increase in ATPase activity
(0.41 ± 0.10 s'). Subsequent irradiation for 2 min at 365 nm increased activity about 3.4-fold to
1.18 ± 0.27 s 1 (Figure 4-9b). Although this construct demonstrated the expected trends, the
increase in activity following the second uncaging was not as significant as expected. This was
likely due to partial removal of the NPE group at 410 nm. Indeed, release of the pSerl9 or
pThrl8 pSerl9 mRLC during the first irradiation at 410 nm would cause a more significant
increase in ATPase activity compared to the modest increase resulting from the intended release
of the pThrl8 mRLC. To analyze the mRLC species following uncaging, Western blots were
probed with an anti-pSer19 mRLC antibody that does not detect pThrl8 mRLC but recognizes
phosphorylation at Ser19 alone or at both Thr18 and Serl9. The Western blot of the exchanged
HMM showed no signal with the caged protein and very slight staining after HMM was
irradiated for 80 s at 410 nm, confirming that minor NPE release occurred after the initial
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irradiation at 410 nm. Nonetheless, by carefully controlling the duration of the first irradiation,
we could achieve sequential release of the mono- and diphosphorylated proteins.
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Figure 4-9. HMM ATPase activity with DEACM-cpThrl8 NPE-cpSerl9 mRLC. a) HMM
ATPase assays with semisynthetic mRLCs from Chapter 2. The graph shows the increases in
activity that would be expected after uncaging DEACM-cpThrl8 and then releasing NPE-
cpSerl9. b) ATPase activity of HMM exchanged with DEACM-cpThrl8 NPE- cpSerl9 mRLC.
Irradiation 1 was at 410 nm for 80 s, and Irradiation 2 occurred at 365 nm for 2 min.
Although the mRLC protein provided an initial model to explore sequential uncaging, the
adjacent caged phosphorylated residues introduced greater complexities. In addition, because
photolysis of either caged site of the mRLC would lead to an increase in activity, it was difficult
to attribute the increases to a particular uncaging event. To further explore this sequential
uncaging approach, we turned to a more simplified peptide-based system in which release of
each caged phosphopeptide would have an opposing effect that could be clearly distinguished in
an activity assay. We also further improved the experimental setup to achieve more selective
uncaging by reducing premature NPE release during the first irradiation.
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4.3 Sequential Uncaging of Wip1 Phosphatase Substrate and Inhibitor Peptides
We chose the wild-type p53-induced phosphatase (Wipi) system as a more tractable
model to test the sequential uncaging approach. Wipl is a Ser/Thr protein phosphatase central
for attenuating the DNA damage and repair response and p53 tumor suppressor activity. It
dephosphorylates and inactivates a number of proteins, including p38 MAP kinase and proteins
that stimulate p53. Wipl is involved in tumorogenesis, and the gene encoding the protein is
23amplified in some cancers. A phosphopeptide substrate based on the phosphorylation site of
p38 has been used for in vitro studies of Wipl activity,24 and a cyclic phosphopeptide inhibitor
of Wipl has been identified.2 5  Thus, a DEACM-caged substrate and NPE-caged inhibitor
constitute an ideal system to test the sequential uncaging scheme for the ability to initiate and
then inhibit the Wip1-catalyzed reaction in a wavelength-dependent and enzyme-independent
fashion (Figure 4-10).
41aP-o-O
Irradiation 1 Irradiation 2
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No Vipl activity Release peptide substrate, Release peptide inhibitor,
Start phosphatase reaction Releas pptde in[I substr*'Ac-TDDEM-cpT-GpYVAT
diNI~ik = cyclic(M-cpS-pYVAC)
Figure 4-10. Sequential uncaging to control activity of Wip1 phosphatase. The DEACM-caged
phosphopeptide substrate enables the first irradiation at 420 nm to initiate the Wipl reaction. A
subsequent irradiation at 365 nm releases the NPE-caged phosphopeptide inhibitor to attenuate
Wip 1 activity.
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We first synthesized NPE- and DEACM-caged phosphopeptides to explore selective
release of the DEACM group in the presence of the NPE group. The peptide sequences were
based on a phosphopeptide substrate (Ac-TDDEMpTGpYVAT)) and cyclic phosphopeptide
inhibitor (cyclic(MpSIpYVAC)) of Wipl. Wipl catalyzes the dephosphorylation of pThr in the
24
substrate peptide. Therefore, to prevent Wip1 activity until irradiation, the substrate was
prepared with DEACM-caged pThr. Additionally, because studies on Wip1 inhibition by cyclic
phosphopeptides revealed that pSer is necessary for inhibition,25 this peptide was synthesized
with NPE-caged pSer to enable 365 nm light to drive inhibitor activation. We used RP-HPLC
analysis to examine the kinetics of peptide photolysis. To prevent NPE uncaging during the first
irradiation, the handheld light source was equipped with a 420-nm cut-on filter. Under these
conditions, irradiation of a mixture of the two peptides led to efficient release of the DEACM
group and generation of the free pThr substrate peptide (Figure 4-11). Importantly, the NPE
group was stable under these conditions with only negligible uncaging, even after irradiation for
3 min. Following this, irradiation at 365 nm released the NPE group to afford the corresponding
pSer inhibitor peptide (Figure 4-12). These studies demonstrate the improved selectivity of
DEACM uncaging achieved with the 420-nm light filter.
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Figure 4-11. Uncaging time course of DEACM-caged substrate and NPE-caged inhibitor
peptides at 420 nm. a) A solution of the DEACM- and NPE-caged peptides (113 [M each) in 10
mM HEPES (pH 7.1) with 70 [M inosine was irradiated at 420 nm for the indicated times. The
reactions were followed by analytical RP-HPLC at 228 nm. Peptides were quantified based on
HPLC standard curves of the caged and noncaged derivatives. The amount of each peptide was
normalized to the amount of inosine present, and the percent of the uncaged substrate peptide is
plotted relative to the initial amount of the DEACM-caged substrate. b) HPLC traces of the
DEACM- and NPE-caged peptides (1 and 2, respectively) before (t = 0 min) and following
irradiation at 420 nm. The released substrate peptide and the DEACM-OH byproduct of
uncaging are denoted by 3 and 4, respectively.
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Figure 4-12. Uncaging time course of the NPE-caged inhibitor at 365 nm. The NPE-caged
inhibitor (113 [M) in 10 mM HEPES (pH 7.1) with 70 [M inosine was irradiated for the
indicated times. The reactions were monitored by RP HPLC at 228 nm. The peptides were
quantified based on HPLC standard curves of the caged and noncaged derivatives. The amount
of each peptide was normalized to the amount of inosine present, and the percent of the uncaged
inhibitor is plotted relative to the amount of NPE-caged inhibitor at t = 0 min.
Encouraged by the model uncaging studies, we tested the caged peptides in a Wip1
phosphatase assay, in which dephosphorylation of the substrate peptide was monitored by
quantification of the released inorganic phosphate. Initially, we evaluated the caged peptides
before and after irradiation to confirm that incorporation of the caging groups conferred the
predicted properties. We compared Wip1 activity with the DEACM-caged substrate and the
native, noncaged substrate (Figure 4-13). As anticipated, no activity was observed before
irradiation, but exposure to 420 nm light for 3 min unmasked the pThr and restored phosphatase
activity to a level similar to that observed with the native substrate subjected to the same
irradiation conditions (0.52 ± 0.03 s-1 and 0.66 ± 0.06 s-1, respectively). Based on Michaelis-
Menten kinetics and using the reported Km of the phosphopeptide substrate (13 ptM),2 this
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activity corresponds to release of 53% of the phosphorylated substrate and is consistent with the
uncaging time course (Figure 4-11 a).
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Figure 4-13. Wip1 activity with DEACM-caged and native substrate peptides. Wip1 activity
was measured with the DEACM-caged substrate peptide (30 tM) with no irradiation and after
irradiation at 420 nm for 3 min (v = 0.52 ± 0.03 s1). The activity of Wip1 with the native
substrate peptide (30 [tM) was determined after separately irradiating the substrate and enzyme
at 420 nm for 3 min and starting the reaction by adding the enzyme to the substrate (v = 0.66
0.06 s-').
We then turned our attention to the NPE-caged inhibitor (Figure 4-14). To assess the
effectiveness of caging pSer within the peptide, we added the caged inhibitor to an assay solution
containing Wip1 and the DEACM-caged substrate after the reaction had first been initiated by
irradiation at 420 nm. Without exposing the caged inhibitor to 420 nm light, activity was slightly
reduced to 0.38 ± 0.04 s-1, demonstrating that masking the pSer in the peptide largely eliminates
inhibitory properties. Next, examination of Wip1 activity following irradiation of both the
DEACM- and NPE-caged peptides at 420 nm was performed to ensure that this treatment did not
significantly affect the NPE group. Indeed, irradiation of the two caged peptides at 420 nm for
3 min yielded Wip1 activity similar to that observed when the NPE-caged inhibitor was present
but not exposed to 420 nm irradiation (0.32 ± 0.01 s-1 and 0.38 ± 0.04 s-1, respectively). Modest
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inhibition resulted from minor release of the NPE-caged inhibitor under these conditions. Based
on the model for competitive inhibition and using the reported inhibitor Ki of 0.7 [tM,25 over
94% of the NPE-caged inhibitor was unaffected by the irradiation at 420 nm. This result is
consistent with the uncaging time course within error and demonstrates that photolysis of the
DEACM group can occur independently of the NPE group.
We then investigated the effect of liberating the NPE-caged inhibitor by 365 nm
irradiation. When the two caged peptides and Wipl were irradiated together first at 420 nm and
then immediately at 365 nm, activity was significantly reduced to 0.10 ± 0.02 s- and was
comparable to that resulting from the native noncaged inhibitor peptide (Figure 4-15). A control
study demonstrated that irradiation itself did not reduce activity (Figure 4-16).
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Figure 4-14. Effect of the NPE-caged inhibitor peptide on Wip1 activity. Wip1 activity was
measured with the DEACM-caged peptide after irradiation for 3 min at 420 nmn in the absence of
the NPE-caged inhibitor (v = 0.52 ±0.03 s-1). Activity when the NPE-caged inhibitor was
present but not exposed to 420 nm light (v = 0.38 ±0.04 s-1) and when the NPE-caged inhibitor
was included with the DEACM-caged substrate during the irradiation at 420 nm for 3 min (v=
0.32 ±0.01 s-1) are also shown.
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Figure 4-15. Effect of the NPE-caged inhibitor on Wip1 activity after irradiation. The
DEACM-caged substrate was incubated with Wip1 and either the NPE-caged inhibitor or the
native inhibitor. The assay solution with the NPE-caged inhibitor was irradiated at 420 nm
(3 min) and then immediately at 365 nm (4 min) (v = 0.10 ± 0.02 s-1). The activity in the
presence of the native inhibitor was determined after irradiating at 420 nm (3 min) and is
similarly low (v = 0.10 ± 0.04 s-). For comparison, the experiment in which the DEACM-caged
substrate was irradiated at 420 nm and then the NPE-caged inhibitor was added but not further
irradiated, is shown.
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Figure 4-16. Effect of 365 nm irradiation on Wip1 activity. Wip1 activity was measured with
the DEACM-caged substrate irradiated at 420 nm (v = 0.52 ± 0.03 s-) and with the DEACM-
caged substrate irradiated at both 420 nm and 365 nm (v = 0.42 ± 0.06 s-').
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The aforementioned sequential uncaging results are summarized in Figure 4-17, which
shows phosphatase activity before irradiation (Region A) and after exposure to 420 nm
(Region B) and then to 365 nm light (Region C). The Wip1 reaction is initiated upon irradiation
at 420 nm and inhibited following exposure to 365 nm light. These experiments demonstrate
that the system provides effective photocontrol over Wip1 activity by enabling two distinct
biochemical processes to be activated in a wavelength-selective manner.
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Figure 4-17. Wipl phosphatase activity. Wip1 was incubated with the DEACM-caged
substrate (30 [M) and the NPE-caged inhibitor (5 pM). No activity occurred before irradiation
(Region A), but irradiation at 420 nm (orange bar) initiated Wip1 activity (Region B). A
subsequent irradiation at 365 nm (yellow bar) completely abolished activity (Region C). If the
assay was irradiated only at 420 nm and was not subjected to the 365 nm irradiation, the reaction
continued.
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Conclusions
In summary, we have developed a method to interrogate multiple sites of peptide or
protein phosphorylation in one system by exploiting the distinct photophysical properties of the
NPE and DEACM caging groups. Photolysis of the DEACM group at 420 nm efficiently
releases it from the phosphopeptide, while exerting a negligible effect over the NPE-caged
peptide. This technique will facilitate detailed study of previously inaccessible complex
phosphorylation pathways, such as those involved in cell migration. For example, paxillin
functions as a scaffold that recruits proteins following phosphorylation of Tyr3l and Tyri 18.26
This approach could be applied to investigate the effects of sequential phosphorylation at these
discrete sites. Alternatively, as in the study with Wip1, the sequential uncaging system can
provide robust photochemical control over a biological reaction. Additionally, the synthesis of
the DEACM-caged phosphoamino acid building blocks provides convenient access to DEACM-
caged peptides and proteins, which can be investigated either in isolation or in concert with an
NPE-caged molecule.
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Methods
O-[7-(Diethylamino)coumarin-4-yl]methyl-O'-p-cyanoethyl-N,N-diisopropylphosphor-
amidite (4-5).
C1
HO N' PO-CN O N
I - 1)-, 0.______
N O O Triethylamine, DCM 0100% 1
*N' PO -,CN
4-4
4-5
7-Diethylamino-4-(hydroxymethyl)coumarin (DEACM-OH, 4-4) was synthesized from
4-methyl-7-diethylaminocoumarin as previously described.2 To a solution of dry DEACM-OH
(4-4) in anhydrous CH 2Cl 2 (4.7 mL/mmol) was added triethylamine (2.2 eq) under Ar.
2-Cyanoethyl NN-diisopropylchlorophosphoramidite (1 eq) was dissolved in anhydrous CH 2Cl 2
(2.4 mI~mmol) and added dropwise to the DEACM-OH solution at 0 'C. The solution was
stirred for 3 h in the dark while warming to room temperature. The reaction was then washed
with saturated NaHCO 3 (2x) and brine (lx). The organic portion was dried over Na2 SO 4, and
the solvent was evaporated to quantitatively obtain an orange oil which was used without further
purification. 'H NMR (300 MHz, CDCl 3) 3 7.33 (d, J=9.0 Hz, 1H), 6.57 (dd, J=2.6, 8.9 Hz, 1H),
6.51 (d, J=2.6 Hz, lH), 6.23 (t, J=1.30 Hz, 1H), 4.82 (qdd, J=1.4, 7.1, 15.4 Hz, 2H), 3.98 - 3.78
(m, 2H), 3.74 - 3.61 (m, 2H), 3.41 (q, J=7.1 Hz, 4H), 2.67 (dt, J=0.5, 6.3 Hz, 2H), 1.23 - 1.18
(m, 18H); 13C NMR (100 MHz, CDCl 3) 3 162.49, 156.31, 152.82, 150.65, 124.58, 117.79,
108.70, 106.45, 106.24, 97.89, 61.75, 58.60, 44.89, 43.55, 24.85, 20.65, 12.61; 31P NMR (121
MHz, CDCl3) 3 -49.72; HRMS (ESI) m/z calcd for C23H3 5N30 4 P [M+H]*: 448.2360, found
448.2364.
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N-a-Fmoc-L-serine allyl ester (4-7).
NaHCO 3 / H20OH Aliquat 336 OH
Allyl bromide, DCM
Fmoc, N' OH 91% Fmoc O
4-6 4-7
A solution of Fmoc-Ser-OH was slowly added to a solution of NaHCO 3 (1 eq) in H20
(3 mL/mmol NaHCO 3). This was then added to a solution of Aliquat 336 (1 eq) and allyl
bromide (5.28 eq) in CH 2Cl 2 (1.1 mI~mmol allyl bromide). The emulsion was stirred vigorously
for 24 h at room temperature and was then extracted with CH 2Cl 2 (3x). The organic extracts
were dried over MgSO 4, and solvent was evaporated. The residue was purified by flash
chromatography (SiO 2, EtOAc:hexanes 1:1) to obtain the product in 91% yield. The 'H and 13C
NMR spectra matched that previously reported.27 HRMS (ESI) m/z calcd for C21H22 NO5 *
[M+H]*: 368.1492, found 368.1489.
N-a-Fmoc-L-threonine allyl ester.
NaHCO3 / H20OH Aliquat 336 OH
Allyl bromide, DCM
Fmoc N OH Fmoc'N 
H O H
N-a-Fmoc-L-threonine allyl ester was synthesized as described for N-a-Fmoc-L-serine allyl
ester. The compound was purified by flash chromatography (SiO 2, EtOAc:hexanes 2:3) to
furnish the product in 94% yield. The 1H and 13C NMR spectra matched that previously
27reported. HRMS (ESI) mlz calcd for C22H24NO5' [M+H]+: 382.1649, found 382.1659.
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N-a-Fmoc-L-tyrosine allyl ester.
OH OH
1.- CS2 003 / MeOH
2. ly[ bromide, DMVF
Fmoc'N OH 83% Fmoc'N O
H 0  H 0
To a solution of Fmoc-Tyr-OH dissolved in MeOH (4 mUmmol) was added Cs2CO3 (0.5 eq).
The mixture was stirred for 2 h at room temperature. The solvent was removed, and the white
residue was evaporated from EtOH (3x). The residue was then dissolved in DMF (4 mI/mmol),
and allyl bromide was added (1.1 eq). The mixture was stirred overnight under Ar at room
temperature. The suspension was poured into 1 M HCl and extracted with Et2O (3x,
24 mL/mmol amino acid). The combined extracts were washed with 1 M HCl (2x), diluted
NaHCO 3 (2x), and brine (lx), and after drying over MgSO 4, the solvent was evaporated. The
residue was purified by flash chromatography (SiO 2, EtOAc:hexanes 1:1) to give the product in
1 13 2783% yield. The 1H and C NMR spectra matched that previously reported. HRMS (ESI) m/z
calcd for C2 7H26NOs* [M+H]*: 444.1805, found 444.1812.
General Method for N-a-Fmoc-phospho(O-[7-(diethylamino)coumarin-4-yl]methyl-O'-p-
cyanoethyl)-allyl ester derivatives of serine, threonine, and tyrosine.
The DEACM phosphoramidite (4-5, 1.3 eq) and 4,5-dicyanoimidazole (1.3 eq) in THF
(3.5 mUmmol) was added dropwise to a solution of the Fmoc allyl ester of serine, threonine, or
tyrosine in anhydrous THF (4.6 mUmmol). The mixture was stirred overnight in the dark at
room temperature. The next day, the solution was cooled to 0 'C and tert-butyl hydroperoxide
(2 eq) was added dropwise. After 1 h, the reaction was warmed to room temperature and stirred
for an additional 2 h. The solvent was evaporated, and the residue was purified by flash
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chromatography (SiO 2 , hexanes with 2.5% EtOH, then SiO2, ethyl acetate:hexanes 7.5:2.5) to
give a yellow solid.
N-a-Fmoc-phospho(O-[7-(diethylamino)coumarin-4-yl]methyl-O'-p-cyanoethyl)-L-serine
allyl ester (4-8).
1. 4-5, THF N CN
OH 4,5-dicyanoimidazole
2. tBuOOH, 0 0 C 0 /
FmocH 0. 75% over 2 steps
O 0
4-7 Fmoc, NO
4-8
Yield: 75%. 'H NMR (500 MHz, CDCl 3) 6 7.75 (dd, J=3.3, 7.5 Hz, 2H), 7.61 (m, 2H), 7.39 (m,
2H), 7.31 (m, 2H), 7.21 (m, 1H), 6.52 (m, 1H), 6.49 (m, 1H), 6.17 (d, J=5.4 Hz, 1H), 5.98 (t,
J=8.3 Hz, 1H), 5.92 (m, lH), 5.35 (m, 1H), 5.27 (m, 1H), 5.19 (m, 2H), 4.71 (m, 2H), 4.67 (m,
1H), 4.59 - 4.20 (m, 7H), 3.37 (m, 4H), 2.74 (dt, J=2.4, 6.0 Hz, 2H), 1.18 (dt, J=1.1, 6.9 Hz,
6H); "C NMR (125 MHz, CDCl 3) 6 168.42, 161.61, 156.22, 155.82, 150.69, 148.55, 143.64,
141.24, 131.09, 127.75, 127.10, 125.12, 124.18, 119.98, 119.42, 116.27, 108.82, 106.38, 105.33,
97.82, 68.02, 67.44, 66.85, 65.21, 62.54, 54.43, 46.95, 44.77, 19.68, 12.37; 31P NMR (202 MHz,
CDCl 3) 5 -0.97, -1.00; HRMS (ESI) m/z calcd for C38H4ON3NaO10 P* [M+Na]*: 752.2344, found
752.2341.
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N-a-Fmoc-phospho(O-[7-(diethylamino)coumarin-4-yl]methyl-O'-p-cyanoethyl)-L-
threonine allyl ester.
N
1. 4-5, THF /CN
OH 4,5-dicyanoimidazole
2. tBuOOH,0 O*C O O
F ' O 78% over 2 steps O- =
H 0
Fmoc'N
H
Yield: 78%. 1H NMR (500 MHz, CDCl3) 6 7.77 (d, J=7.4 Hz, 2H), 7.62 (t, J=7.1 Hz, 2H), 7.40
(t, J=7.4 Hz, 2H), 7.32 (m, 2H), 7.25 (m, 1H), 6.57 (m, 1H), 6.51 (m, 1H), 6.18 (d, J=4.2 Hz,
1H), 5.92 (m, 1 H), 5.76 (t, J=10.5 Hz, 1H), 5.35 (dt, J= 1.2, 17.5 Hz, 1 H), 5.27 (m, 1H), 5.16
(m, 3H), 4.68 (m, 2H), 4.57 (td, J=2.3, 9.6 Hz, 1H), 4.43 (m, 2H), 4.27 (m, 3H), 3.40 (m, 4H),
2.78 (m, 2H), 1.48 (dd, J=6.4, 16.8 Hz, 3H), 1.20 (dt, J=3.1, 7.1 Hz, 6H); "3C NMR (125 MHz,
CDCl 3) 6 169.18, 161.64, 156.52, 156.23, 150.72, 148.67, 143.55, 141.28, 131.16, 127.76,
127.11, 125.14, 124.20, 119.99, 119.31, 116.35, 108.82, 106.31, 105.36, 97.83, 76.59, 67.42,
66.72, 65.07, 62.38, 58.36, 47.07, 44.79, 19.73, 18.44, 12.39; 3 1P NMR (202 MHz, CDC3) a
-1.76, -1.90; HRMS (ESI) m/z calcd for C39H42N3NaO1 OP* [M+Na]*: 766.2500, found 766.2500.
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N-a-Fmoc-phospho(O-[7-(diethylamino)coumarin-4-yl]methyl-O'-p-cyanoethyl)-L-tyrosine
allyl ester.
/-
NC
OH 1. 4-5, THF CN
4,5-dicyanoimidazole O O'2. tBuOOH, 0 IC O
FmocN 63% over 2 steps 0 0
H 
0
Fmoc'N 04
H 
0
Yield: 63%. 'H NMR (500 MHz, CDCl3) 37.76 (d, J=7.6 Hz, 2H), 7.58 (d, J=7.1 Hz, 2H), 7.40
(t, J=7.4 Hz, 2H), 7.31 (t, J=7.3 Hz, 2H), 7.23 (d, J=9.0 Hz, 1H), 7.16 (d, J=8.2 Hz, 2H), 7.10 (d,
J=8.5 Hz, 2H), 6.55 (dd, J=2.4, 9.0 Hz, 1H), 6.48 (t, J=2.5 Hz, 1H), 6.07 (s, 1H), 5.89 (m, lH),
5.53 (dd, J=3.6, 8.0 Hz, 1H), 5.34 (d, J=16.5 Hz, 1H), 5.28 (m, 3H), 4.66 (m, 3H), 4.44 (m, 1H),
4.36 (m, 3H), 4.21 (t, J=7.0 Hz, 1H), 3.40 (q, J=6.9 Hz, 4H), 3.14 (m, 2H), 2.74 (m, 2H), 1.19 (t,
J=7.0 Hz, 6H); 13C NMR (125 MHz, CDCl3) 6 170.85, 161.62, 156.21, 155.60, 150.75, 149.02,
148.44, 143.76, 141.27, 133.69, 131.30, 131.00, 127.71, 127.05, 125.11, 124.19, 120.03, 119.96,
119.31, 116.07, 108.74, 106.44, 105.28, 97.74, 66.91, 66.21, 65.54, 62.85, 54.74, 47.11, 44.74,
37.30, 19.70, 12.40; 3 1P NMR (202 MHz, CDCl3) 3 -6.18, -6.20; HRMS (ESI) m/z calcd for
C44H44N 3NaO1 OP [M+Na]': 828.2657, found 828.2670.
General Method for N-a-Fmoc-phospho(O-[7-(diethylamino)coumarin-4-yl]methyl-O'-p-
cyanoethyl) derivatives of serine, threonine, and tyrosine.
N-a-Fmoc-phospho(O-[7-(diethylamino)coumarin-4-yl]methyl-O'-p-cyanoethyl)-ally ester
derivatives of serine, threonine, and tyrosine were dissolved in EtOH:H 20 (9:1, 26 mL/mmol)
and refluxed. Tris(triphenylphosphine)rhodium(I) chloride (0.07 eq) was added, and the mixture
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was refluxed for 3 h. The solvent was evaporated, and the residue was purified by flash
chromatography.
N-a-Fmoc-phospho(O-[7-(diethylamino)coumarin-4-yl]methyl-O'-p-cyanoethyl)-L-serine
(4-1).
N 
p
CN CN
-N Wilkinson's catalyst -
o 0 EtOH:H 20 (9:1) , O
O-P=O 73% OP0
0 0 0 0
Fmoc, NXO Fmoc, Nf4OH
4-8 4-1
The compound was purified by flash chromatography (SiO 2, CH2Cl 2, 5% EtOH, 0.5% formic
acid) to yield an orange solid (73%). 'H NMR (500 MHz, CDCl3) 5 7.71 (d, J=7.5 Hz, 2H), 7.58
(m, 2H), 7.36 (t, J=7.4 Hz, 2H), 7.27 (m, 2H), 7.19 (m, 1H), 6.48 (m, 2H), 6.30 (m, 1H), 6.24 (d,
J=14.1, 1H), 5.23 (d, J=7.1 Hz, 2H), 4.68 - 4.23 (m, 7H), 4.15 (t, J=7.2 Hz, 1H), 3.33 (m, 4H),
2.72 (dt, J=5.9, 19.2 Hz, 2H), 1.15 (m, 6H); 13 C NMR (125 MHz, CDC13) £ 170.44, 162.68,
156.05, 150.81, 149.20, 143.74, 143.59, 141.19, 127.71, 127.10, 125.18, 124.22, 119.93, 116.51,
109.04, 105.80, 105.29, 97.64, 68.60, 67.42, 65.31, 62.87, 54.20, 46.93, 44.72, 19.58, 12.38; 31P
NMR (202 MHz, CDC13) (5 -1.76; HRMS (ESI) m/z calcd for C 35H35N 3010P~ [M-H]~: 688.2066,
found 688.2052.
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N-a-Fmoc-phospho(O-[7-(diethylamino)coumarin-4-yl]methyl-O'-p-cyanoethyl)-L-
threonine (4-2).
N N
CN / CN
Wilkinson's catalyst -
O / EtOH:H20 (9:1) , O
O-P=O 82% O-P=O
0 0 0
Fmoc, OFmoc OHON OH 0  HH4 0 0
4-2
The compound was purified by flash chromatography (SiO2 , CH2Cl 2, 5% EtOH, 0.5% acetic
acid) to yield an orange solid (82%). 1H NMR (500 MHz, CDCl3) 6 7.71 (dd, J=2.6, 7.4 Hz,
2H), 7.61 (m, 2H), 7.36 (m, 2H), 7.27 (m, 2H), 7.21 (t, J=8.9 Hz, 1H), 6.44 (m, 2H), 6.21 (d,
J=4.8 Hz, 1H), 6.11 (m, 1H), 5.22 (m, 3H), 4.59 (m, lH), 4.40 - 4.28 (m, 4H), 4.20 (t, J=7.0 Hz,
1H), 3.32 (m, 4H), 2.77 (t, J=6.0 Hz, 2H), 1.47 (m, 3H), 1.13 (m, 6H); 13C NMR (125 MHz,
CDCl 3) 5 171.26, 162.37, 156.82, 156.06, 150.78, 149.10, 143.55, 141.19, 127.69, 127.07,
125.19, 124.29, 119.91, 117.01, 108.94, 105.89, 105.24, 97.55, 77.19, 67.36, 65.25, 62.89, 58.17,
47.02, 44.67, 19.60, 18.48, 12.38; 3 'P NMR (121 MHz, CDCl3 ) 5 -2.78, -2.91; HRMS (ESI) m/z
calcd for C36H37N30 10P- [M-H]-: 702.2222, found 702.2252.
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N-a-Fmoc-phospho(O-[7-(diethylamino)coumarin-4-yl]methyl-O'-p-cyanoethyl)-L-tyrosine
(4-3).
/ N /--N 
-
CN CN
0O Wilkinson's catalyst O O
O- o =O EtOH:H20 (9:1) / O =O
0 O 89% 0 0
Fmoc'N Fmoc' OHN N
H H 0
4-3
The compound was purified by flash chromatography (SiO 2, CH 2Cl2 , 5% EtOH, 0.5% acetic
acid) to yield an orange solid (89%). 'H NMR (500 MHz, CDCl 3) 3 7.75 (d, J=7.4 Hz, 2H), 7.59
(d, J=7.4 Hz, 2H), 7.38 (t, J=7.2 Hz, 2H), 7.30 (t, J=7.4 Hz, 2H), 7.16 (m, 5H), 6.55 (dd, J=2.5,
9.0 Hz, 1H), 6.46 (t, J=2.4 Hz, 1H), 5.85 (d, J=10.4 Hz, IH), 5.75 (m, 1H), 5.27 (d, J=6.5 Hz,
2H), 4.66 (dd, J=5.5, 12.7 Hz, 1H), 4.48 - 4.33 (m, 4H), 4.20 (t, J=7.0 Hz, 1H), 3.37 (dd, J=7.0,
14.0 Hz, 4H), 3.15 (m, 2H), 2.78 (dd, J=5.7, 9.6 Hz, 2H), 1.17 (t, J=6.9 Hz, 6H); 13C NMR (125
MHz, CDCl 3 ) 3 172.75, 162.97, 155.95, 155.67, 150.92, 149.45, 148.88, 143.71, 141.27, 134.20,
131.13, 127.71, 127.06, 125.14, 124.12, 120.06, 119.95 116.33, 109.14, 105.39, 105.19, 97.62,
66.84, 65.17, 63.06, 54.76, 47.16, 44.75, 37.40, 19.73, 12.38; 3 1P NMR (121 MHz, CDCl3) 3
-6.50, -6.71; HRMS (ESI) m/z calcd for C41H39N30 10P~ [M-H]-: 764.2379, found 764.2375.
Caged mRLC Synthesis
The mRLCs containing the DEACM and NPE caged phosphoamino acids were synthesized by
expressed protein ligation, as described in Chapter 2. Exchange into HMM and actin-activated
ATPase assays were also performed as described in Chapter 2.
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Peptide Synthesis
All peptides were synthesized by 9-fluoenylmethoxycarbonyl (Fmoc)-based solid phase peptide
synthesis either manually or on an automated peptide synthesizer using standard Fmoc-protected
amino acids (Novabiochem). Each peptide synthesis was performed on a 0.04 mmol scale using
Fmoc-PAL PEG resin (Novabiochem, 0.2 mmol/g). Phosphopeptides were synthesized by
employing commercially available Fmoc-Thr(PO(OBzl)-OH)-OH, Fmoc-Ser(PO(OBzl)-OH)-
OH, and Fmoc-Tyr(PO(OBzl)-OH)-OH (Novabiochem). The caged residue N-a-Fmoc-
phospho(1-nitrophenylethyl-2-cyanoethyl)-L-serine was synthesized according to Rothman, et
al.6 Caged residues (0.08 mmol) were always manually coupled with HATU (0.08 mmol),
HOAt (0.08 mmol), and 2,4,6-collidine (0.10 mmol) to prevent @-elimination of the
phosphotriester.
Manual Synthesis. The resin (0.2 g, 0.04 mmol) was swelled in DCM (5 mL) for 5 min and then
in DMF (5 mL) for 5 min. Fmoc deprotection was performed by incubating the resin with
20% (v/v) 4-methylpiperidine in DMF (5 mL, 5 x 5 min) and then washing the resin with DMF
(5 mL, 5 x 1 min). The next Fmoc-amino acid (0.24 mmol) dissolved in DMF (5 mL) with
benzotriazole-1-yl-oxy-tris-pyrrolidino-phosphonium hexafluorophosphate (PyBOP, 0.12 g,
0.24 mmol) was added. NN-Diisopropylethylamine (DIPEA, 113 tl, 0.48 mmol) was added,
and the reaction was allowed to proceed for at least 45 min. The success of coupling was
evaluated by a trinitrobenzene sulfonic acid (TNBS) test, and if no beads turned red, the
procedure was repeated using the next amino acid. The N-termini of the noncaged and caged
substrate peptides were acetylated by reaction with acetic anhydride and pyridine (0.15 M each
in DMF).
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Automated SPPS. Peptides were prepared by automated solid phase peptide synthesis (Applied
Biosystems 431A synthesizer) employing standard Fmoc-protected amino acids (4 equivalents
relative to resin loading per coupling), HOBt and HBTU coupling reagents, and
4-methylpiperidine deprotections. Double couplings and acyl capping were performed.
Following synthesis, the peptides were cleaved from the resin, and the side chain protecting
groups were removed in 10 mL of TFA/triisopropyl silane/ethanedithiol/H 20 (92.5/2.5/2.5/2.5,
v/v/v/v) for 2 h. The TFA was evaporated, and the peptide was triturated with cold diethyl ether
(40 mL, 3x).
Peptides were purified by reversed phase HPLC with a Waters 600 automated control module on
a YMC C18 semi-preparative column (YMC-Pack, ODS-A, 20 x 250 mm, 5 tm, 12 nm) eluting
with acetonitrile/water containing 0.1% (v/v) TFA. For detection, a Waters 2487 dual
wavelength absorbance detector was used to record at 228 nm and 280 nm. HPLC conditions
were 5% acetonitrile in water with 0.1% TFA for 5 min followed by a linear gradient from 5% to
95% acetonitrile in water with 0.1% TFA over 45 min. Following lyophilization, correct mass
was validated by ESI-MS on a Mariner electrospray mass spectrometer (PerSeptive Biosystems).
Purity was confirmed by analytical HPLC with a Beckman Ultrasphere C18 reversed phase
column (YMC Pack, ODS-A, 4.6 x 250 mm, 5 [tm, 12 nm).
Cyclic Peptide Inhibitor Synthesis
Synthesis of the cyclic peptide inhibitor was based on a modified protocol from Long, et al.28
Following peptide synthesis, the N-terminus of the peptide was acetylated with chloroacetic
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anhydride (0.3 M) and HOAt (0.27 M) in 9:1 DMF:DCM. The reaction was repeated until
complete acetylation was achieved, as assessed with a TNBS test. The peptide was then cleaved
from the resin as described above. The dried peptide was dissolved in H20 (40 mIJ100 mg
resin) with 1% (v/v) DMF and added dropwise to H2 0 (30 mL). The pH was adjusted to 8.0-8.5
with triethylamine, and the solution was stirred overnight to induce intramolecular cyclization.
The next day, the solution was acidified to pH 4 using acetic acid. ESI-MS analysis showed an
increase in 16 amu over the expected molecular weight, indicating that the Met residue had
become oxidized to methionine sulfoxide during the synthesis. Following lyophilization, the
peptide was incubated in 0.73 M DTT overnight at 37 'C to reduce the residue.29 The peptide
was then purified by HPLC as described above.
Peptide Characterization
[M-H~ HPILC
Peptide Sequence Molecular [M-H]- [M- d (tR)[bIFormula Calculated Foundlai (mi)
Substrate Ac-TDDEMpTGYVAT C5 1H8oN12 O28P2 S 1401.43 1401.55 17.21
DEACM-Caged Ac-TDDEM-cpT-GYVAT C65H95N13 03oP2S 1630.54 1630.44 20.49Substrate
Inhibitor cyclic(MpSIpYVAC) C36H58N80 16P2S 2  983.28 983.59 20.32
NPE-Cged cyclic(M-cpS-IpYVAC) C44 H65N9O18P252  1132.33 1132.56 25.01
[a] The data were collected by negative ion electrospray ionization mass spectrometry. [b] Retention
times were obtained from reversed phase HPLC analytical runs (YMC Pack, ODS-A, 4.6 x 250 mm, 5 pm,
12 nm) using the following method: 5% acetonitrile in water with 0.1% TFA for 5 min, followed by a linear
gradient of 5-95% acetonitrile in water with 0.1% TFA over 40 min at 0.9 mL min".
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Peptide Quantification
The noncaged Wip1 peptides were quantified based on absorption of pTyr at 267 nm
(, = 652 M- cm ).3 The DEACM-caged substrate was quantified based on absorbance at
392 nm (s = 17,700 M' cm'),'9 and the NPE-caged inhibitor was quantified in MeOH at 260 nm
with s = 5,700 M1 cm'.
Wip1 Cloning
A plasmid encoding the full Wip1 phosphatase was obtained from the NIH Mammalian Gene
Collection. The gene fragment encoding the catalytic portion of the protein (residues 1 - 420)
was amplified by PCR using the program shown in Chapter 2. The forward primer encoded an
NdeI restriction site and was used to append a hexahistidine tag to the N-terminus of the protein.
The reverse primer encoded the NotI restriction site. The sequences of the primers are given
below:
Forward primer: 5'- CGAGTGAACTCCATATGGGTTCTCATCACCATCACCATCACGGTA
TGGCGGGGCTGTACTCG-3'
Reverse Primer: 5'-GCAGTCTCGATTGCGGCCGCTTACTTGACTGGTGGTGTAGAACATG
G-3'
The Wip1 DNA fragment was digested with NdeI and NotI according to manufacturer's
protocols and ligated into the pET24a(+) vector (Novagen). The ligation product was
transformed into DH5a cells (Invitrogen) and grown on LB plates supplemented with kanamycin
(30 tg/mL).
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Wip1 Expression
The Wipl-pET24a(+) vector was transformed into BL-21 Gold(DE3) competent cells (Agilent
Technologies). The protein was expressed in a l-L culture in LB containing kanamycin
(30 tg/mL) by incubating at 37 'C with shaking at 200 rpm. Once an OD of -0.6 at 600 nm was
reached, the culture was cooled to 16 'C, and IPTG was added to 0.2 mM to induce protein
expression. The culture was incubated overnight at 16 'C with shaking. The next day, the cells
were harvested by centrifugation, and the cell pellets were stored at -80 *C until use.
Wip1 Purification
The protein was purified following a modified protocol from Yamaguchi, et al.24 The pellet was
thawed in PBS buffer (25 mM NaH 2PO4 , 25 mM Na2HPO4, 300 mM NaCl, pH 7.9, 40 mUL
cells harvested) with 2 mM f-mercaptoethanol, 1 pL/mL Protease Inhibitor Cocktail Set III
(100 [M AEBSF, 80 nM Aprotinin, 5 [M Bestatin, 1.5 [M E-64, 2 [tM Leupeptin, 1 iM
Pepstatin A), 0.2% (v/v) Triton X-100, and 1 mg/mL lysozyme. The cells were incubated on ice
for 20 min and then sonicated on ice at 40% amplitude, 1 s on/1 s off for 45 s with a Sonics
Vibra Cell sonicator. Cell debris were pelleted at 12,000 x g for 45 min at 4 'C, and the lysate
was incubated with Ni-NTA resin (Qiagen, 3 mL) for 1 h at 4 'C. The resin was collected with a
brief centrifugation and then washed with Wash Buffer (PBS containing 5 mM imidazole, 500
mM NaCl, 10% (v/v) glycerol, 0.2% (v/v) ethanol, and 1 mM p-mercaptoethanol). The protein
was eluted with Wash Buffer containing 150 mM imidazole and dialyzed into modified
phosphatase buffer (50 mM Tris, 100 mM NaCl, 0.1 mM EGTA, 0.2% (v/v) BME, pH 7.5). The
protein concentration was determined by measuring absorbance at 280 nm (s = 50,420 M' cm-).
The protein yield was 5 mg/L.
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Phosphatase Assays
Wip1 phosphatase activity was measured using a Malachite Green assay31 following a modified
protocol from Yamaguchi, et al.24 Stock solutions for the Malachite Green assay include
Solution A (8 mL H2SO 4 , 40 mL H20, 0.059 g malachite green), Solution B (15% (w/v)
ammonium molybdate tetrahydrate in H2 0), and Solution C (11% (v/v) Tween20). The working
solution was generated by combining Solution A (5 mL) with Solution B (1.25 mL) and mixing
for 30 min. This solution was then filtered through a 0.22 [tm filter, and Solution C (100 iLL)
was added. Wip1 (10 nM) was incubated with the substrate and inhibitor peptides, if indicated,
in a solution of phosphatase buffer (50 mM Tris, 0.1 mM EGTA, 0.2% (v/v) BME, pH 7.5)
supplemented with 10% (v/v) glycerol, 30 mM MgCl 2 , and 34 [tg/nL BSA at 25 'C. If a caged
substrate or inhibitor was used, timing for the assay was started immediately after irradiation was
complete. At each time point, an aliquot (155 - 185 pL) was mixed with 50 [tL of the malachite
green solution, and water was added to give a final volume of 200 L. The solutions were
incubated at room temperature for 30 min, and the absorbances were read at 650 nm. The
amount of phosphate present in each sample was calculated based on a phosphate standard curve
with phosphate amounts between 0.5 and 3.5 nmol.
Uncaging
The complete assay solution was transferred to a quartz uncaging vessel with a 1 mm pathlength.
The vessel was placed directly on the light source and cooled with ice. Irradiation at 420 nm was
performed using a handheld light source with a Coralife 9W Actinic bulb equipped with a
420-nm cut-on, colored-glass alternative filter from Newport. Irradiation at 365 nm was
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performed similarly, except that a UVP High Performance Ultraviolet Transilluminator with
light centered at 365 nm was used.
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NMR Characterization: lH and 13C NMR of 0-[7-(Diethylamino)coumarin-4-yl]methyl-O'-p-
cyanoethyl-N,N-diisopropylphosphoramidite (4-5)
7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5
f1 (ppm)
3.0 2.5 2.0 1.5 1.0 0.5 0.0
150 130 110 90 80 70 60 50 40 30 20 10 0
fi (ppm)
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1H and 13C NMR of N-a-Fmoc-phospho(O-[7-(diethylamino)coumarin-4-yl]methyl-O'-p-
cyanoethyl)-L-serine allyl ester (4-8).
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1H and 13C NMR of N-a-Fmoc-phospho(-[7-(diethylamino)coumarin-4-yl]methyl-O'-p-
cyanoethyl)-L-threonine allyl ester
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'H and "C NMR of N-a-Fmoc-phospho(O-[7-(diethylamino)coumarin-4-yl]methyl-O-p-
cyanoethyl)-L-tyrosine allyl ester
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'H and 13C NMR of N-a-Fmoc-phospho(O-[7-(diethylamino)coumarin-4-yl]methyl-O'-p-
cyanoethyl)-L-serine (4-1)
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NMR of N-a-Fmoc-phospho(O-[7-(diethylamino)coumarin-4-yl]methyl-O'-p-
cyanoethyl)-L-threonine (4-2)
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'H and 13C NMR of N-a-Fmoc-phospho(O-[7-(diethylamino)coumarin-4-yl]methyl-O'-p-
cyanoethyl)-L-tyrosine (4-3)
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Chapter 5 : Development of a 4-DMN-Based
Sensor for Cdc42
A significant portion of the work described in this chapter has been published:
Goguen, B. N.; Loving, G. S.; Imperiali, B. Development of a Fluorogenic Sensor for Activated
Cdc42. Bioorg. Med. Chem. Lett. 2011, In press.
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Introduction
Fluorescent probes have been used to monitor a variety of dynamic signaling interactions,
including protein-protein interactions, enzyme activation, and changes in protein conformation. 1,2
In addition to enabling biochemical studies in real-time, these tools have been utilized in high-
thoughput assays to screen for new small molecule drugs and inhibitors.3 4 These methods
generally rely on a change in a fluorescence-based read out, such as fluorescence resonance
energy transfer (FRET), fluorescence anisotropy, fluorescence lifetime, quantum yield, or
5
emission wavelength. Solvatochromic fluorophores, which have emissive properties that are
dependent on the nature of the solvent environment, are ideal for measuring protein interactions
because they are capable of providing information on even subtle changes in protein
2
conformation. While many such fluorophores are commercially available, the Imperiali group
has been particularly interested in the development and application of those derived from the
dimethylaminonaphthalimide family. 6-9 In particular, 4-NN-dimethylamino-1,8-naphthalimide
(4-DMN) has recently been demonstrated to be a powerful probe of protein binding
interactions. 10 When the 4-DMN fluorophore is in an unbound, aqueous-solvated state, the
quantum yields of fluorescence are exceedingly low (CD < 0.05). However, in a hydrophobic
environment, such as that at the interface of a protein-protein interaction, increases in
fluorescence can exceed 100-fold. Thus, when the fluorophore is appropriately positioned in a
sensor protein, it behaves as an "off-on" switch to indicate a binding event.
The 4-DMN chromophore can be readily incorporated into peptides and proteins either as
the amino acid building block 4-NN-dimethylamino-1,8-naphthalimido-alanine (4-DMNA)10 or
through cysteine labeling with maleimide or a-bromoacetamide-activated derivatives." The
properties of these fluorophore analogs have been investigated with calmodulin (CaM), a well-
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characterized protein that undergoes significant conformational changes in the presence of
calcium. The CaM-Ca complex tightly binds a number of peptide motifs, including the M13
peptide, which is derived from skeletal myosin light chain kinase. Addition of Ca2+-CaM to an
M13 peptide containing the 4-DMNA residue resulted in up to a 900-fold increase in
fluorescence compared to that of the peptide alone.' 0 Additionally, studies with CaM, which had
been modified with a 4-DMN cysteine labeling reagent, demonstrated up to 100-fold increases in
fluorescence in the presence of Ca compared to that of the apo state." In contrast,
commercially available environment sensitive fluorophores, such as the 5-((2-
aminoethyl)amino)naphthalene-1-sulfonic acid (EDANS) and nitrobenzoxadiazole (NBD)
groups (Figure 5-1), exhibited only up to a 10-fold increase in fluorescence under the same
conditions.10' These studies illustrate the great potential of the 4-DMN fluorophore as a sensor
of protein binding events. In this chapter, we exploit the unique properties of this fluorophore to
generate a sensor for the Rho GTPase Cdc42. The design and synthesis of the sensor and in vitro
fluorescence characterization are described. Initial studies of the sensor in cellular applications
are also presented.
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Figure 5-1. Structures of the environment sensitive fluorophores NBD, EDANS, merocyanine,
and 4-DMN.
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Rho-family GTPases are small proteins central to the regulation of the actin cytoskeleton
and cell migration. Alternating between an inactive GDP-bound and active GTP-bound state,
these proteins function as molecular switches through transient interactions with effector
proteins.' 2 One prominent member of the Rho-family GTPases is Cdc42, which is responsible
for the reorganization of actin filaments into parallel bundles for filopodial protrusions.
Additionally, Cdc42 activation is involved in establishing cell polarity, a critical step not only in
cell migration, but also in morphogenesis and for the asymmetric organization of cellular
components during division. 13,14 Cdc42 participates in the signaling cascades of MAP kinases,
including p38 and ERK, to induce the transcription of proteins that mediate differentiation,
growth, apoptosis, and inflammatory responses. 14 More recent studies have revealed that the
protein is also involved in intracellular trafficking in the Golgi.15 Evidence implicating Cdc42
and associated activator and effector proteins in human disease, including cancer and immune
disorders, illustrates the many varied functions of this GTPase.14 Due to the fundamental role of
Cdc42 in cellular processes, methods to interrogate its interactions and to monitor the real-time
activation state of the protein in vitro and in cells are essential.
Multiple FRET-based sensors to detect activated Cdc42 have been developed for in vitro
and cellular applications. For example, Itoh, et al. generated a sensor to detect Cdc42 activation
by fusing Cdc42 and PAK1 between the cyan fluorescent protein (CFP) and yellow fluorescent
protein (YFP) FRET pair.16 Because PAKI is an effector of Cdc42 and binds only the activated
conformation of the protein, the sensor exhibits low FRET when Cdc42 is inactive. In contrast,
upon Cdc42 stimulation, the sensor adopts a closed conformation and undergoes an increase in
FRET. In a similar approach, Seth, et al. created a sensor by expressing an autoinhibited Cdc42-
binding domain between CFP and YFP. In the absence of activated Cdc42, this sensor
200
maintains a folded conformation and generates high FRET. However, binding of activated
Cdc42 relieves the autoinhibiton and unfolds the sensor to decrease the FRET signal. Although
these two sensors are genetically encoded and can be readily used for cellular or in vitro studies,
only very modest 2 - 3-fold changes in FRET output are achieved even when Cdc42 is fully
activated. Additionally, the Itoh sensor measures the effect of Cdc42 activators, rather than
Cdc42 itself, and when applied for cellular studies, the Seth sensor can only report activation
when Cdc42 is overexpressed.
An elegant alternative to these FRET-based sensors was generated by incorporating an
environment sensitive fluorophore into a protein fragment known to bind only the activated
conformation of Cdc42. This sensor, which was derived from the Cdc42/Rac interactive binding
(CRIB) domain of the Wiskott-Aldrich syndrome protein (WASP), was modified with an
indolenine benzothiophen-3-one- 1,1 -dioxide-(I-SO) merocyanine derivative 8 (Figure 5-1) and
exhibited a 3-fold increase in fluorescence intensity in the presence of activated Cdc42 compared
to incubation with the inactive form of the protein. 19 Due to the long excitation and emission
wavelengths and high extinction coefficient of the merocyanine fluorophore, this sensor has been
successfully used in live cell imaging studies and has been applied in combination with FRET-
based sensors of the RhoA and Rac GTPases to interrogate coordinated endogenous GTPase
activity at cell protrusions.20 To extend these studies and to exploit the high environment
sensitivity of the 4-DMN fluorophore, we developed a complementary sensor for Cdc42 with
4-DMN and used it to monitor in vitro Cdc42 activity (Figure 5-2). We anticipated that the
4-DMN fluorophore would provide advantages for in vitro studies due to excellent signal-to-
noise ratios and could be adapted for use in a cellular context.
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Figure 5-2. 4-DMN-Based sensor for active GTP-bound Cdc42. Labeling of the WASP
fragment with 4-DMN generates a sensor that discriminates between the inactive and active
forms of Cdc42 through a fluorescence increase. Image was modified from Protein Data Bank
files 2WMN and 1CEE.
Results and Discussion
5.1 Sensor Design and Synthesis
The Cdc42 sensor was based on the CRIB domain of the WASP effector protein (residues
230-277) and incorporated the 4-DMN fluorophore as part of an amino acid construct in place of
phenylalanine at position 271. Residues at this site had been previously reported to undergo
changes in solvent environment upon interaction with Cdc42(GTP) due to exposure to
hydrophobic interactions at the binding interface. 19,21 To increase heterologous expression levels
and protein stability, the GB1 protein (56 residues)2 was fused to the N-terminus of the sensor,
and to facilitate purification, a hexahistidine tag was incorporated at the C-terminus. Because the
length of the linker tethering the fluorophore to the protein can significantly affect the
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fluorescent properties of the sensor,'1 we tested a panel of five analogs, which append the
4-DMN fluorophore to the sensor with varying linker lengths, ranging from no linker to chains
between 4 and 9 A. We developed two complementary approaches for the site-specific
incorporation of 4-DMN into the WASP fragment (Scheme 5-1). In the first strategy, we
examined a cysteine-labeling method using previously reported 4-DMN-modified
a-bromoacetamide and maleimide reagents" and in an alternative approach, we exploited protein
semisynthesis to incorporate 4-DMNA, which eliminates the need for a linker.'0 Because this
amino acid derivative is similar in size to tryptophan, this route introduces a more conservative
mutation, and potential structural perturbations are minimized. We then compared the
fluorescence intensities of the sensors in the presence of inactive GDP-bound and active
GTP-yS-bound Cdc42.
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Scheme 5-1. Approaches for the synthesis of 4-DMN-labeled Cdc42 sensors. a) Generation of
the sensor by cysteine labeling with 4-DMN-modified a-bromoacetamides and maleimides. The
GB1-WASP-His 6 protein was obtained through heterologous expression in E. coli, and Cys271
was labeled with 4-DMN reagents of varying linker length. b) Incorporation of the 4-DMNA
amino acid into the sensor through expressed protein ligation. The N-terminal portion of the
sensor was expressed in E. coli as a fusion to an intein, allowing cleavage with sodium
2-mercaptoethanesulfonate (MESNa) to yield the corresponding thioester. A peptide containing
the 4-DMNA amino acid was generated by Fmoc-based solid phase peptide synthesis. Reaction
of the recombinant and peptide fragments in the native chemical ligation reaction yielded the
full-length sensor.
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For the 4-DMN labeling strategy, we expressed the GB1-WASP protein with a
Phe271Cys mutation (5-6), which introduced a single cysteine residue into the protein, to enable
selective labeling of the protein sensor with 4-DMN thiol-reactive reagents (Scheme 5-1a).
Following expression in E. coli and purification by Ni-NTA affinity chromatography (yield:
6 mg/L), the protein was labeled through an overnight incubation with a 20-fold excess of the
cysteine-modifying reagent in the presence of tris(2-carboxyethyl)phosphine (TCEP).
Purification of the protein from excess fluorophore by desalting yielded 5-1, 5-2, 5-3, and 5-4.
Labeling efficiencies for all derivatives routinely reached around 60-70% (Figure 5-3).
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Figure 5-3. Generation of the 4-DMN-labeled WASP protein by cysteine labeling. 15% SDS
PAGE gel of GB1-WASP(230-277)-His 6 labeled with 5-9. a) The gel was stained with
InstantBlue Coomassie-based staining solution. b) The 4-DMN-labeled protein can be
visualized by imaging the gel on a transilluminator that emits light centered at 365 nm.
The second approach for incorporation of the 4-DMN chromophore utilized expressed
protein ligation, in which the N-terminal portion of the protein was prepared as a thioester (5-11),
and the C-terminal fragment of the sensor containing the 4-DMNA amino acid was synthesized
by Fmoc-based solid phase peptide synthesis (5-12, Scheme 5-1b). The recombinant fragment
(GB1-WASP(230-268)) was expressed as a fusion to intein and chitin binding domains. After
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GDP or GTP-yS, which is a non-hydrolyzable analog of GTP. Incubation of each 4-DMN-based
sensor with the inactive GDP-bound form of the protein resulted in a negligible 1.1 - 1.9-fold
increase in fluorescence over that of the sensor alone. However, dramatic increases in
fluorescence, ranging from 11- to 32-fold, were observed in the presence of the active GTP-yS-
bound Cdc42 compared to incubation with the inactive form of the protein (Figure 5-5a). Thus,
the sensor readily discriminates between the two states of the protein and effectively acts as a
signal of Cdc42 activation in the GTP-bound state. Concurrent with the increase in fluorescence
intensity was a hypsochromic shift in the emission maximum from 534 nm in the absence of
Cdc42 to 514 nm in the presence of the activated protein.
) 1.0 *SensorAlone b) 1.0- - Sensor 5-3 aloneC COSensor + Cdc42(GDP) : - Sensor 5-3 + Cdc42(GDP)
0.8 U Sensor + Cdc42(GTP-yS) 0.8 - Sensor 5-3 + Cdc42(GTP-yS)
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Figure 5-5. Fluorescence properties of the 4-DMN-based sensors for activated Cdc42. a) The
relative fluorescence intensity of each sensor derivative alone and in the presence of
Cdc42(GDP) and Cdc42(GTP-yS) is plotted. The fold differences in emission maxima with
active and inactive Cdc42 are noted. b) Fluorescence spectra of sensor 5-3 alone and after
incubation with Cdc42(GDP) and Cdc42(GTP-yS). Measurements were taken with 150 nM
sensor and 700 nM Cdc42 at 25 'C.
Whereas the fluorescence of all five sensors was similarly low in the presence of the
inactive GDP-bound protein, deviations in fluorescence intensities appeared upon Cdc42
activation. Of all the derivatives, probe 5-3, which included the longest linker, exhibited the
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most promising properties with a 32-fold increase in emission intensity and the strongest
fluorescence signal upon binding activated Cdc42 (Figure 5-5b). In this construct, the long 9-A
linker presumably provides the greatest flexibility for the 4-DMN fluorophore, likely allowing it
to better embed within the hydrophobic interface of the two proteins. This result supports a
previous study demonstrating that linker length is a significant factor contributing to the
fluorescence properties of a sensor and that empirical studies are required to determine which
construct provides the optimal characteristics." Importantly, because signal from the sensor
alone or in the presence of Cdc42(GDP) is extremely low, background fluorescence is virtually
non-existent. This switch-like property of the 4-DMN sensor is particularly useful because
significant fluorescence differences can be observed without removing excess, unbound sensor
before analysis.
We examined a double mutant of the sensor (His246Asp, His249Asp), which does not
bind activated Cdc42. The mutant sensor (5-14) was generated with 4-DMN maleimide reagent
5-9 under the same cysteine labeling conditions as for sensor 5-3 (Scheme 5-2). This labeled
mutant did not demonstrate fluorescence increases, even in the presence of Cdc42(GTP-yS),
confirming that the fluorescence differences with all sensors resulted from the sensor recognizing
activated Cdc42 (Figure 5-6).
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Scheme 5-2. Synthesis of a mutant Cdc42 sensor. The H246D, H249D WASP mutant was
labeled with 4-DMN maleimide 5-9 to yield sensor 5-14.
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Figure 5-6. Fluorescence of a non-binding mutant sensor (5-14). The relative fluorescence
intensities of sensor 5-3 and mutant (H246D, H249D) sensor 5-14 are shown. In these assays,
150 nM sensor and 700 nM Cdc42 were used.
5.3 Use of the Sensor as a Probe of Cdc42 Activity
After demonstrating that the sensors exhibit excellent fluorescent responses to activated
Cdc42, we explored the use of these tools to monitor nucleotide exchange and GTPase activity in
real-time. We envisioned that this would provide a convenient method to measure the in vitro
activity of Cdc42 and interactions with guanine nucleotide exchange factors (GEFs), which
activate Cdc42 by exchanging GDP for GTP, and GTPase activating proteins (GAPs), which
accelerate the rate of GTP hydrolysis. In the case of nucleotide exchange, the addition of
GTP-yS to a solution of Cdc42 pre-equilibrated with GDP resulted in a continuous increase in
the fluorescence of 5-3, while addition of GDP did not change the signal (Figure 5-7). Thus, we
anticipate that the nucleotide exchange promoted by GEFs can be easily monitored, allowing
convenient characterization of these regulating proteins and enabling rapid screens of GEF
inhibitors.
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Figure 5-7. Application of the sensor to monitor Cdc42 nucleotide exchange. Cdc42 was pre-
equilibrated with GDP, and the fluorescence of sensor 5-3 was monitored immediately upon the
addition of GTP-yS or GDP. Measurements were taken with 150 nM 4-DMN sensor 5-3 and
700 nM Cdc42 at 30 *C.
Alternatively, the 4-DMN-based probes can be used to monitor GTP hydrolysis. For this
assay, Cdc42 was pre-loaded with GTP, and a 54% decrease in the fluorescence of sensor 5-3
was observed as the nucleotide was hydrolyzed over 20 min (Figure 5-8). As controls,
Cdc42(GTP-yS) and the GTP-bound form of the constitutively active Gln6lLeu mutant of
Cdc42, which demonstrates severely inhibited GTPase activity, were tested. A 5% decrease in
fluorescence was observed with GTP-bound Cdc42(Q61L), while an 11% decrease occurred
with GTP-yS-bound Cdc42. These modest decreases confirm that the sensor faithfully reports
GTP hydrolysis. However, because the WASP fragment has been shown to inhibit the intrinsic
rate of GTP hydrolysis with a Ki of 4.2 [tM,23 this application may be best suited for comparing
relative rates of hydrolysis. In particular, the half-life of GTP hydrolysis for Cdc42 has been
reported to be 14 min at 20 C. 24 In the presence of the 4-DMN-labeled WASP domain, a
similar t1u2 was observed (15 min), but because the reaction was conducted at 30 *C, this result
indicates that the WASP sensor does indeed inhibit the rate of nucleotide hydrolysis.
Nonetheless, the tool provides advantages over current approaches for evaluating Cdc42 activity,
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which include discontinuous radioactivity-based filter binding approaches,24 because dynamic
activity can be monitored directly in a continuous fashion with a simple fluorescence plate
reader. Additionally, with a high signal-to-noise ratio, the probe exhibits great sensitivity and
can be readily adapted for high-throughput screening of small molecule modulators of Cdc42 or
associated regulatory proteins.
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Figure 5-8. Time course of Cdc42 GTPase activity. Wildtype (WT) or a constitutively active
Q61L mutant of Cdc42 was pre-loaded with GTP-yS or GTP and purified to remove excess
nucleotide. The fluorescence of sensor 5-3 (150 nM) was monitored continuously upon the
addition of Cdc42 (about 700 nM) to the assay solution at 30 'C.
Finally, we measured the dissociation constant of the 4-DMN sensor with GTP-yS-bound
Cdc42 to demonstrate the utility of the probe in quantifying bimolecular interactions and to
ensure that incorporation of the fluorophore did not significantly alter binding. To eliminate
potential complicating effects resulting from the presence of unmodified GB 1-WASP in samples
obtained through the cysteine-labeling approach, the purified sensor generated by expressed
protein ligation was initially employed for these studies. Fluorescence spectra from titrations in
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which Cdc42(GTP-yS) was added to 5-5 were fit to a 1:1 binding model, which yielded an
observed KD of 385 ± 9 nM. The observed KD for sensor 5-3 was similar (341 ± 22 nM, Figure
5-9). These values agree well with the dissociation constants of similar WASP fragments, which
lie within the mid-nanomolar range.
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Figure 5-9. Determination of the dissociation constant between 4-DMN-modified sensor 5-3
and Cdc42(GTP-yS). Fluorescence spectra from titrations in which increasing amounts of
Cdc42(GTP-yS) were added to a fixed concentration of sensor 5-3 (300 nM) were fit to a 1:1
binding model, which yielded an observed KD of 341 ±22 nM.
5.4 Future Directions: FRET Capture
A currently ongoing effort is to apply "FRET Capture" to the Cdc42 sensor. This newly
developed technology effectively shifts the emission of 4-DMN toward longer wavelengths by
coupling the bound 4-DMN emission with an appropriate FRET acceptor dye. This modification
is desirable in a cellular context because the longer emission wavelengths would show less
interference with cellular autofluorescence, which can obscure the 4-DMN signal and complicate
image analysis. Dr. Elke Socher, a post-doctoral associate in the Imperiali lab, has demonstrated
that the 4-DMN fluorophore can behave as a FRET donor when appropriately paired with a
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second non-solvatochromic dye, which serves as the FRET acceptor. Under these conditions,
FRET-Capture only occurs when 4-DMN is in a bound and fluorescent state. When exposed to
polar solvents, excitation of the 4-DMN donor induces negligible emission of the acceptor
fluorophore because the excited state of 4-DMN rapidly relaxes. However, if 4-DMN is
positioned in a hydrophobic binding pocket, excitation leads to energy transfer to the acceptor
and acceptor emission. Alexa Fluor 555, with an excitation maximum at 555 nm and an
emission maximum at 565 nm, has been shown to be an efficient FRET acceptor for 4-DMN
(Figure 5-10a).
To examine this approach, a model system based on the previously characterized
interaction between CaM and the M13 peptide was employed. As described in the introduction
of this chapter, studies have demonstrated that if either CaM or the M13 peptide is labeled with
4-DMN, fluorescence increases up to 100- or 900-fold upon the addition of calcium or CaM,
respectively. With FRET Capture, if Alexa Fluor 555-labeled CaM is incubated with the
4-DMN-labeled M13 peptide in the absence of calcium, binding does not occur, and excitation of
the 4-DMN chromophore at 395 nm does not induce emission of either fluorophore (Figure
5-10b). Conversely, in the presence of calcium, CaM binds the M13 peptide, and 4-DMN
excitation stimulates emission of the Alexa Fluor 555 acceptor. This approach enables a sensor
to indicate a binding event through fluorescence that is shifted about 55 nm toward longer
wavelengths compared to the emission of 4-DMN. Additionally, a drawback of traditional
FRET methods results from donor emission in the absence of a binding event. However, FRET-
Capture is advantageous because background fluorescence of both the donor and acceptor is
virtually eliminated.
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Figure 5-10. FRET Capture. a) Excitation and emission spectra of the 4-DMN / Alexa Fluor
555 FRET Capture pair. b) Fluorescence spectra of FRET Capture with the CaM model system.
The spectra of the 4-DMN-modified M13 peptide in the presence of CaM and EGTA or Ca2+ are
shown in green. EGTA prevents interactions with CaM, while Ca2+ promotes binding. The
spectra from the FRET Capture pair, in which the 4-DMN-modified M13 peptide and the Alexa
Fluor 555-labeled CaM are incubated with EGTA or Ca 2, are shown in red. A 24-fold increase
in Alexa Fluor 555 fluorescence occurs in the presence of Ca2 +. This data was obtained by
Dr. Elke Socher.
To apply FRET Capture to the Cdc42 sensor, we envision incorporating both the 4-DMN
donor and the Alexa Fluor 555 acceptor into the WASP fragment (Figure 5-11). For selective
modification of two sites within the sensor, an alternative labeling strategy is proposed in which
Alexa Fluor 555 is appended through cysteine alkylation. The 4-DMN fluorophore is introduced
through the Cu(I)-catalyzed 1,3-dipolar cycloaddition (Click chemistry) between a 4-DMN azide
derivative and an alkynyl-modified homopropargylglycine (HPG) residue within the WASP
fragment. HPG, which is recognized by the amino-acyl tRNA synthetase for methionine, 26 can
be incorporated into a protein using methionine-deficient growth media that is supplemented
with additives that suppress methionine biosynthesis during protein expression.27
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Inactive GDP-bound Cdc42 Active GTP-bound Cdc42
Nucleotide H
DP Exchange
T
Alexa Fluor 55
GTP Hydrolysis
Unbound 4-DMN / AF 555-labeled WASP 4-DMN /AF 555-labeled WASP
bound to active Cdc42
Figure 5-11. Proposed FRET Capture for the Cdc42 sensor. The WASP fragment is labeled
with Alexa Fluor 555 and 4-DMN. This sensor does not bind Cdc42(GDP), and fluorescence is
low. Activation of Cdc42 leads to sensor binding, and excitation of 4-DMN at 395 nm induces
Alexa Fluor 555 emission. (The structure of Alexa Fluor 555 is unpublished.)
To generate the Cdc42 sensor, a Gly243Cys, Phe271Met mutant WASP will be expressed
under conditions to incorporate HPG, which has been synthesized by Dr. Andrew Krueger, a
post-doctoral associate in the lab (Figure 5-12). The 4-DMN azide, which has also been
synthesized by Dr. Krueger, can then be site-specifically conjugated to the protein using Click
chemistry methods. In the next step, the cysteine residue will be labeled with the commercially
available Alexa Fluor 555 maleimide. As FRET efficiency is dependent on many factors,
including fluorophore distance and orientation, multiple sites for Alexa Fluor 555 labeling can be
tested to find the position that enables the most efficient FRET when activated Cdc42 is present.
We anticipate that this construct will generate fluorescence increases in the presence of activated
Cdc42 and will exhibit longer wavelength emission than the sensor based on 4-DMN alone.
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Figure 5-12. Scheme for the generation of the FRET Capture Cdc42 sensor. A plasmid
encoding a G243C, F271M mutant is transformed into E. coli cells for expression. The protein is
expressed with additives that suppress methionine biosynthesis, enabling exogenously added
HPG to be incorporated in place of methionine. Following purification, the protein is reacted
with 4-DMN-azide, and subsequent modification with the commercially available Alexa Fluor
555 maleimide yields the sensor for FRET Capture.
5.5 Cellular Studies
The remarkable in vitro fluorescence properties of the 4-DMN-labeled Cdc42 sensor
prompted us to explore the applicability of the sensor for live cell imaging. We sought to
determine whether the sensor could report endogenous Cdc42 activation through increases in
fluorescence. For all experiments, sensor 5-3 was introduced into cells through microinjection,
and studies were performed with cells that had been stimulated to activate Cdc42 or during
processes in which the protein is known to be active. These studies were conducted at the Nikon
Imaging Center at Harvard Medical School in collaboration with Professor Gaudenz Danuser.
To provide an internal control to correct for changes in sensor fluorescence resulting
from changes in cell shape or volume, a second sensor labeled with Alexa Fluor 594 instead of
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4-DMN was co-injected with the 4-DMN-based sensor. This construct was expected to exhibit
the same subcellular localization as the 4-DMN-based probe, but because the fluorescence of
Alexa Fluor 594 does not change with solvent exposure, it can be used as a standard for
ratiometric analysis. The experiments were performed on an inverted fluorescence microscope,
and for imaging the 4-DMN-based sensor, excitation through a CFP filter set (436/10 nm) and
emission with a YPF filter set (535/30 nm) were used. The Alexa Fluor 594 signal was detected
with a standard TRITC filter set.
The initial experiments with this sensor focused on examining changes in fluorescence
resulting from growth factor addition. Mouse embryonic fibroblasts (MEFs), the standard cell
line used by the Hahn and Danuser laboratories for GTPase biosensors,28 were cultured in media
lacking serum to reduce activity of growth factor-stimulated pathways and to enable the effects
of Cdc42 activation to be more readily detected. The cells were microinjected with 5-3 and the
Alexa Fluor 594-labeled sensor, and time-lapsed images (every 10 s for 15 min) were taken
before and after the addition of platelet derived growth factor (PDGF),29 which stimulates
Cdc42. However, these studies could not be used to assess the sensor fluorescence because
imaging on the microscope readily induced cell blebbing, rounding, and death. The overnight
serum-starving conditions necessary for this experiment increased the sensitivity of the cells to
phototoxicity from imaging. In particular, while 4-DMN offers valuable features for in vitro
study, a drawback for some cellular applications is the modest extinction coefficient
(8,800 M- cm'1) and brightness of the fluorophore. Thus, long exposure times are necessary to
increase the signal of the sensor over that of the background. In these experiments, the repeated
800-ms exposures, coupled with the relatively short wavelengths of the CFP excitation filter,
induced apoptotic pathways.
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To increase the viability of the cells in all subsequent studies, the cells were cultured with
serum before and during the experiments. Under these conditions, studies were focused on
imaging Cdc42 activity during membrane protrusions, a process previously shown to require the
active GTPase.20 To promote membrane ruffling, the cells were plated on fibronectin-coated
glass coverslips about 3 h before microinjection. After microinjection and a 1 h recovery period,
the cells that were actively extending protrusions were imaged. Unfortunately, few of the
injected cells produced robust protrusions during the course of observation. In most cases,
protrusions stopped after imaging was initiated. Like the experiments with the serum-starved
cells, this effect was attributed to phototoxicity from imaging.
In an attempt to improve these results, two other microscope systems with more powerful
illumination and camera systems were tested. First, the API OMX, which uses laser-powered
illumination, rather than a lamp-based source, was employed. Laser-based illumination reduces
exposure of the cells to extraneous light because laser emission is characterized by a much
narrower bandwidth compared to lamp-generated illumination. The power of laser sources is
also greater than that from an arc lamp. This diminishes the exposure time necessary to produce
images with adequate signal. This feature is useful because cells can often tolerate brief pulses
of intense light better than longer exposures of dimmer light.30 Although this microscope offered
better imaging parameters, few injected cells extended protrusions during imaging. Even with
non-injected cells, the number of cells that produced active protrusions was low. This difficulty
was compounded by the limited numbers of cells that were microinjected and the technical
challenges associated with locating the injected areas of the dish on the OMX microscope. Thus,
further studies will be necessary to evaluate the use of this system for monitoring the 4-DMN-
based sensor.
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A second microscope system was used to maintain better cell viability while increasing
signal intensity over background fluorescence. This microscope was equipped with an electron-
multiplying charge-coupled device (EM-CCD) camera. In contrast to the CCD camera
employed in previous studies, the EM-CCD model has the capacity to amplify the detected
fluorescence signal. Although this type of camera increases the noise of each pixel more than a
standard CCD camera, 30 it was advantageous because it could intensify the 4-DMN signal from
an image obtained with a low exposure time. Additionally, this microscope featured a live cell
incubation chamber to maintain the temperature at 37 'C and to increase the viability of the cells.
Due to the challenges in observing Cdc42 activity during cell protrusions, control
experiments were designed to more conveniently assess the applicability of the 4-DMN-based
sensor. For these studies with the EM-CCD camera, the fluorescence response of sensor 5-3 was
compared to that from 4-DMN-labeled mutant sensor 5-14, which does not demonstrate
increases in fluorescence upon Cdc42 activation. Each sensor was injected at the same 4-DMN
and Alexa Fluor 594 concentrations, and the 4-DMN/Alexa Fluor 594 fluorescence intensity
ratios were evaluated for each sensor at four regions near the edges of the cells (Figure 5-13).
The average ratio for sensor 5-3 was 2.3-fold greater than that for sensor 5-14 (Figure 5-14).
This result indicates that activation of endogenous Cdc42 can be observed within a cellular
environment through the fluorescence output of the 4-DMN-based sensor. Although Cdc42 was
not stimulated in these experiments, the signal from sensor 5-3 represents the basal levels of
Cdc42 activation in the cells. It is interesting to note that the variability in the fluorescence ratios
of sensor 5-3 was greater than that of the mutant sensor. In particular, sensor 5-14 showed low
fluorescence regardless of the amount of activated Cdc42 within the cell, whereas sensor 5-3
reported differences in activation due to heterogeneity among the cells. This result was also
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verified on the microscope system equipped with the CCD camera. However, a 1.5 s exposure
was necessary to attain the same background-subtracted signal intensity as an 800 ms exposure
with the EM-CCD camera.
4-DMN Signal Alexa Fluor 594 Signal
Sensor 5-3
Sensor 5-14
Figure 5-13. Images of cells injected with sensor 5-3 and mutant sensor 5-14. These images
were taken on a microscope equipped with an EM-CCD camera. The pixel intensities of both
sensors have been adjusted to the same scale for each fluorescence channel.
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Figure 5-14. Comparison of the 4-DMN/Alexa Fluor 594 fluorescence intensity ratios resulting
from sensor 5-3 and mutant sensor 5-14. For both experiments, cells were injected with a
solution of 50 [M 4-DMN sensor and 10 sM Alexa Fluor 594 sensor. a) The 4-DMN/Alexa
Fluor 594 intensity ratios are plotted for individual cells. Each value represents the average of
four ratios measured within each cell. b) The average fluorescence intensity ratios for sensors
5-3 and 5-14 are shown. The error bars indicate the standard error of the mean.
These results are particularly promising because the sensor constructed with the
merocyanine dye was unable to indicate differences in basal Cdc42 activation compared to the
corresponding mutant sensor. The merocyanine sensor demonstrated a 2-fold increase in
fluorescence only when the cells expressed a constitutively active Cdc42 mutant. 19 Future
studies will focus on application of the 4-DMN-based sensor for monitoring the activity of
Cdc42 during cell protrusions. The promising results obtained with the EM-CCD camera
indicate that this system may provide the optimal compromise between cell viability and signal
intensity. The increased dynamic range of the sensor compared to previously reported sensors of
activated Cdc42 suggests that it may provide even more detailed information about the role of
the protein in cellular processes.
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Conclusions
In summary, we have developed a powerful probe for detecting the activated form of
Cdc42 by incorporation of the 4-DMN solvatochromic fluorophore into the WASP binding
domain. Cysteine labeling of the WASP fragment or protein semisynthesis furnishes a sensor
that discriminates between the inactive and active conformations of Cdc42 through dramatic
increases in fluorescence. These remarkable properties can be exploited to monitor the
nucleotide exchange and GTPase activities of Cdc42 as well as the influence of regulatory
proteins. By offering a large dynamic range and high sensitivity, this 4-DMN-based sensor
promises to be valuable in the study of Cdc42 and represents another example of the versatility
of the 4-DMN fluorophore as a probe of important protein binding interactions. Current efforts
to apply FRET Capture to this sensor will further improve the fluorescence properties by
extending the emission to wavelengths that are more suitable for cellular studies. Finally,
promising studies with the sensor in a cellular environment indicate that the 4-DMN fluorophore
can be effectively applied to monitor cellular events.
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Methods
GB1-WASP Cloning, Expression, and Purification
The gene encoding GB 1-WASP(230-277)-His 6 was synthesized by Bio Basic Inc., and the codon
usage was optimized for expression in E. coli. The plasmid was treated in a double digestion
with NcoI and XhoI restriction enzymes according to the manufacturer's protocol, and the
GB1-WASP fragment was ligated into the pET14b vector (Novagen). The ligation product was
transformed into DH5a cells (Invitrogen) and grown on LB plates supplemented with
carbenicillin (50 [g/mL).
The sequence of the GB1-WASP(230-277)-His 6 protein is given below. The GB1 portion is
highlighted in magenta, the Phe271Cys mutation is shown in red, and the His6 tag is shown in
teal.
M KKKISKA
DIGAPSGFKHVSHVGWDPQNGFDVNNLDPDLRSLCSRAGISHHHHHH
The GB1-WASP-pET14b vector was transformed into BL-21 Gold(DE3) cells (Agilent
Technologies) for expression. The protein was expressed in a 1-L culture of LB containing
carbenicillin (50 [tg/mL) by incubation at 37 'C with shaking at 200 rpm. Once an OD of -0.6 at
600 nm was reached, the culture was cooled to 16 'C, and IPTG was added to 0.2 mM to induce
protein expression. The culture was incubated overnight at 16 *C with shaking. The next day,
the cells were harvested by centrifugation, and the cell pellets were stored at -80 *C until use.
The GB1-WASP protein was purified by Ni-NTA affinity chromatography. The pellet was
thawed in PBS buffer (25 mM NaH2PO4, 25 mM Na2HPO4, 300 mM NaCl, pH 7.9, 40 mIlL
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cells harvested) with 10 mM f-mercaptoethanol, 10 mM imidazole, 5 mM MgCl 2 , 1 pXL/mL
Protease Inhibitor Cocktail Set III (100 [tM AEBSF, 80 nM Aprotinin, 5 1 M Bestatin, 1.5 [M
E-64, 2 pM Leupeptin, 1 [M Pepstatin A), and 1 mg/mL lysozyme. The cells were incubated on
ice for 20 min and then sonicated on ice at 40% amplitude, 1 s on/1 s off for 45 s with a Sonics
Vibra Cell sonicator. Cell debris were pelleted at 100,000 x g for 45 min at 4 'C, and the lysate
was incubated with Ni-NTA resin (Qiagen, 3 mL) for 1 h at 4 *C. The resin was collected with a
brief centrifugation and then washed with Wash Buffer (100 mL, PBS containing 10 mM
imidazole, 10 mM f-mercaptoethanol, 5 mM MgCl 2 ). The imidazole concentration in the Wash
Buffer was increased to 30 mM, and the resin was washed with an additional 100 mL of this
buffer. The protein was eluted with PBS containing 250 mM imidazole and dialyzed into
Labeling Buffer (20 mM HEPES, 150 mM NaCl, pH 7.5). The protein concentration was
determined by measuring absorbance at 280 nm (& = 15,340 M- cm'1 (value was calculated
based on the protein sequence)). The molecular weight of the GB1-WASP-His 6 fragment is
12,206, and routine yields were 6 mg/L.
The mutant WASP sensor (H246D, H249D) was generated by site-directed mutagenesis using
QuikChange protocols. The primers encoding these mutations are given below:
Direct strand: 5'-CAAGCGGCTTCAAAGACGTTTCTGACGTTGGTTGGGAC-3'
Reverse complement: 5'-GTCCCAACCAACGTCAGAAACGTCTTTGAAGCCGCTTG-3'
Expression, purification, and labeling of the mutant protein proceeded as described for the
wildtype WASP sensor.
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Cysteine Labeling with 4-DMN Thiol Modifying Agents
Before labeling the GB 1-WASP sensor, which had been dialyzed into labeling buffer (20 mM
HEPES, 150 mM NaCl, pH 7.5), the protein solution (30 - 40 ptM) was incubated with 1 mM
tris(2-carboxyethyl)phosphine (TCEP) for about 3 h at room temperature to ensure that the
cysteine was in the reduced state. Immediately before the addition of the cysteine labeling
reagent, an additional 0.5 mM TCEP was added. The 4-DMN-labeling agent" was added to the
protein solution from a 100 mM stock solution in DMSO in a 20-fold molar excess over protein.
After briefly vortexing the solution, the reaction was rotated overnight at 4 'C. The next day, the
reaction was quenched by the addition of P-mercaptoethanol to 10 mM. The protein was purified
from excess labeling agent using a HiTrap Desalting column (GE Healthcare, 5 mL), eluting
with assay buffer (50 mM Tris, 50 mM NaCl, 5 mM MgCl2 , 1 mM DTT, pH 7.9). Fractions
containing protein were pooled and concentrated. The degree of labeling was estimated by
comparing the concentration of 4-DMN (440 nm, s = 8800 M-1 cm'1) in the protein solution to
the total concentration of protein, which was measured with a BioRad assay using unlabeled
GB 1-WASP as a standard.
Peptide Synthesis for Expressed Protein Ligation
Peptides were prepared by automated solid phase peptide synthesis (Applied Biosystems 431A
synthesizer) on a 0.04 mmol scale using a 0.2 mmol/g loading Fmoc NovaPEG Rink Amide LL
resin and employing standard Fmoc-protected amino acids (4 equivalents relative to resin
loading per coupling), HOBt and HBTU coupling reagents, and 4-methylpiperidine
deprotections. Double couplings and acyl capping were performed. The 4-DMNA amino acid
was synthesized as previously described.'0
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Following synthesis, the peptides were cleaved from the resin, and the side chain protecting
groups were removed in 10 mL of TFA/1,2-ethanedithiol/H 20 (94:2:2, v/v/v) for 3 h. The TFA
was evaporated, and the peptide was triturated with cold diethyl ether (10 mL, 3x).
Peptides were purified by reversed phase HPLC with a Waters 600 automated control module on
a YMC C18 semi-preparative column (YMC-Pack, ODS-A, 20 x 250 mm, 5 ptm, 12 nm) eluting
with methanol/water containing 0.1% (v/v) TFA. For detection, a Waters 2487 dual wavelength
absorbance detector was used to record at 228 nm and 280 nm. HPLC conditions were 5%
methanol in water with 0.1% TFA for 5 min followed by a linear gradient from 5% to 100%
methanol in water with 0.1% TFA over 35 min at 10 mL min-. Following lyophilization, correct
mass was validated by ESI-MS on a Mariner electrospray mass spectrometer (PerSeptive
Biosystems).
Peptide Characterization
NH 2-CL(4-DMN)SRAGISHHHHHH-CONH 2
Exact mass calculated for C85H 17N330 19S, 1935.89; [MH 3]3+ calculated, 646.3; [MH 3]3, found,
646.4. tR= 23.3 min.
The retention time was obtained from a reversed phase HPLC analytical run (YMC-Pack,
ODS-A, 4.6 x 250 mm, 5 [tm, 12 nm) using the following method: 5% acetonitrile in water with
0.1% TFA for 5 min, followed by a linear gradient of 5-95% acetonitrile in water with 0.1% TFA
over 40 min at 0.9 mL min'.
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Protein Thioester Synthesis for Expressed Protein Ligation
The gene encoding GB1-WASP(230-268) was cloned into the pTWIN2 vector (New England
Biolabs). The gene fragment was amplified by PCR as described in Chapter 2. The forward
primer encoded an NdeI restriction site, and the reverse primer encoded the SapI restriction site.
The sequences of the primers are given below:
Forward primer: 5'- GGTGGTCATATGGGTCAGTATAAACTGGC -3'
Reverse primer: 5'- GGTGGTTGCTCTTCCGCAGCGCAGATCCGGATCCAGGTTATTA -3'
The amplified fragment was digested with Ndel and SapI according to the manufacturer's
protocols and ligated into the pTWIN2 vector. The ligation product was transformed into DH5a
cells (Invitrogen) and grown on LB plates supplemented with carbenicillin (50 [tg/mL).
The GB1-WASP-pTWIN2 vector was transformed into BL-21 Gold(DE3) competent cells
(Agilent Technologies). The protein was expressed in a l-L culture of LB containing
carbenicillin (50 [tg/mL) by incubation at 37 'C with shaking at 200 rpm. Once an OD of -0.6 at
600 nm was reached, the culture was cooled to 16 'C, and IPTG was added to 0.2 mM to induce
protein expression. The culture was incubated overnight at 16 'C with shaking. The next day,
the cells were harvested by centrifugation, and the cell pellets were stored at -80 'C until use.
The protein was purified and converted to the corresponding thioester by thawing the pellet in
HBS (20 mM HEPES, 500 mM NaCl, 1 mM EDTA, pH 7.0, 40 mUL cells harvested) with
1 pUmL Protease Inhibitor Cocktail Set III (100 RM AEBSF, 80 nM Aprotinin, 5 FM Bestatin,
1.5 [M E-64, 2 [M Leupeptin, 1 [M Pepstatin A). The cells were lysed by sonication on ice at
40% amplitude, 1 s on/1 s off for 45 s with a Sonics Vibra Cell sonicator. Cell debris were
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pelleted at 100,000 x g for 45 min at 4 'C, and the lysate was filtered through a 0.22 [tm filter
and incubated for 2 h with chitin resin (New England Biolabs, 7 mL), which had been pre-
equilibrated in HBS. The resin was collected by a brief centrifugation and washed with HBS
(200 mL). The resin was rinsed with one column volume of cleavage buffer (20 mM HEPES,
500 mM NaCl, 1 mM EDTA, 100 mM sodium 2-mercaptoethanesulfonate, pH 8.5) and was then
incubated overnight in the buffer at room temperature. The following day, the cleaved protein
was collected, and the resin was further washed with the cleavage buffer to increase recovery of
the protein thioester. The concentration of this protein (molecular weight = 10,300) was
measured using a BioRad assay with BSA as a standard. The yield of the eluted protein was
2.5 mg/L.
Native Chemical Ligation
The protein thioester was concentrated to about 12 mg/mL in an Amicon Ultra centrifugal filter
device (MWCO 3,000). Native chemical ligation reactions were performed by combining the
synthetic peptide (1.2 mM) dissolved in DMSO (about 6% of the final reaction volume) with the
protein thioester (0.8 mM) in a buffer containing 150 mM sodium 2-mercaptoethanesulfonate
and 30 mM Tris, pH 8.0. The reactions were incubated for 18 h at room temperature. The
mixture was then diluted to 2 mg/mL and dialyzed against PBS (5 mM NaH2PO4, 5 mM
Na2HPO4, 150 mM NaCl, pH 7.5, 3 x 2 L) in a Slide-A-Lyzer dialysis cassette (3,500 MWCO,
Pierce) to remove the thiol additives. The native chemical ligation reaction proceeded to about
60% relative to unligated protein.
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Purification of Semisynthetic Sensor 5
To remove the unligated protein from the ligation reaction, the protein was purified by Ni-NTA
affinity chromatography. The crude ligation was incubated with 1 mL Ni-NTA resin in PBS
(25 mM NaH2PO4, 25 mM Na2HPO4, 300 mM NaCl, pH 7.9) containing 5 mM imidazole. After
1 h at 4 'C, the resin was collected and washed with 50 mL PBS containing 5 mM imidazole.
The protein was eluted with 12 mL of PBS containing 250 mM imidazole. The protein was then
purified from excess peptide by size exclusion chromatography (AKTAprime plus system) on a
HiLoad 16/60 Superdex 75 preparative grade column equilibrated in assay buffer (50 mM Tris,
50 mM NaCl, 5 mM MgCl 2 , 1 mM DTT, pH 7.9).
Cdc42 Cloning, Expression and Purification
A plasmid containing the gene for Cdc42 was provided by Prof. Martin Schwartz (University of
Virginia). The gene encoding Cdc42 was amplified by PCR according to protocols described in
Chapter 2. The forward primer encoded an NdeI restriction site, and the reverse primer encoded
a hexahistidine tag and an EcoRI restriction site. The sequences of the primers are given below:
Forward: 5'-CGAGGGAACTCCATATGCAGACAATTAAGTGTG-3'
Reverse: 5'-GTCGACGAATTCTTAGTGATGGTGGTGGTGGTGGAATATACAGCACTTC
CTTTTGGG-3'
The Cdc42 DNA fragment was digested with NdeI and EcoRL according to the manufacturer's
protocols and ligated into the pET24a(+) vector (Novagen). The ligation product was
transformed into DH5a cells (Invitrogen) and grown on LB plates supplemented with kanamycin
(30 [tg/mL).
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The Cdc42-pET24a(+) vector was transformed into BL-21 Gold(DE3) competent cells (Agilent
Technologies). The protein was expressed in a 1-L culture of LB containing kanamycin
(30 ptg/mL) by incubation at 37 'C with shaking at 200 rpm. Once an OD of -0.6 at 600 nm was
reached, the culture was cooled to 16 'C, and IPTG was added to 0.2 mM to induce protein
expression. The culture was incubated overnight at 16 'C with shaking. The next day, the cells
were harvested by centrifugation, and the cell pellets were stored at -80 'C until use.
Cdc42 Purification
The protein was purified following a modified protocol from Nalbant, et al.19 The pellet was
thawed in a modified TBS buffer (30 mM Tris, 250 mM NaCl, 5 mM MgCl 2, 10% (v/v)
glycerol, 2 mM p-mercaptoethanol, pH 7.5) with 10 mM imidazole, 1 mg/mL lysozyme, and
1 [tUmL Protease Inhibitor Cocktail Set III. The cells were lysed by sonication on ice at 40%
amplitude, 1 s on/i s off for 45 s with a Sonics Vibra Cell sonicator. Cell debris were pelleted at
100,000 x g for 45 min at 4 'C, and the lysate was incubated for 2 h with Ni-NTA resin (3 mL).
The resin was first washed with the modified TBS buffer (100 mL) and then with the TBS buffer
supplemented with 30 mM imidazole (100 mL). The protein was eluted with TBS buffer
containing 250 mM imidazole. The Cdc42 was then dialyzed into assay buffer (50 mM Tris,
50 mM NaCl, 5 mM MgCl 2, 1 mM DTT, pH 7.9). Protein concentration was measured by UV
absorbance (s = 16,118 M 1 cm 1 at 280 nm; the value was calculated based on the protein
sequence). The molecular weight of Cdc42-His 6 is 22,133, and routine yields were 35 mg/L.
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Site-directed mutagenesis of the Cdc42 gene was performed using QuikChange protocols to
incorporate the Gln6lLeu mutation to render the protein constitutively active. The primers
encoding these mutations are given below:
Direct strand: 5'-CTTTTTGATACTGCAGGGCTGGAGGATTATGACAGATTACG-3'
Reverse Complement: 5'-CGTAATCTGTCATAATCCTCCAGCCCTGCAGTATCAAAAAG-
3'
The mutant protein was expressed and purified under the same conditions used for the wildtype
protein.
Nucleotide Exchange
Cdc42 (about 100 [M) was exchanged with GDP or GTP-yS by incubation with 25 mM EDTA
and 2 mM GDP or 1 mM GTP-yS for 45 min at 30 'C. The reaction was then placed on ice, and
MgCl 2 was added to 35 mM.
Fluorescence Assays
Fluorescence assays were conducted with 700 nM Cdc42 and 150 nM 4-DMN-labeled WASP in
assay buffer (50 mM Tris, 50 mM NaCl, 5 mM MgCl 2 , 1 mM DTT, pH 7.9) unless otherwise
noted. For emission spectra, the excitation wavelength was 435 nm, and the spectra were
collected from 460-650 nm. For excitation spectra, the emission wavelength was 514 nm, and
the spectra were collected from 350-490 nm. The excitation and emission slit widths were both
10 nm. Data were collected with increments of 1 nm and an integration time of 0.1 s. All
spectra were corrected for background fluorescence by subtracting the spectrum of a blank
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sample containing only the assay buffer. Each scan was collected in triplicate, and experiments
were conducted at 25 'C, unless otherwise noted.
KD Measurement
To measure the dissociation constant between the 4-DMN-based sensor and Cdc42(GTP-yS),
fluorescence spectra were analyzed from titrations in which the concentration of the sensor was
maintained at 300 nM and Cdc42(GTP-yS) was added at increasing concentrations from below
the expected KD until fluorescence saturation was achieved (50 nM - 30 [M). The value of the
dissociation constant was determined using Sigma Plot or SPECFIT/32TM Global Analysis
System for Windows (version 3.0.39) with analysis of wavelengths from 455 to 650 nm. The
titration was performed in duplicate.
Kinetic Assays: Nucleotide Exchange
Assays to monitor Cdc42 nucleotide exchange were conducting at 30 'C in the presence of
sensor 5-3 (150 nM) by adding GTP-yS or GDP (final concentration of 200 [tM) to Cdc42
(700 nM) which had been pre-equilibrated with GDP. The excitation wavelength was 435 nm,
and emission was monitored at 514 nm with excitation and emission slits of 10 nm.
Measurements were taken every 5 s for 40 min.
Kinetic Assays: GTPase Activity
Measurements of Cdc42 GTPase activity were performed by exchanging GTP or GTP-yS into
Cdc42. A solution of Cdc42 (100 pIM) was incubated with 25 mM EDTA and 1 mM GTP or
GTP-yS. Following a 45 min incubation at 30 'C, the reaction was placed on ice, and MgCl 2
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was added to 35 mM. To remove excess nucleotide, the solution was diluted 100-fold and then
concentrated in a Millipore 0.5 mL 5,000 MWCO centrifugal filter unit at 4 'C. This process
was repeated 3 times to incrementally eliminate excess nucleotide. The solution was maintained
on ice until the assay to prevent GTP hydrolysis before measurements were taken. The assay
buffer and 150 nM WASP were pre-warmed to 30 'C in the fluorescence cuvette. Cdc42 was
then added to 700 nM, and fluorescence measurements were taken immediately thereafter. The
excitation wavelength was 435 nm, and emission was monitored at 514 nm with excitation and
emission slits of 10 nm. Measurements were taken every 5 s for 20 min.
Labeling the WASP Fragment with Alexa Fluor 594 Maleimide
The GB1-WASP(230-277)-His 6 fragment was labeled at Phe271Cys with Alexa Fluor 594 C5
maleimide (Invitrogen, PN: A10256). The fluorophore stock solution was prepared in DMSO at
a final concentration of 12.5 mM. The protein (30 - 40 [tM) was labeled under the same
conditions as for sensor 5-3, except that only 10 fluorophore equivalents were used. Following
purification by desalting, the protein was further purified from excess fluorophore by repeated
concentration and dilution with a 5,000 MWCO centrifugal filter unit at 4 'C. Fluorophore
concentration was measured by absorbance with s = 73,000 M-1 cm-1 at 590 nm.
Cellular Experiments
Mouse embryonic fibroblast cells (MEFs) were cultured at 37 'C with 5% CO2 in Dulbecco's
Modified Eagle Media (DMEM) supplemented with 10% (v/v) FBS, 50 U/mL penicillin, and
50 [tg/mL streptomycin. No. 1.5 coverslips (25 mm) were prepared by incubation in PBS
containing fibronectin (5 tg/mL) overnight at 4 'C or for 1 h at 37 'C. For experiments
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involving stimulation with PDGF, cells were plated on the fibronectin-coated glass coverslips
overnight in starvation media (DMEM supplemented with 50 U/mL penicillin and 50 [tg/mL
streptomycin). PDGF in PBS was added to 10 ng/mL for stimulation. For experiments to image
cell protrusions, cells were plated on the fibronectin-coated glass coverslips in the standard
culture media 3 h before microinjection. For both sets of experiments, the culture media was
exchanged for imaging media (M199 supplemented with 25 mM HEPES, pH 7.2) 1 h before
microinjection. FBS (2%, v/v) was included in the imaging media if cells were not serum-
starved.
Glass micropipettes were generated from borosilicate glass capillaries with filament (O.D.
1.0 mm, I.D. 0.50 mm) using a Sutter P-1000 micropipette puller. Microinjection was performed
with a Sutter XenoWorks digital microinjection system on a Nikon TE300 inverted microscope.
Following microinjection, the media was exchanged, and the cells were incubated at 37 'C with
5% CO 2 for at least 30 min. For imaging, the cells were mounted in a 20/20 Technologies stage
incubation chamber at 37 'C. Images were collected on a Nikon Ti motorized inverted
microscope equipped with a 40X objective lens and Perfect Focus System to maintain constant
focus. The 4-DMN signal was obtained with the Wheel FRET filter set (excitation: 436/10 nm,
emission 535/30 nm), and the Alexa Fluor 594 fluorescence was obtained with the TRITC filter
set (excitation 545/30 nm, emission 620/60 nm). DIC images were also taken. Images were
acquired with a Hamamatsu ORCA-R2 cooled CCD camera controlled with MetaMorph7
software. For time-lapsed sequences, images were taken every 10 s for 15 min. Imaging was
also performed on an Applied Precision DeltaVision OMX system equipped with an on-stage
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heater. Solid state illumination lasers were used for excitation. 4-DMN was excited with the
CFP line (426-450 nm), and Alexa Fluor 594 was excited with the mCherry line (563-588 nm).
The comparison of sensors 5-3 and 5-14 was conducted on a Nikon Ti-E motorized inverted
microscope with Perfect Focus System. The cells were mounted in an incubation enclosure at
37 'C with 5% CO 2. The 4-DMN signal was obtained with excitation at 430/25 nm and
emission at 535/30 nm. The Alexa Fluor 594 signal was obtained with excitation filters of
572/35 nm and emission filters of 636/60 nm. Images were acquired with a Hamamatsu
ImagEM C-9100-13 EM-CCD camera controlled with MetaMorph7 software. For these
experiments, the stock microinjection solution was composed of 50 sM of the 4-DMN-labeled
sensor and 10 IM of the corresponding Alexa Fluor 594-labeled sensor.
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Appendix: Optimization of Paxillin
Expression
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Introduction
Paxillin is a 61-kDa, multi-domain scaffold protein that functions as an essential
component of focal adhesions, which are the structures that connect the cell to the extracellular
matrix and facilitate signaling between the cell and the environment.' The N-terminal portion of
paxillin contains several binding sites for signaling proteins, while the C-terminal region
includes a series of Zn-binding LIM domains that localize the protein to focal adhesions and
anchor the protein to the plasma membrane. Paxillin assembles and activates structural and
signaling proteins at adhesions to regulate gene expression and coordinate events in cell
migration.2 For instance, paxillin recruits regulators of the Rho GTPases to down regulate RhoA
and to stimulate Racl and promote lamellopodia formation. Additionally, this scaffold is
involved in coordinating adhesion assembly and disassembly throughout migration.3
Paxillin contains multiple sites of phosphorylation that modulate protein recruitment and
create discrete sites for protein binding. For instance, phosphorylation of Tyr31 and Tyrl 18 by
Src and focal adhesion kinase (FAK) generates binding sites for proteins containing Src
homology 2 (SH2) domains, which are adaptor modules that bind a phospho-Tyr-containing
consensus sequence (Figure Al). Paxillin is also phosphorylated on several serine and threonine
2
residues during adhesion and following growth factor stimulation. The multitude of
phosphorylation sites and extensive network of proteins that regulate the modification make the
protein a complex target to study; as a result, relatively little information is known about the
effects of discrete paxillin phosphorylation on focal adhesion formation and cell migration.
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H2N - LIM1 LIM2 LIM3 LIM4 COOH
FAK PTP-PEST
= "LD" motifs (LDXLLXXL) GITI
Figure A-1. Representation of the domains of paxillin. Src, ERK, and JNK phosphorylate
paxillin at the indicated sites, and FAK and GITI are known binding partners.
To probe the role of paxillin, and particularly the influence of pTyr31 in migration,
Dr. Elizabeth Vogel-Taylor, a former graduate student in the Imperiali lab, developed a
semisynthetic approach to incorporate 1-(2-nitrophenyl)ethyl (NPE)-caged pTyr31 into the full-
length protein.4 The caging group masks the effects of phosphorylation until irradiation liberates
pTyr31 paxillin, which then exerts native effects within the system. This approach facilitates
study of the specific effect of Tyr31 phosphorylation and allows the remaining portion of the
protein to direct proper localization and maintain appropriate binding interactions with other
partners.
For the semisynthesis of the caged paxillin, the N-terminal portion of the protein
(residues 2-36) was prepared by solid phase peptide synthesis as a C-terminal thioester, and the
NPE-caged amino acid building block5 was incorporated at position 31 (Figure A-2). The
C-terminal portion of the protein (residues 38-557) was expressed as a fusion to glutathione-S-
transferase (GST) and included a tobacco etch virus (TEV) protease cleavage site N-terminal to
an Asn37Cys mutation. TEV cleavage removed the GST and revealed the N-terminal cysteine,
which reacted with the caged peptide thioester through the native chemical ligation reaction to
yield the full-length paxillin protein.
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FLAG fI H2Njt
via heterologous expression
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Figure A-2. Semisynthesis of caged paxillin by protein semisynthesis. The C-terminal portion
of the protein is expressed as a fusion to GST. TEV cleavage releases GST and reveals the N-
terminal cysteine required for native chemical ligation. Reaction of the protein fragment with a
peptide containing the caged phosphorylated residue generates the full-length protein.
Full-length paxillin was then characterized through in vitro assays to ensure that the
semisynthetic approach yielded a protein with native properties.4  Semisynthetic paxillin was
shown to bind known protein partners, including FAK, G-protein coupled receptor kinase
interacting protein 1 (GITl), and the protein tyrosine phosphatase PTP-PEST. It also functioned
as a substrate for known paxillin kinases, including Src, ERK, and JNK (Figure A-1). Following
validation that the semisynthetic protein retained native interactions, initial studies of the effects
of Tyr31 paxillin phosphorylation on focal adhesion dynamics were performed.6 These studies
involved microinjection of the cpTyr31 paxillin into paxillin-null mouse embryonic fibroblast
cells that had been transfected with GFP-vinculin. GFP-vinculin was used as a marker of focal
adhesions and enabled the kinetics of adhesion assembly to be quantified. Global irradiation of
cells microinjected with the caged protein induced new protrusions and focal adhesions, which
assembled with a half-life of 3 - 5 min.
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The promising uncaging results indicate the potential of semisynthetic paxillin to unravel
the impact of one defined site of phosphorylation within the entire protein. However, additional
studies are needed to confirm the initial results and to obtain statistically significant data
regarding the half-life of focal adhesion formation. Additionally, experiments to examine the
effects of localized paxillin uncaging are planned. Unfortunately, the stocks of the semisynthetic
protein prepared by Dr. Vogel-Taylor had degraded before these additional studies could be
performed by collaborators. This prompted us to re-examine challenges associated with the
semisynthesis. While the native chemical ligation of paxillin furnished sufficient quantities of
protein for cellular studies, large-scale fermentation was required due to poor heterologous
expression levels of the GST-paxillin construct in Escherichia coli. Thus, before the
semisynthesis was repeated, avenues to enhance the paxillin expression levels were explored.
Poor heterologous expression of paxillin in E. coli was due in part to the presence of
many rare codons within the gene. Specifically, each amino acid except tryptophan is encoded
by at least two different codons. The frequency with which different organisms use each
degenerate codon varies,7 and this codon bias is reflected in the tRNA population within the
organism. In any given organism, tRNA molecules that are specific for the more frequently used
codons are produced in greater abundance than those for rare codons. Thus, heterologous
expression of mammalian proteins can be problematic if the recombinant gene contains many
codons that are rare in the expression host. During expression of these proteins, the tRNAs for
the rare codons are depleted, and translation becomes slow or prematurely terminates.
With respect to E. coli, paxillin contains 61 rare codons, which total 11% of the DNA,
and 28 of these rare codons encode proline residues that are clustered in a proline-rich region
(Figure A-3). This non-optimized codon usage contributes to low yields of the full-length
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protein and leads to production of significant amounts of the truncated protein. For these studies,
Dr. Vogel-Taylor performed protein expression in E. coli cell lines that had been engineered for
enhanced expression of rare codons, such as BL-21 CodonPlus RP competent cells. The crude
yield of the paxillin fragment after purification by glutathione sepharose was 4.5 mg/L (Figure
A-4). However, the material obtained from this purification was dominated by truncation
products rather than the desired GST-Pax(38 - 557)-FLAG protein. A second purification by
FLAG-affinity chromatography was necessary to eliminate the truncated protein and furnished
the desired paxillin fragment in a 0.5 mg/L yield. Thus, in order to obtain adequate quantities of
protein for the semisynthesis (-5 mg), GST-paxillin was routinely purified from 10-L
fermentations.
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Figure A-4. Purification of GST-Paxillin(38 - 557)-FLAG. The protein and GST-tagged
paxillin truncation products were isolated from the crude cell lysate using glutathione sepharose.
A second purification with anti-FLAG agarose removed the truncation products and yielded the
full-length GST-paxillin-FLAG protein in a 0.5 mg/L yield.
Results and Discussion
In an effort to improve paxillin expression, the paxillin gene was optimized for codon
usage in E. coli and synthesized by GenScript. This technology was cost-prohibitive when the
paxillin project was first initiated, but recent advances have made this service more widely
accessible.8 The rare codons in the gene were replaced with those that are more common in E.
coli, while also maintaining codon variety.9 The gene encoding residues 38-557 was then
subcloned into the pGEX-4T-2 vector to incorporate the N-terminal GST tag. Following
expression in BL21-Gold cells, the protein was isolated via the N-terminal GST domain using
glutathione sepharose. This purification furnished the protein in a 2.8 mg/L yield (Figure A-5).
While the yield from this purification was slightly lower than the yield of the native gene,
expression of the optimized gene afforded the GST-paxillin-FLAG construct as the dominant
component and resulted in significantly fewer truncation products. Purification of this protein
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using anti-FLAG affinity chromatography is still necessary; however, this result represents a
significant improvement over previous methods because the desired construct is obtained in good
yield without the need for large-scale growths. Additional optimization of expression conditions
and cell lines may further increase the yield of the protein.
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Figure A-5. Expression of GST-paxillin. a) 10% SDS-PAGE gel of the paxillin purification
with glutathione sepharose. b) Western blot probed with an anti-FLAG epitope antibody.
Conclusions
Paxillin expression was greatly improved by employing the synthesized gene with
optimized codon usage. Expression of this gene yielded the desired construct as the primary
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product and significantly reduced the presence of truncated proteins. Only 1- or 2-L cultures,
rather than the previously required 10-L fermentation growths, are currently necessary to obtain
sufficient amounts of the pure protein. This development increases the efficiency and
convenience of the semisynthesis. The semisynthetic paxillin can then be exploited in cellular
studies to further examine dynamics at focal adhesions.
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Methods
Paxillin Cloning
The paxillin gene (residues 1 - 557) with a C-terminal FLAG tag was synthesized by Genscript
with codon optimization for E. coli. The region corresponding to residues 38 - 557, including
the C-terminal FLAG tag, was amplified by PCR as described in Chapter 2. The forward primer
for PCR encoded a 5' EcoRI restriction site, followed by the TEV protease cleavage sequence
(ENLYFQ) and the Asn37Cys mutation, and the reverse primer was used to encode a 3' XhoI
restriction site. The sequences of the primers used for PCR are given below:
Forward primer: 5'-GCGGGAATTCGCGAGAACCTGTATTTCCAGTGCCACACCTATCAG
GAAATC-3'
Reverse primer: 5'-GCCCGCCTCGAGTTATTTATCATCATCATC-3'
The PCR amplicons were digested with EcoRI and XhoI according to manufacturer's protocols
and ligated into the pGEX-4T-2 vector, which had been digested with EcoRI and XhoI and
treated with CIP. The ligated plasmid was transformed into DH5a cells (Invitrogen) and grown
on Luria-Bertani (LB) plates containing carbenicillin (50 pg/mL).
The plasmid was sequenced in three sections to ensure full coverage of the paxillin gene. The
pGEX-4T-2 forward primer (GE Healthcare) was used for the beginning of the gene, and
sequencing primers for the middle and end of the paxillin gene were synthesized:
Nucleotide 552: 5'-TGTTCCGGAAACGAACTCTC-3'
Nucleotide 1145: 5'-CTCCGCGTTGCTATTACTGT-3'
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GST-Paxillin Expression
The pGEX-paxillin plasmid was transformed into BL-21 Gold cells (Agilent Technologies), and
the bacteria were grown on LB plates containing carbenicillin (50 pg/mL). A single colony was
selected and grown in LB media (5 mL) supplemented with carbenicillin (50 [tg/mL), which was
used to inoculate 1 L of LB containing carbenicillin (50 pg/mL). The culture was incubated in a
shaker at 225 rpm and 37' C until an OD of -0.6 at 600 nm was reached. The culture was
cooled to 160 C, and isopropyl-l-thio-3-D-galactopyranoside (IPTG) was added to 0.2 mM to
induce protein expression. The culture was incubated overnight at 16' C with shaking. The cells
were harvested by centrifugation, and the cell pellets were stored at -80' C until use.
GST Purification of GST-mRLC
The cell pellet was thawed on ice and brought up in 40 mL of PBS (5 mM NaH2PO4, 5 mM
Na2HPO4 , 150 mM NaCl, pH 7.7) containing 1 mg/mL lysozyme, 1 mM DTT, and 1 ptL/mL
protease inhibitor cocktail III (Calbiochem: 100 [M AEBSF, 80 nM Aprotinin, 5 [M Bestatin,
1.5 [M E-64, 2 iM Leupeptin, 1 [M Pepstatin A) for each liter of cells harvested. The cells
were incubated on ice for 20 min, and NP40 alternative (400 tL) was added. The cells were
sonicated on ice at 40% amplitude, 1 s on/1 s off for 1 min. Cell debris were pelleted at 90,000 x
g for 50 min at 40 C, and the lysate was filtered through a 0.2 [tm filter. Glutathione Sepharose 4
Fast Flow (Amersham Biosciences, 3 mL) was incubated with the cell lysate for 1 h at 4 *C. The
resin was isolated with a brief centrifugation and washed with 150 mL PBS at 4 'C. The protein
was eluted in four 3-mL fractions with elution buffer (50 mM Tris, 10 mM reduced glutathione,
2 IUmL protease inhibitor cocktail III, pH 8.0). Protein concentration was determined through
a BioRad assay with BSA as a standard.
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